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ABSTRACT 
Periodontitis in humans is associated with adverse pregnancy outcomes (APOs).  
However, periodontitis treatment trials (scaling and root planing) have not been 
successful at reducing the risk of APOs.  Oral colonization with the periodontal 
pathogen Porphyromonas gingivalis leads to low fetal weight in C57BL/6J mice.  
We speculated that spread of P. gingivalis to the placenta of the C57BL/6J 
mouse would alter the placental microbiome, inducing local inflammation.  We 
hypothesized that the frequency of P. gingivalis-specific CD4+ T cells producing 
IFN-γ in the uterine-draining (para-aortic) and oral draining (cervical) lymph 
nodes (PaLN-CLN) would correlate with low fetal weight in C57BL/6J mice.  We 
discovered that frequency of P. gingivalis-specific CD4+ T cells producing IL-17A, 
IFN-γ, or IL-4 in PaLN-CLN of C57BL/6J (Jackson Labs) or C57BL/6UofM (In-
House Bred) mice was not correlated with reduced fetal weight.  Decreasing fetal 
weight was correlated with increasing amounts of P. gingivalis DNA in the 
placentas of C57BL/6J and C57BL/6UofM dams.  BALB/cJ (Jackson), 
C57BL/6NCrl, and BALB/cAnNCrl (Charles River) mice harbored P. gingivalis 
DNA in their placentas but did not experience low fetal weight in response to oral 
colonization with P. gingivalis.  Therefore, these results suggest that both 
microbiome and genetics are important in determining fetal weight outcomes in 
response to oral colonization with P. gingivalis.     
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APOs: adverse pregnancy outcomes 
CAL: clinical attachment level  
CLN: cervical lymph node 
E17: embryonic day 17 
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Preamble 
Women with periodontitis during pregnancy are predicted to be at higher 
risk of adverse pregnancy outcomes (APOs) based on data obtained from 
observational studies.  Investigators have attempted to reduce the risk of APOs 
with standard non-surgical periodontal treatment [Scaling and Root Planing 
(SRP)] delivered in the second trimester of pregnancy.  One such treatment 
study was the Obstetrics and Periodontal Therapy Trial (OPT), funded by the 
National Institute of Dental and Craniofacial Research (NIDCR).  OPT included 
the Hennepin County Medical Center in Minneapolis in collaboration with 
University of Minnesota periodontists and clinical researchers.  Unfortunately, 
while the SRP treatment significantly improved periodontal health, it failed to 
reduce the risk of APOs.  These findings were corroborated by a second NIDCR 
funded study, Maternal Oral Therapy to Reduce Obstetric Risk Study (MOTOR) 
and by meta-analysis of multiple large, well-controlled clinical trials testing 
identical treatment and a variety of similar APOs.  
Some critics maintain that the failure of treatment trials to reduce the risk 
of APOs indicate that there is no association between periodontal disease and 
APOs.  This criticism applies a faulty logic because it assumes a priori that 
microorganisms residing only in the periodontal pocket are the sole contributors 
to APOs.  The thesis presented here provides evidence that SRP trials failed to 
reduce risk of APOs because they did not prevent or treat the spread of 
periodontal pathogens to the placental tissue.  Once in the placental tissue, 
2 
 
 
periodontal pathogens could either mediate direct placental tissue damage or 
elicit an inflammatory immune response that impairs the fetoplacental unit, 
eventually leading to APOs.  Additionally, this thesis produces data suggesting 
that development of APOs in response to oral pathogens is modulated by both 
maternal microbiome and genetics.   
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Relevant Background 
Periodontal Disease and Periodontitis 
The broad term “periodontal disease” includes both gingivitis and 
periodontitis.  Gingivitis always precedes periodontitis but not all gingivitis cases 
progress to periodontitis.  Periodontitis is a complex chronic disease, induced by 
oral microorganisms eliciting a chronic inflammatory response in the susceptible 
host.  Periodontitis eventually results in inflammation-mediated destruction of 
alveolar bone around the root of the tooth and loss of connective tissue 
attachment to the root surface.  Ultimately periodontitis leads to tooth loss (1, 2).  
To conclude that APOs are associated with severe periodontitis, it is critical to 
measure periodontitis accurately in clinical trials and observational studies. 
 
Measuring Periodontitis 
Periodontitis is defined as a permanent loss of clinical attachment level 
(CAL).  CAL is commonly associated with deep periodontal pockets.  The 
standard definitions of periodontal disease severity are based on the frequency 
of periodontal sites fitting within a predefined CAL category measured in 
millimeters:  slight/mild periodontitis (CAL 1-2 mm); moderate periodontitis (CAL 
3-4 mm); severe periodontitis (CAL ≥5 mm) (3-7).  The extent of periodontitis is 
considered localized when the aforementioned, predefined amount of CAL is 
present in less than 30% of sites versus generalized if greater than 30% of sites 
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measured are affected (3-6).  The most thorough examination measures six sites 
per tooth, in all teeth or a in selected subset of teeth in the mouth.  Measuring 
fewer sites or fewer teeth in a clinical trial may save time but also may skew the 
estimate of periodontitis extent and severity.  
Probing depth (PD) is another measure of periodontal disease.  The 
difference between CAL and PD can be difficult to define to the non-dentist.  The 
two measures have several similarities.  Both are related to the loss of 
attachment of fibers that normally connect the cementum covering the dentin of 
the tooth root, to the adjacent gingiva and surrounding bone (7).  CAL and PD 
are measured in millimeters by inserting a calibrated probe into the “pocket” 
between the tooth and gingiva until it reaches the bottom of the gingival sulcus, 
where the probe tip is stopped by the connective tissues attaching to the 
cementum of the root (attachment point) (1, 7, 8).   
CAL is measured from the bottom of the pocket to the cemento-enamel 
junction, which is the anatomically defined fixed reference point on the tooth (9).  
In contrast PD is measured from the bottom of the pocket to the top of the 
gingiva, and thus is dependent on the state of inflammation or recession of the 
gingiva at the time the measurement is taken (9).  Clinical studies have 
suggested that measuring PD without measuring CAL may lead clinicians to 
overlook sites with persistent, progressive loss of CAL over time without changes 
on the depth of the gingival pocket (9).   
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Accuracy of CAL or PD measurement depends on the skill of the 
examiner, the shape and size of the probe tip, the pressure with which the tip is 
applied and whether a standard or constant pressure probe is used, the angle 
that the probe is inserted, the presence of subgingival deposits on the root 
surface, and the extent of inflammation (10-12).   
A third, less invasive method of measuring periodontitis severity is to use 
radiographs to evaluate the loss of bone support around the tooth.  Radiographs’ 
reproducibility varies depending on the incident angle, the operator and specific 
instrumentation used.  When all the pros and cons are considered, CAL is 
generally the preferred method of clinicians to diagnose periodontitis.   
Generally, due to the amount of technical measurement-error associated 
with the variables listed above, it is not possible to detect disease progression via 
changes in CAL until a significant loss of attachment (2mm or greater) has 
occurred (1, 8).  The sensitivity of measuring disease progression is low.  Also, 
the time of detection of disease progression (2 mm CAL change) is temporally 
removed from the actual bone-destructive event (13).  Loss of CAL represents a 
cumulative historical measure of periodontal disease and is not a measure of 
current, active disease state (14, 15).  Connective tissue attachment loss can be 
caused by non-bacterial inflammatory sources such as trauma and therefore 
attachment loss by itself does not constitute evidence of a microbial insult (7, 16).  
Given those caveats, PD measure may be more representative of the current 
active inflammatory or microbial burden than CAL measure if CAL loss is present 
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concurrently.  It is important to note that CAL can change without a change in PD 
and vice versa (9).   
Lastly, bleeding on probing (BOP) is a measure of gingival inflammation 
that is often used in conjunction with CAL or PD (14).  Normal, uninflamed 
gingiva should not bleed upon gentle, non-invasive probing.  The absence of 
BOP indicates that a site with increased PD and CAL is unlikely to progress to a 
more advanced disease state, with an excellent negative predictive value of 98% 
(8).  
In summary, measuring periodontitis has many complexities that can lead 
to erroneous assessment of the extent and severity of disease during clinical 
studies.  This can confound measures of association between the periodontal 
clinical status and a clearly measurable outcome such as preterm and/or low 
birth weight.   
 
Known Risk Factors for Periodontitis 
Prevalence of Periodontitis 
Within individuals aged 30-79 in the United States alone, the prevalence 
of adult chronic periodontitis ranged from 37.7 to 52.8% by state, with a mean of 
45.1%.  This data was calculated from the National Health and Nutrition 
Education Study (NHANES) 2009–2014 full-mouth, six-site-per-tooth gold-
standard periodontal surveillance protocol within adults who had ≥ 2 
interproximal sites with CAL ≥ 3 mm and ≥ 2 interproximal sites with PD ≥ 4 mm 
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or one site with PD ≥ 5 mm and no health conditions requiring antibiotic 
prophylaxis before periodontal probing.  Prevalence of severe periodontitis, 
defined by CAL ≥5 mm in more than 30% of the sites that are measured, ranged 
from 7.27 to 10.26% by state (mean 8.9%) (17).   
 
Microbiology 
The importance of the both host immunity and the oral microbiome in 
initiation and progression of periodontitis can be shown through experiments 
utilizing germ-free mice.  Germ-free mice, which lack a microbiome and 
consequently have an under-developed immune system, do not experience 
destruction of the alveolar bone as a consequence of aging (18, 19).  
Conventional specific-pathogen-free rodents, with a diverse oral microbiota, do 
lose alveolar bone as they age.  Co-caging germ free animals with specific-
pathogen-free mice leads to alveolar bone loss in the formerly germ-free mice 
(18, 19).   
The tooth, coated in a film of salivary and serum proteins, provides an 
ideal attachment surface for long-term biofilm formation (1).  When a symbiotic 
microbiome is present, a healthy state of homeostasis between bacteria and host 
immunity is maintained.  When the relative proportions and diversity of microbes 
found in the healthy state is perturbed, the composition of the microbial 
community changes to a state of dysbiosis, where certain species thrive more 
than others (20).  The dysbiosis hypothesis can be applied to periodontitis.  In 
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this context, it could be proposed that certain strict periodontal anaerobes, found 
at low abundance in the normal, healthy oral microbiome, overgrow and displace 
the normal microbial species (18, 21-23).  The dysbiotic microbiome then triggers 
a damaging host inflammatory response, and can also produce bacterial by-
products that are directly pathogenic (24).  Dysbiotic microbiomes are 
hypothesized to alter normal homeostatic host-microbiome communication in 
susceptible individuals (25).   
Identifying the key species involved in oral health as compared to 
periodontitis poses several unique challenges, some arising from the fact that the 
mouth is an open system (25).  The composition of microorganisms in the oral 
cavity can vary greatly between individuals (1).  The relative importance of 
individual factors such as diet and host genetics in determining the composition 
of the oral microbiome is still debated (1, 25, 26).  The community of bacteria that 
thrives above the gum line (supragingival) is different from the community that 
grows below the gum line on the root (subgingival).  Nor do structures in the 
mouth such as the tongue and hard palate have identical microbiomes (25, 27).  
In the oral cavity, small variations in sampling site can make a big difference in 
species identified (1).  Even though the individual species may vary highly, the 
metabolic activity of communities found in oral health are relatively stable and 
different from those found in periodontitis (28). 
P. gingivalis, Tannerella forsythia and Treponema denticola are classically 
associated with deep periodontal pockets (23, 29, 30).  Fusobacterium 
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nucleatum is another bacterium associated with deepening of periodontal 
pockets and disease progression.  P. gingivalis, T. denticola, and F. nucleatum 
can induce lymphocyte suppression (13, 31).  All these species can also be 
found, albeit at lower numbers, in periodontally healthy individuals (29, 32, 33).  
They thus behave more like commensals or opportunistic pathogens rather than 
true pathogens because they possess opportunistic traits when overgrowing 
within the community.  The shifting microbial community as a whole therefore 
may be considered the etiological agent of periodontitis instead of a single 
species (34).   
Most periodontal microorganisms associated with disease or disease 
progression were originally identified by culture techniques.  Newer molecular 
studies employing techniques such as 16s rRNA sequencing, high-throughput 
next generation sequencing, and bioinformatics have confirmed and expanded 
the understanding of the periodontal and oral microbiome (24, 25, 35).  Culture-
independent molecular techniques have identified many previously unrecognized 
periodontitis-associated organisms.  These include the phylum Synergistetes and 
genera Spirochetes, Filifactor and Dialister (24, 34, 36).  Newly identified 
periodontitis-associated species and genera also include but are not limited to 
Anaeroglobus geminatus, Eubacterium saphenum, Filifactor alocis, 
Porphyromonas endontalis, Candidatus, Saccharibacteria, Prevotella denticola 
(24, 37-39). 
10 
 
 
Of course, bacteria are not the only microorganisms that reside in the oral 
cavity.  For example, members of the Archaea domain, fungi, protozoans, and 
viruses also live within the oral microbiome (1, 25).  Herpes viruses and Epstein-
Barr virus in particular may be involved in the proliferation of B cells in 
periodontitis lesions (13).  
Despite the extreme inter-patient diversity of species within the periodontal 
pocket, the overall metabolic capability of the community appears to be the 
critical factor in sustaining the microbial community in health versus disease.  
Human oral microbial communities undergo conserved changes in metabolism 
during disease. (28).  The metabolic capability or profile of diseased microbiomes 
across individuals strongly resemble one another, even though the individual 
species present can vary greatly.  The metabolic profile thus demonstrates 
conserved community gene expression.  Overall enzyme expression was also 
conserved across disease-associated communities despite variance in species 
present.  This suggests that many different organisms are capable of filling the 
same conserved metabolic niches (28). 
However, the microbiota of the oral biofilm (dental and periodontal plaque 
biofilm) is not sufficient to induce measurable periodontal disease pathology by 
itself (1, 40, 41).  The microbiota of the oral biofilm drives a chronic host 
inflammatory process that results in the characteristic loss of clinical attachment, 
destruction of bone support, and subsequent tooth loss (1).  Thus, host factors, 
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notably those impacting the host immune system, also play a role in development 
and progression of periodontitis.   
 
Host Factors 
Immune dysregulation associated with a dysbiotic microbiome in 
periodontitis can manifest as an exaggerated inflammatory response against the 
microbial community of the periodontal pocket.   This response is characterized 
by an inappropriate type of immune response (cellular vs. humoral) to clear a 
particular pathogen, inefficient clearance of specific microorganisms, failure to 
resolve inflammation, or a combination of all of the above (40).  As a 
consequence of these conditions chronic gingival inflammation in susceptible 
individuals leads to the clinical manifestations of periodontitis.   
The risk of developing periodontitis is not the same for all individuals (42-
44).  Hispanic, non-Hispanic black, or non-Hispanic Asian American ethnicity, 
age greater than 65, male sex, and uncontrolled diabetes mellitus increase the 
risk of developing adult chronic periodontitis (17, 45-49).  Smoking and low 
socioeconomic status (defined by poverty or education) are conditions that can 
increase risk of developing adult chronic periodontitis.   
While the risk of developing periodontitis in humans derives in part from 
habits and the microbial environment, periodontitis has a significant genetic 
component (43, 44).  Monozygotic twins are more similar for all clinical measures 
of adult periodontitis than dizygotic twins.  Based on twin studies, adult 
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periodontitis is estimated to have an approximately 50% heritability after 
adjusting for behavioral variables such as smoking (50).  Probing depth, 
attachment loss, and plaque all showed a significant genetic component in twin 
studies (51).  While adult periodontitis is estimated to have a significant 
heritability component, no evidence has been detected for heritability of gingivitis 
(50). 
A few single gene disorders affecting immune cell function are known to 
be associated with severe, and often early-onset, periodontitis.  For example, 
aggressive periodontitis has been associated with a number of syndromes 
involving decreased neutrophil number or function (44).  Papillon-Lefèvre or 
leukocyte adhesion deficiency syndromes (LAD) are just a couple of examples 
(44, 52, 53).   
The majority of cases of periodontitis are not tied to single gene or 
Mendelian disorders.  Despite strong and clear evidence of heritability, genome-
wide association studies have only found weak associations between genes 
controlling immune function and periodontitis (40).  This implies that periodontitis 
is usually a manifestation of complex, multi-gene interactions, with each gene 
contributing a small amount of overall risk of developing periodontitis (54).  
Periodontitis is thus both polymicrobial and polygenetic (2).   
 Suggested polymorphisms associated with periodontitis include upstream, 
downstream, and within gene single nucleotide polymorphisms (SNPs) of the 
interleukin 1(IL-1) family, COX2, interleukin 10 (IL-10), DEFB1, and the S100A8 
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subunit of calprotectin (2, 55-59).  The IL-1 family, COX2, and IL-10 have known 
roles in the inflammatory response.  DEFB1 encodes an antimicrobial peptide, 
and calprotectin is antimicrobial through sequestration of essential ions.  While 
these polymorphisms in genes or gene regulatory sequences significantly 
correlate immune function genes with periodontitis, the clinical relevance of these 
correlations remains poorly understood.   
The key role of the immune response in the pathogenesis of periodontitis 
is demonstrated in animal models where immunocompetent mice lose more 
alveolar bone in response to colonization with a periodontal pathogen 
(Porphyromonas gingivalis) than immunodeficient mice (60).  What is less clear 
is which components of the immune response contribute to the etiology of 
periodontitis.  In addition to neutrophils as discussed above, autoimmune B cells, 
natural killer T cells, activated natural killer cells, and CD4+ T cells have all been 
proposed as agents of host-mediated inflammation and bone loss in periodontitis 
(13, 32, 44, 61-73).  Perhaps different individuals have different specific 
conditions or factors leading to dysregulation of immunity, but the underlying 
thread connecting all periodontitis susceptible individuals is dysregulation of host 
inflammation in response to an altered microbiota.   
 
Societal Impact of Periodontal Disease 
The global economic impact of oral diseases was estimated at 442 billion 
USD (74) in 2010, with direct treatment costs estimated at USD 298 billion.  This 
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corresponds to 4.6% of the global health expenditure.  This estimate includes 
dental caries (cavities) and oral cancer (75).  In the United States fewer adults 
are covered by dental insurance than medical insurance, and for those who have 
dental insurance, coverage tends to be less comprehensive than medical 
coverage (76).  Of the 92-114 billion dollars spent on dental visits in the United 
States in 2014, 44% were paid out-of-pocket, the highest percentage of any type 
of out-of-pocket expenditure for personal health care (77, 78).  Periodontal 
procedures were estimated at 2.5% of all dental procedures in 1999 (79).  The 
percentage of adults aged 18-64 who were unable to receive necessary dental 
care due to “cost” ranged between 9.3-12.6% in 1999 to 2014 (76).  
Many studies have reported an association between lower quality of life 
and both periodontitis and gingivitis, with quality of life deceasing as disease 
severity increased (80-83).  Individuals with periodontal disease, including severe 
chronic periodontitis, report more pain, more emotional stress (fear and anxiety), 
and greater insecurity in general.  Individuals with periodontal disease report a 
lower functional capacity, such as speech impediments or being unable to finish 
meals.  They may also experience social limitations or feelings of embarrassment 
over the state of their oral health (75, 84, 85).  These factors may interact with 
one another, for example, a person with difficulty finishing meals may opt out of 
social situations that involve food.  A small study found that individuals who were 
having difficulty accepting tooth loss were more likely to experience lack of 
confidence and more likely to feel inhibited by loss of teeth than individuals who 
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accepted their tooth loss (86).  Unfortunately, current quality of life studies are 
mostly associative studies focused on generating mathematically testable 
quantitative data by the use of “yes/no” and “on a scale of” questionnaires.  
These studies may be lacking nuance that would be better addressed by a 
qualitative methodology such as key informant interviews.  
Lastly, periodontal disease has been associated with several systemic 
conditions such as cardiovascular and pulmonary disease, rheumatoid arthritis, 
stroke, pneumonia, Alzheimer’s disease, and as previously mentioned diabetes 
mellitus (27, 87, 88).  Periodontal disease, and especially inflammation 
associated with periodontal disease, has the potential to lead to an increased risk 
of developing many other debilitating disorders such as APOs.   
 
Adverse Pregnancy Outcomes 
Measuring Adverse Pregnancy Outcomes (APOs) 
Pre-Birth Outcomes 
Chorioamnionitis is the inflammation of the fetal membranes (chorion 
and/or amnion) of the placenta, often due to bacterial invasion.  It is diagnosed 
based on maternal fever in the absence of maternal respiratory or urogenital 
infection and the presence of at least two of the following:  maternal leukocytosis, 
maternal tachycardia, or fetal tachycardia (89).   
Preeclampsia is a hypertensive disorder defined as elevated gestational 
blood pressure, such as that greater than 140/90, usually on at least two 
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separate occasions, and the presence of proteinuria (90, 91).  Urinary tract 
infections have also been associated with preeclampsia (92).  Preeclampsia 
affects only 5-10% of pregnancies but contributes significantly to maternal and 
perinatal mortality and morbidity (90, 91).   
Chorioamnionitis and preeclampsia are both associated with adverse birth 
outcomes. 
 
Birth Outcomes 
Preterm birth (PTB) in humans is defined as birth before or at 37 weeks of 
gestation, with extreme prematurity being defined as at or below 32 weeks of 
gestation.  Survival at less than 24 weeks gestation occurs only in very rare 
situations (93).  In the United States in 2015, the prevalence of PTB was 9.63%. 
PTB increased between 2007 and 2015 among non-Hispanic black and Hispanic 
women (94). 
Low birth weight (LBW) is defined in humans as birth weight below 2500 g 
and very low birth weight at less than 1500 g (95).  Newborn survival at less than 
500 g of weight is rare (93).  The prevalence of LBW in the United States in 2015 
was 8.07% (94).  Since both conditions are related, they are often referred to 
together in the literature as preterm low birth weight (PLBW).  PLBW in many 
cases is a consequence of preterm labor (PTL) and/or premature rupture of 
membranes (PROM) (96).  PTL can be associated with subclinical infection and 
intrauterine inflammatory response (97).   
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Known Risk Factors for Adverse Pregnancy Outcomes 
Host Factors 
Known host risk factors for APOs include: maternal age greater than 34 
years or less than 17 years, low socioeconomic status, inadequate prenatal care 
such as missed prenatal ultrasound appointments, recreational drug abuse, 
alcohol use, smoking or other tobacco use, hypertension, diabetes, multiple 
pregnancies, and previous incidence of PLBW (15, 98).  These risk factors 
should not be assumed to be entirely independent of one another.   
Some racial and ethnic groups, such as non-Hispanic black women, are 
especially susceptible to LBW.  Whether the increased risk of APOs in certain 
ethnicities is due to an increased prevalence of other associated risk factors, 
such as low socioeconomic status, in these groups is still debated.  Problems 
related to PTB or LBW were the primary cause of deaths among black infants 
born in the United States (98).  In 2013 the Infant Mortality Rate (IMR), defined 
as deaths within the first year of life per 1,000 live births, for blacks was 11.11 as 
compared to approximately 5 for whites and Hispanics.  American Indian or 
Native Alaskans had an Infant Mortality rate of 7.61 (93).  The risk of APOs, 
and/or infant mortality following PLBW, is therefore not equal for every 
pregnancy, even within the same woman.   
Some of the difference in risk of APOs between racial or ethnic groups 
may be explained by differences in the vaginal microbiome.  For example, white 
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women were more likely to have a vaginal flora dominated by Lactobacillus than 
black women, and black women were more likely to have microbiomes 
dominated by strict anaerobes (99).  The increased prevalence of vaginal 
anaerobes may also correspond with the higher rate of bacterial vaginosis in 
black versus white women (51 versus 23%, respectively) (100).  It thus behooves 
us to evaluate not only maternal host factors but also maternal microbial factors 
in the pathogenesis of PLBW.   
 
Microbial Factors 
Intrauterine infections and infections of the genitourinary tract have been 
associated with PTB and LBW (98, 101, 102).  There is clear evidence that 
bacterial vaginosis (BV) is an independent risk factor for PLBW, PROM, PTL, 
and chorioamnionitis (98, 101, 102).  BV results from an overgrowth of organisms 
that replace the normal vaginal microbiome (98).  The normal vaginal community 
of Lactobacillus at pH 4.5 is displaced and replaced by organisms surviving at 
higher pH such as Gardnerella vaginalis, Mycoplamsa mainis, Mycoplasma 
hominis, and Bacteriodes spp. (98, 101).  Gardnerella vaginalis and Bacteroides 
spp. in particular have been associated with both BV and PTL (103).  
Bacteroides spp. have also been associated with PLBW and PROM (103, 104).  
Despite the name, BV does not necessarily involve inflammation of the vaginal 
walls or cervix but can be diagnosed by presence of vaginal epithelial cells 
covered in adherent bacteria (98).  An estimated 50% of women with BV are 
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asymptomatic yet still at an increased risk of PTB or LBW (98).  The odds ratio of 
preterm delivery among women with BV has been demonstrated to be between 
1.4 to 2.8, to as high as 6.9 in a limited number of studies (98, 101, 102).  
Vaginal infections with species not normally associated with BV have also 
been reported in association with APOs.  Escherichia coli, Klebsiella spp., 
Haemophilus spp., Ureaplasma urealyticum, and S. aureus in the vaginal flora 
have been associated with PTL (103, 104).  Klebsiella spp., Haemophilus spp., 
and Trichomonas vaginalis were associated with PROM (103, 104).  Group B 
streptococci in the vagina or urine of pregnant women has been associated with 
PTB and PROM (105-107).   
Of course, host maternal immunity may influence the ability of key 
pathogenic microorganisms to colonize the female reproductive tract.  Therefore, 
the host microbiome and host immunity should not be considered as separate 
from one another.  However, many cases of PTB or LBW are not associated with 
any known risk factors, maternal or microbial.  This suggests that there are 
additional risk factors that are not currently understood (98).  Failure to account 
for the known associated risk factors is also unfortunately a problem in the 
design of many studies attempting to identify novel risk factors, such as 
periodontitis, for PLBW (108, 109).   
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Societal Impact of Adverse Pregnancy Outcomes 
The Infant Mortality Rate (IMR) as shown in Table 1 demonstrates the 
high personal cost that PTB and LBW impose on families.   
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Table 1.  2013 Infant Mortality Rate (Deaths per 1000 Live Births) in the 
United States (93) 
 
Gestational Weeks IMR  Weight at Delivery IMR 
     
Normal Term Birth 
37-41 weeks 
2.19 
 Full Term Weight 
≥ 2500 grams 
2.05 
     
Preterm Birth 
< 37 weeks 
34.79 
 Low Birth Weight 
< 2500 grams 
50.26 
     
Very Preterm Birth 
< 32 weeks 
163.71 
 Very Low Birth Weight 
< 1500 grams 
219.56 
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PTB and LBW have consequences beyond infancy.  For example, 
gestational age at delivery strongly determines the risk of impaired 
neurodevelopment.  Fifty-two percent of infants born at 24-28 weeks, 24% of 
those born at 28–31 weeks, and 5% of those born at 32–36 weeks were 
estimated to have some degree of neurodevelopmental deficit (110).  There is 
also evidence that PTB or LBW increase the risk of diabetes mellitus in 
adulthood (95).  Individuals that were born preterm and had very low birth weight 
(below 1500 grams) were at higher risk of having insulin resistance, glucose 
intolerance and higher blood pressure at 18 to 27 years of age than those born at 
term (95).   
Children born prematurely had increased rates of chronic coughing, 
wheezing, asthma, and asthma-like symptoms from infancy through their school 
years.  These conditions lead to an increased risk of childhood hospitalization for 
breathing disorders in those born prematurely (111-113).  To give one final 
example, adults between the ages of 18 and 27 who were born premature and 
with very low birth weight have less bone mineral density than term birth and 
normal weight peers (114).   
Given the prevalence of PTB and LBW and their cost to society, families, 
and individuals, identifying strategies to reduce or eliminate APOs is a critical 
public health priority.  We will now evaluate the connection between oral health 
and PLBW to support the notion that preventative treatment of periodontitis may 
lead to a reduction in devastating APOs.  
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Pregnancy Gingivitis versus Periodontitis in Pregnancy 
To understand the literature connecting oral health to APOs it is important 
to distinguish pregnancy gingivitis from periodontitis.  Pregnant women are 
particularly susceptible to gingival inflammation and gingival bleeding, and thus 
subsequent bacteremia (115-117).  However, pregnancy gingivitis is very 
different from periodontitis in pregnancy, and the two should not be confused.  
Pregnancy gingivitis is an extremely common, reversible condition of 
gingival inflammation has been characterized as “non-specific, vascularizing, and 
proliferative inflammation with large amounts of infiltrated inflammatory cells” 
(118).  Women with healthy gingiva and free of dental plaque are unlikely to 
develop pregnancy gingivitis.  In pregnancy gingivitis, the gingiva may become 
dark red and bleed easily.  Deeper probing depths may not be indicative of true 
periodontal destruction in pregnant women.  Swelling and gingival inflammation 
without bone loss may account for increased probing depth.  Pregnancy gingivitis 
is associated with the high levels of steroid hormones (estrogens).  Feeding on 
these hormones, microbial species such as Prevotella intermedia bloom within 
the microbial community (118-124).  When good oral hygiene practices are 
implemented or maintained, pregnancy gingivitis resolves itself within a few 
months of birth with no permanent changes in CAL (118, 121, 122, 124).  
Pregnancy gingivitis is not considered a risk factor for APOs.   
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Periodontitis is also associated with a shift in the relative composition of 
the oral microbiome, but the shift is unrelated to pregnancy status or pregnancy 
hormones.  This is an important distinction to make, as gingivitis and periodontitis 
are both forms of periodontal disease.  The difference in dominant species 
present in pregnancy gingivitis versus periodontitis in pregnancy may explain 
why pregnancy gingivitis is not associated with APOs, even though an increased 
risk of bacteremia would be present in both conditions (117-121, 123, 124).  
Unfortunately, some studies that have been included in meta-analysis measuring 
the association between periodontitis and APOs measure an association 
between gingivitis and APOs (125).   
 
Periodontitis Definition Affects Studies of Adverse Pregnancy 
Outcomes 
One problem with interpreting any association between periodontitis and 
pregnancy outcomes is that the cut-off point of periodontitis severity and extent 
utilized to separate a “case” from a “control” is not consistent across many 
studies of APOs (6, 126).  One particularly clever analysis demonstrated that 
varying case definitions may change the significance of the association between 
periodontitis and APOs (126).  This study utilized 14 different case definitions of 
periodontitis on the same data set and discovered that only 6 of the 14 tested 
definitions yielded a significant association between periodontitis and various 
APOs.  The robustness and validity of any reported association between 
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periodontitis and proposed outcomes, including but not limited to APOs, is 
therefore critically dependent on the criteria used to define a periodontitis patient 
and study inclusion criteria. 
Failure to control for confounders can also bias study results.  Increasing 
age, diabetes mellitus, low socioeconomic status, non-Hispanic black ethnicity, 
and tobacco use are risk factors that are associated with both periodontitis and 
APOs (15, 45, 46, 98).  Failure to control for these factors could lead to reporting 
of spurious associations between periodontitis and APOs (108, 109, 127).  
 
Association of Periodontitis and Adverse Pregnancy Outcomes  
To effectively reduce the cost of APOs to families and society, novel 
therapeutic interventions must be designed that can fill the current gap in 
preventive care.  To design these future interventions, the risk factors and 
etiological agents of APOs must be understood.  While many risk factors for 
APOs are known, some clearly are not well established.  Based on observational 
and epidemiological studies, periodontitis has been proposed as one of those 
missing risk factors.  Scaling and Root Planing (SRP) trials were an attempt to 
develop a novel therapeutic intervention to prevent APOs, but they failed.  These 
SRP studies nonetheless have progressed our understanding of the mechanism 
that connects periodontitis with APOs and can lead us to design more effective 
therapies to prevent APOs in women with periodontitis. 
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Prevalence of Periodontitis in Pregnant Women  
Periodontitis prevalence during pregnancy is important in determining 
whether the risk of APOs due to periodontitis has a significant impact on public 
health.  Data from the National Health and Nutrition Education Study (NHANES) 
has been used to estimate the prevalence of periodontitis in United States 
population.  NHANES, until 2001, measured only two periodontal sites on each 
tooth (mesial and mid-buccal) of two randomly selected quadrants.  Since not all 
6 sites around a tooth were measured, it is likely that the true prevalence of 
periodontitis was underestimated (45).  Some have suggested partial-mouth 
examinations may underestimate actual periodontitis prevalence rates by as 
much as 50 percent (128).  NHANES began using 6 sites per tooth, full mouth 
evaluations of periodontitis in 2009 (129).  Unfortunately, 2004 is the last 
reported time period wherein the prevalence in periodontitis in pregnant women 
specifically was evaluated with NHANES data.  Periodontitis was defined in 
NHANES for the period between 1999 and 2004 as one periodontal site with ≥3 
mm of clinical attachment loss (CAL) and ≥4 mm of probing depth (PD) (130).   
Within the NHANES data set 1999-2004 using the above definition, the 
prevalence of periodontitis in pregnancy was higher with increasing maternal 
age.  The prevalence of periodontitis during pregnancy was 6.7% in women aged 
35-44 versus 2-3% in women aged 15-34 of all ethnicities and all education 
levels.  The prevalence of periodontitis during pregnancy also increased with 
lower levels of education, as 5.7% of women with below-high-school education 
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level versus only 2-3% of women with a high school diploma or advanced degree 
were affected when all ethnicities and all ages are considered.  
Determining something as seemingly simple as prevalence can be 
dependent on definition of periodontitis.  The following table shows the 
differences between two studies which utilized different definitions of periodontitis 
to evaluate the prevalence of periodontitis in pregnant women by ethnicity (130, 
131).  The study with a broad definition of periodontitis (131) found a higher 
prevalence than the study with a narrower definition (130), as would be expected 
(Table 2).  It is unlikely that the prevalence of periodontitis in pregnant women 
truly significantly decreased between 1994 and 2004.   
28 
 
 
 
Table 2.  Prevalence of Periodontitis in Pregnant Women in NHANES Data 
Set varies by Definition of Periodontitis 
 
 Xiong et al. 2006 (131) 
Azofeifa et al. 2016 
(130) 
 
 
 
NHANES data 1988-
1994 n=268 
NHANES data 1999-
2004 n=772 
Periodontal disease 
definition 
at least one site with 
CAL or PD ≥4mm 
 
at least one periodontal 
site with ≥3 mm CAL 
and ≥4 mm of PD 
 
 
Non-Hispanic Whites 
 
10.7% 
 
2.0% 
Non-Hispanic Blacks 29.1% 2.2% 
Mexican-Americans 20.6% 9.3% 
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Observational Studies of Periodontitis and APOs 
Observational studies include case-control, cross-sectional, longitudinal, 
and cohort studies.  Due to the heterogeneity in the definition of periodontitis 
used to assign women to case or control groups, there are few meta-analysis of 
observational studies testing the association between periodontitis and APOs 
(108, 109).  One meta-analysis of 15 observational studies found that 
periodontitis significantly increased the risk of PTB (odds ratio (OR) 2.73, 95% CI 
2.06-3.6, p<0.0001) and LBW (OR 1.5, 95% CI 1.26-1.79, p = 0.001) (132).  A 
systematic review concluded that there were twice the number of case-control 
and cohort studies that detected an association between periodontitis and APOs 
as compared to studies that did not detect an association (108).  Epidemiological 
studies also find an association between periodontitis and APOs (133).  
Therefore, we can unequivocally conclude that a significant fraction of women 
experiencing APOs (~2.0 to 9.3%) are also affected by periodontitis, with the 
caveat that periodontitis case definition influences the extent of association 
between periodontitis and APOs.  This fact led to the hypothesis that treating 
periodontitis would reduce APOs. 
 
Scaling and Root Planing to Prevent APOs 
Several large, randomized control treatment trials (RCTs) using scaling 
and root planing (SRP) were thus designed to test whether a periodontal 
therapeutic intervention could reduce the risk of APOs in women with 
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periodontitis.  Two NIDCR funded trials, OPT and MOTOR, independently 
determined that second trimester SRP therapy did not either increase or reduce 
the risk of APOs in women with periodontitis (134).   
A meta-analysis of current SRP studies used Cochrane’s risk of bias tool 
to assess methodological quality of studies that were evaluated.  Studies were 
separated into “high” and “low” quality studies based on risk of bias, such as 
selection bias or attrition bias (125).  This analysis found that SRP treatment did 
not reduce the risk of PTB (OR 0.93, 95% CI 0.79-1.101) (125).  Interestingly, low 
quality trials suggested that treatment was beneficial to prevent PTB (OR 0.52, 
95% CI 0.38-0.72) whereas high quality trials suggested no effect of treatment 
(OR 1.15, 95% CI 0.95-1.40).  The same difference in high vs low quality studies 
can be seen in regards to the effects of SRP treatment on LBW.  Low quality 
studies found a benefit of SRP treatment on reducing the risk of LBW (OR 0.44, 
95% CI 0.30-0.66) whereas high quality studies did not (OR 1.07, 95% CI 0.85-
1.36) (134-138).  Combining low and high quality studies demonstrated that SRP 
treatment had no effect on LBW (OR 0.85, 95% CI 0.70-1.04) (125).  It has been 
observed that smaller studies, which are more vulnerable to the effects of bias, 
are more likely than larger studies to show a positive effect of treatment of 
periodontitis on PLBW (139). 
                                            
1 Odds ratio (OR) with a confidence interval that spans the value 1 are non-significant (p > 0.05).  
Odds ratio with a confidence interval where both values are less than 1 or both values are greater 
than 1 are significant (p ≤ 0.05).   
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On an interesting note, leaving aside quality of evidence, 5 studies within 
this meta-analysis looked at both CAL and PD, 5 studies evaluated only CAL, 
and 1 study used PD only to define disease severity.  Two studies additionally 
considered BOP (125).  One study was evaluating patients experiencing 
gingivitis, not periodontitis (140).  These details are important in light of the 
knowledge that heterogeneity in how cases and controls are defined influences 
the extent of association between APOs and periodontitis.   
Additional meta-analysis of SRP treatment agreed that in high-quality 
studies SRP does not reduce the risk of PTB (OR 0.81, 95% CI 0.64-1.02), (OR 
1.082, 95% CI 0.891-1.314), (RR 0.88, 95% CI 0.72-1.09) or the risk of LBW (OR 
0.72, 95% CI 0.48-1.07), (OR 1.181, 95% CI 0.960-1.452), (RR 0.78, 95% CI 
0.53-1.17), just to list those RCT that evaluated risk of bias in included trials (139, 
141, 142).  Collectively we can therefore conclude that in high-quality, low risk of 
bias studies, SRP does not reduce the risk of APOs.  These findings prompted 
researchers to question the mechanism behind the association between 
periodontitis and increased risk of APOs found in observational studies (108, 
109, 132, 133). 
 
A Potential Explanation for the Failure of SRP Therapy to 
Prevent APOs 
Some critics maintain that failure of treatment trials indicate that there is 
no association between periodontitis and APOs.  This criticism applies a faulty 
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logic because it assumes a priori that microorganisms residing only in the 
periodontal pocket are the sole contributors to APOs.  However, there are 
alternative explanations for the lack of reduction in APOs with periodontal 
treatment.  For example, SRP could have been either the wrong treatment to 
resolve the issue, or SRP could have been delivered too late in pregnancy to 
prevent APOs (127).  One meta-review on SRP and APOs noted that the 
selected studies, except two, used “mild periodontitis” definition as inclusion 
criteria (125).  This raises the additional possibility that SRP may not be as 
effective in treating APOs in women with mild cases of periodontitis as it could 
have been if only severe cases of periodontitis were treated.  Including mild 
periodontitis cases in treatment studies may have diluted the potential effect of 
treatment on APOs.   
Another possibility is that while SRP changes the composition of the 
periodontal microbiota by mechanically disrupting the biofilm within the 
periodontal pocket, SRP has no impact on potential hematogenous spread of 
periodontal pathogens to the placenta occurring prior to SRP treatment.  Notably, 
for safety reasons, all SRP trials were performed during second trimester.  Since 
gingival inflammation during pregnancy increases the likelihood of transient 
bacteremia, it is plausible that periodontal pathogens seed the placental tissue 
and either the pathogens themselves or the inflammatory immune response to 
them may impair the developing fetus (115-117).  This hypothesis is corroborated 
by recent studies showing that the placenta harbors a unique, low abundance 
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microbiome that is similar to the oral microbiome (143).  This finding is in stark 
contrast with previous assumptions that deemed the placenta an essentially 
sterile environment (144-146).  The composition of the newly discovered 
placental microbiome changes in association with various APOs (143, 145, 147).   
Periodontitis-associated microorganisms, like P. gingivalis, seeding the 
placenta could have a direct effect on placental viability and function through 
bacterial virulence factors (direct theory).  The maternal inflammatory immune 
response may influence the ability of periodontal pathogens to colonize the 
placenta.  Alternatively, the maternal inflammatory immune response against 
periodontal pathogens and/or dysbiotic placental microbiome may compromise 
nutrient transfer to the fetus and increase the risk of APOs (indirect theory).  
Placental colonization with periodontal microorganisms, therefore, appears to be 
a plausible mechanism by which periodontitis increases the risk of APOs.   
This thesis will present evidence obtained from a mouse model of 
periodontitis to argue that periodontitis increases the risk of APOs because of the 
spread of periodontal pathogens to the fetoplacental unit. 
 
Periodontal Pathogens Implicated in Adverse Pregnancy 
Outcomes  
Porphyromonas gingivalis and Fusobacterium nucleatum are two 
anaerobic species commonly associated with both periodontitis and APOs in 
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humans (23, 26, 30).  Found in relatively low abundance compared to all other 
microorganisms, P. gingivalis can have large pathogenic effects by changing the 
local nutrient foundation of the microbial community (18, 148, 149).  P. gingivalis 
therefore meets the definition of a keystone pathogen.  Changes in the nutrient 
base destabilize the relative proportions of the normal microbial community.  The 
resulting dysbiotic microbiome alters the host-microbiome homeostasis, leading 
to a more pro-inflammatory response (148).  P. gingivalis is unable to induce 
bone destruction when inoculated by itself into germ-free animals, whereas in 
conventional or specific pathogen free (SPF) murine colonies P. gingivalis drives 
alveolar bone destruction.  This further demonstrates the need for a microbial 
community to elicit pathogenic effects as P. gingivalis increases the overall 
community virulence by enabling proportional shifts in the composition of a 
previously friendly microbiome (2, 150).  
There is evidence for a role of P. gingivalis in not only periodontitis but 
also in APOs.  P. gingivalis can be detected in placentas of fetal growth restricted 
BALB/c mouse fetuses after subcutaneous inoculation with P. gingivalis (151, 
152).  Oral inoculation of BALB/c mice with P. gingivalis plus other periodontal 
pathogens leads to upregulation of toll-like receptor 4 (TLR4) mRNA in placental 
labyrinth tissue.  The TLR4 pathway is known to be involved in the pathogenesis 
of some cases of PTB (153).  Changes in TLR regulation demonstrate that P. 
gingivalis can induce a host inflammatory immune response in placental tissues.   
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F. nucleatum has also been linked to APOs in both mice and humans 
(154, 155).  F. nucleatum interacts with a diverse range of oral species and 
positively influences the biomass of other Gram negative anaerobes (33).  
Parenteral inoculation with human plaque samples into pregnant mice results in 
preferential seeding of F. nucleatum to the placentas (115) possibly through the 
action of fap2 (156) and/or fadA adhesion proteins (157, 158).  F. nucleatum can 
lead to murine fetal death through stimulation of TLR4 and not through direct 
bacterial toxicity (159).  These findings suggest that P. gingivalis and F. 
nucleatum elicit a detrimental inflammatory response or that the direct virulence 
of the microorganisms can be responsible for APOs.  
 
Evidence of Periodontal Pathogens in the Placenta 
Species-specific PCR-based Detection of P. gingivalis and F. 
nucleatum in Placentas Associated with APOs 
Species-specific conventional PCR- or quantitative (qPCR)-based studies 
differ from DNA sequencing studies in that they start with an a priori defined set 
of potential species to evaluate.  This tends to bias species-specific studies 
towards the detection of well-established cultivatable periodontal pathogens over 
lesser characterized uncultivatable species (160).  Conventional PCR is not as 
efficient at quantitating microorganisms as DNA sequencing or qPCR.  
Nonetheless, conventional PCR can provide important information about the 
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presence but not the abundance of various organisms in conditions of disease 
versus health.  
When analyzed with conventional PCR, placental tissue samples in 
women with PLBW infants have yielded higher species counts than controls 
(160).  Specifically, F. nucleatum was detected in 94% of placentas from mothers 
with periodontitis and PLBW as compared to 36.4% of full-term placentas from 
mothers without periodontitis.  F. nucleatum has also been detected in the 
placenta of a stillborn infant from a mother who experienced excessive gingival 
bleeding during pregnancy.  This F. nucleatum strain was genetically identical to 
that found in the mother’s oral cavity (155).  Nested PCR has revealed that F. 
nucleatum was more prevalent in mothers with periodontitis and PTB (p = 0.033) 
(160).   
Preeclampsia has also been associated with maternal periodontitis (90).  
Pooled samples from maternal and fetal placental tissues of preeclampsia 
patients revealed the presence of Actinobacillus actinomycetemcomitans, F. 
nucleatum, and P. intermedia (91).  P. gingivalis, F. nucleatum, Tannerella 
forsythensis, and Treponema denticola were detected in significantly higher 
numbers in preeclampsia patients than in control subjects when detected with 
qPCR (91).  In another study, conventional PCR placental samples from 
preeclampsia patients revealed presence of Bacillus, Variovorax, Prevotella 
shahii, Porphyromonas, Dialister, and Lactobacillus.  Importantly, this study did 
not detect the presence of bacterial DNA in maternal blood in any patient (161).  
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This suggests that oral microorganisms can enter the bloodstream infrequently or 
at below detectable levels after manipulation of the gingiva with brushing or even 
after chewing food, or possibly even shielded within a few phagocytes (150).  
However, upon reaching the placenta through the blood oral pathogens may 
colonize and grow locally to detectable levels.   
 
Species-specific Immunohistochemistry and 
Immunofluorescence in Placentas Associated with APOs. 
Placental sections from chorioamnionitis-affected human placentas 
associated with PTB showed 30% more intense immunostaining for P. gingivalis 
antigens than normal placental controls.  Staining was observed in placental 
synctiotrophoblasts, chorionic trophoblasts, decidual cells, amniotic epithelial 
cells, and vascular cells.  The most commonly stained areas regardless of case 
or control status were trophoblasts, decidual cells, and vasculature cells (89).   
A second study reported that P. gingivalis in the placenta was associated 
with shorter gestations and delivery by caesarean section, but not with 
chorioamnionitis or preeclampsia (162).  P. gingivalis antigen were only detected 
in the villous mesenchyme of PTB birth placentas but not of full term controls.  In 
contrast, P. gingivalis antigen were detected in syncytiotrophoblasts of both 
preterm and full term gestation placentas (162).  Notably, in this same study 
preeclampsia patients had P. gingivalis antigens only in the umbilical cord but not 
in the placenta.   
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Collectively, PCR-based and immunohistological findings suggest that at 
least two well established periodontal pathogens, F. nucleatum and P. gingivalis, 
can be detected in placentas associated with APOs in humans and mice.  It is 
possible that P. gingivalis colonization of certain areas of the placenta leads to 
different APOs.  Since there is disagreement between studies on the localization 
of P. gingivalis in the fetoplacental unit and subsequent APOs, more studies are 
needed to confirm the exact relationship between colonization of specific areas of 
the placenta and specific APOs.   
Detection of increased systemic levels of interferon-gamma (IFN-γ) in 
animal models of APOs suggests that the maternal immune response may 
induce inflammation and subsequently impairs fetal growth.  Presence of oral 
pathogens such as P. gingivalis in placentas associated with APOs suggests that 
periodontal pathogens could be inducing an IFN-γ driven maternal immune 
response that is detrimental to placental and fetal health.  Alternatively, the 
changes P. gingivalis induces in the nutrient base leading to a more pathogenic 
oral or placental microbiome may be driving increased IFN-γ production.  Certain 
subsets of CD4+ T cells are major, but not sole, producers of IFN-γ.  Additionally, 
the presence of P. gingivalis in the placenta could act as a local re-stimulator of T 
cells, leading to local production of IFN-γ in the placenta by CD4+ T cells.  
However, IFN-γ produced by CD4+ T cells responding to oral pathogens has not 
yet been definitively established as a contributor to fetal growth restriction.   
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Evidence of CD4+ T cell Role in Periodontitis and Adverse 
Pregnancy Outcomes 
The type of defense mounted against a given pathogen depends in part 
on immune response characteristics of the host.  For example, the T cell 
response to the obligate intracellular bacterium Mycobacterium leprae in humans 
can lead to either tuberculoid leprosy (Th1-driven) or lepromatous leprosy (Th2-
driven).  The Th2 type response leads to the inability to contain the infection and 
to a more severe pathology (163).  Similarly, there is evidence that the type of Th 
response to periodontal pathogens such as P. gingivalis within a given individual 
may lead to host resistance or host susceptibility to alveolar bone destruction and 
APOs.  Additionally, genetically-defined differences in adaptive host immunity 
might influence the ability of key periodontal pathogens such as P. gingivalis to 
invade and permanently colonize the host oral or placental microbiome.   
Before presenting the specifics of CD4+ T cells in periodontitis and APOs, 
it is prudent to define key CD4+ T cell subsets and their roles in immunity.  The 
number of CD4+ T cell subsets has expanded over time after the characterization 
of novel phenotypic behavior of each subset (97).  The subsets most relevant to 
both periodontitis and APOs today are discussed in table 3. 
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Table 3. Phenotypes of Effector CD4+ T helper (Th) and T regulatory (Treg) 
Cell Subset  
 
T cell 
subset 
Characteristic 
cytokines 
Role in immunity 
Th1 IFN-γ 
Defense against intracellular 
pathogens, assists macrophages 
Th2 IL-4, IL-5 
Immunity against extracellular 
pathogens, humoral immunity, helps 
class switched antibody production 
by B cells 
Th17 
IL-17 family 
(IL-17A and IL-17E) 
Defense against fungi, immunity at 
mucosal sites, assists neutrophil 
recruitment 
Treg 
FoxP3 transcription 
factor 
Control and dampen other immune 
cell responses 
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Evidence for a Role of CD4+ T cells in Periodontitis 
Numerous studies demonstrated that deletion of CD4+ T cells results in 
resistance to alveolar bone loss (reviewed in (164)).  Knockout of major 
histocompatibility (MHC) class II genes leads specifically to absence of CD4+ T 
cells and results in protection against alveolar bone loss after oral P gingivalis 
colonization (73).  Genetic deletion of alpha chain of T cell receptor prevents the 
development of both CD4+ and CD8+ T cells and results in a similar protective 
effect against bone destruction (69, 72).  Mice lacking IFN-γ or IL-6 are not 
susceptible to bone destruction (69).  Subcutaneous immunizations of C57BL/6 
mice with P. gingivalis antigens, combined with adjuvants known to elicit a Th1 
response, resulted in extensive alveolar bone destruction with periapical 
granulomas heavily infiltrated by osteoclasts after re-challenge with whole P. 
gingivalis.  Th2-biased mice had minimal bone lesions without obvious osteoclast 
infiltration (165).  Given the evidence that T cells can impact periodontal 
outcomes in mice, we looked for evidence of T cell involvement in human 
periodontitis.   
 
Evidence for a Role of Th1 and Th2 cells in Periodontitis 
Human studies have been contradictory as to the role of the cytokines 
produced by Th cells in periodontitis.  Most studies have concluded Th1 cells 
were associated with stable periodontal lesions, whereas Th2 cells were 
associated with periodontal disease progression, but not all studies agree (13, 
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166).  Problematically, these studies were done before the understanding that T 
helper cells constituted more subsets than just Th1 and Th2.  This means that in 
early studies some conclusions about T cell behavior in periodontitis that were 
attributed to the actions of Th1 may have actually been driven by Th17 cells.   
T cells in human diseased gingival tissue predominantly express CCR5 
and CXCR3 chemokine receptors characteristic of Th1 cells.  Ligands for these 
receptors were also elevated in diseased tissues (167, 168).  IFN-γ-producing 
Th1 cells can be a source of membrane bound and soluble receptor activator of 
nuclear factor kappaβ ligand RANKL (169-172).  P. gingivalis colonization can 
induce RANKL production by T and B cells.  RANKL induces differentiation of 
mature osteoclasts, which are responsible for bone resorption (169, 173).   
Other studies found Th2 cells to be more abundant in periodontitis lesions 
(174).  A slightly increased Th2 response (higher Th2/Th1 ratio) was found in 
peripheral blood of aggressive periodontitis patients as compared to chronic 
periodontitis patients or healthy controls (32).  Unstimulated cells isolated from 
chronically-inflamed tissues of patients with early-onset or advanced periodontitis 
mostly produced Th2 cytokines (175). 
Finally, some studies have reported that CD4+ Th cells isolated from 
inflamed gingival tissues of periodontitis patients can express both Th1 and Th2 
cytokines (176, 177).  This may explain the dichotomy between studies that 
report a dominance of Th1 cells and those that report a majority Th2 cells in 
periodontitis lesions.  
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The dominance of Th1 or Th2 cells may also depend on the type of 
periodontal pathogens present.  P. gingivalis in chronic periodontitis patients is 
associated with a higher percentage of IFN-γ producing CD4+ T cells, leading to 
a higher IFN-γ/IL-4 (Th2) ratio of cytokine (32).  Lack of IFN-γ in IFN-γ-knockout 
mice protects against alveolar bone loss induced by A. actinomycetemcomitans, 
but leads to disseminated bacterial infection and death (178).  In contrast, T. 
forsythia-induced alveolar bone loss in BALB/c mice was mediated by a TLR2-
dependent Th2 response (179).   
 
Evidence for a Role of Th17 and Treg cells in Periodontitis 
IL-17 expression is greater in periodontitis tissues when compared to 
healthy control tissue (180-185).  Cytokines necessary for Th17 cell 
differentiation are detected in inflamed periodontal tissue (40).  Elevated levels of 
mRNA for Th17-driving cytokines like IL-1β, IL-6 and IL-21 were detected in 
gingival tissue of periodontitis patients compared to healthy controls (181, 186, 
187).  In severely inflamed periodontitis sites, macrophages producing IL-23 
appear to amplify the memory Th17 response (182).  Cell culture supernatants 
from human antigen presenting cell culture stimulated with the periodontal 
pathogen P. gingivalis induced a Th17 response (188).   
Increasing numbers of IL-17+ T cells in specific pathogen free rodents may 
be correlated with age-associated alveolar bone loss (19).  The endogenous 
inhibitor of neutrophil adhesion (Del-1), inhibits IL-17-dependent, neutrophil-
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induced pathology, and consequently inflammation-associated bone loss in mice 
and non-human primates (189, 190).  
The role of IL17 in periodontitis is still debated because of data originating 
from animal models.  Female C57BL/6J mice lacking the IL-17 receptor (IL-
17RAKO) experienced reduced serum chemokine levels and reduced neutrophil 
migration to bone after P. gingivalis inoculation (191).  Female BALB/cJ IL-
17RAKO were defective in production of immunoglobulin G (IgG) against P. 
gingivalis and lacked essential chemokine responses.  In contrast males failed to 
upregulate granulocyte colony-stimulating factor. (192).  These two studies 
demonstrate then that this specific immune defect in two strains of female mice 
leads to increased susceptibility to alveolar bone loss.  
Treg cells (CD4+ CD25+ FoxP3+) play a critical role in modulating the 
production of pro-inflammatory cytokines in gingival tissues protecting against 
bone destruction.  Tregs downregulate the immune response of other CD4+ T 
cells via IL-10 and TGF-β (193).  IL-10 also inhibits RANKL activity and 
deficiency of Treg cells leads to an increase in RANKL activity with increased 
bone alveolar destruction (194).  Treg cells attenuate experimental periodontitis 
in A. actinomycetemcomitans infected C57BL/6 mice (195).  
Interestingly, FoxP3+ T cells were found in greater numbers in gingivitis 
lesions than IL-17A producing cells.  This was especially true for intensely 
inflamed gingival tissue, and B and plasma cell-predominant gingival tissues 
(196-198).  The association of increased Tregs and increased severity of disease 
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suggests not that Tregs are responsible for periodontal destruction, but that 
Tregs attempt to dampen the pro-inflammatory response but are ultimately 
unable to constrain inflammation.  
Ultimately, it is likely that different T cell subsets are associated with 
different stages of disease, or with the difference between stable and progressive 
periodontal lesions.  It is also likely that unique microbial communities stimulate 
the differentiation of naïve CD4+ T cells into different subsets of effector CD4+ T 
cells.  Certain communities may drive the type of inflammation that protects from 
bone destruction and other communities may promote bone destruction 
depending on the overall cytokine milieu.  Undoubtedly, different genetic make-
ups may also lead to periodontitis or APOs “susceptible” and periodontitis or 
APOS “resistant” individuals.   
 
Evidence for a Role of Th1 cells in APOs 
There is a strong body of experimental evidence demonstrating the 
involvement of high levels of systemic IFN-γ in APOs.  Studies showing a role of 
Th1 related to failure of fetoplacental implantation in humans have been mixed.  
Since many of these studies were performed prior to the understanding of Th17 
and Treg cells, it has been suggested that the balance of Treg to Th1 cells is 
important rather than absolute numbers in determining whether higher Th1 cells 
are detrimental to fetoplacental implantation outcomes (97).  Similarly, a high 
frequency of Th1 and low Th2 type cells is associated with spontaneous abortion, 
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as opposed to absolute numbers of either.  Th1 type cytokines (IL-2, IFN-γ, 
TNFα) are up-regulated in PTL, but so are the Th2 cytokines (IL-4, IL-6) (97).   
Th1-type immunity dominates in preeclampsia, but IFN-γ, which is 
commonly used as a measure of Th1 activity, can also be produced by other 
immune cells such as natural killer cells.  High serum Th1-type immunity, 
combined with significantly lower numbers of Treg cells in women with 
preeclampsia, may represent a failure of immune tolerance (97).   
Th1-associated cytokines have also been implicated in APOs in mice.  
Non-pregnant C57BL/6/J mice respond to Leishmania major by producing IFN-γ, 
and experience failure of implantation, fetal resorption, and problems with 
placental development.  In contrast BALB/c mice have a Th2 response against 
Leishmania that is insufficient to clear the pathogen and can lead to lethality of 
the dam, but does not lead to fetal loss per se (199, 200).  Pregnant C57BL/6J 
are less able clear L. major infection due to greater amount of systemic IL-10 
leading to a more severe pathology.  Administration of IL-2 or IFN-γ, or 
stimulation of Th1-type cytokine production through TLR ligation, leads to 
increased incidence of abortion in mice (97).  Subcutaneous inoculation of 
BALB/c mice with P. gingivalis leads to fetal growth restriction correlated with an 
increase in CD4+ Th1 type cytokines such as IFN-γ (151, 152).   
Other animal models have also demonstrated an association between 
Th1-type cytokines such as IFN-γ and APOs.  The placenta of rabbits is more 
like the one of humans than the one of mice.  IFN-γ has been linked with 
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apoptosis of the rabbit placenta, particularly the placental trophoblasts, and 
reduced progesterone production (201, 202).  Studies show conflicting evidence 
for both a detrimental role and a protective role of IFN-γ in fetal death and 
abortion in cattle infected with Neospora caninum (203-205).  In rats and 
humans, IFN-γ has been associated with apoptosis of placental cytotrophoblasts.  
Apoptosis has also been shown in response to IFN-γ in primary rat placental 
decidual cells (206, 207).  At least one study has shown that the Th1-associted 
cytokine TNFα, but not IFN-γ, is correlated with intrauterine inflammation in rats 
(208).  Subcutaneous P. gingivalis induce low fetal weight in hamsters secondary 
to increased prostaglandin E2 (PGE2) and tumor necrosis factor alpha (TNFα) 
(209, 210).    
Importantly, IFN-γ is necessary for vascular remodeling early in mouse 
pregnancy.  Thus, too much or too little IFN-γ can both be detrimental (97).  The 
balance of Th1 to either Th2 or Treg cells could be key to unveiling a potential 
role for Th1-associated cytokines in APOs.   
 
Evidence for a Role of Th17 in APOs 
The role of Th17-associated cytokines in APOs has been far less studied 
than the role of Th1-associated cytokines.  For example, whether Th17 cells are 
involved in spontaneous abortion, or present in reproductive tissues as a 
consequence of abortion, is still debated (97).  Although Th17 cells may protect 
the uterine cavity against extracellular microbes, it appears that the Th17 
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response is dampened during pregnancy (97).  During pregnancy, the signs and 
symptoms of IL-17/Th17-driven rheumatoid arthritis are alleviated. Th17 cell 
numbers are also increased in the chorioamniotic membranes from PTB infants 
of mothers with chorioamnionitis.  Th17 cells can be observed to promote 
inflammation at the fetomaternal interface in preterm delivery.  (97).  In normal 
pregnancy, peripheral blood shows increased Treg and decreased Th17 cells 
whereas in preeclampsia women show the opposite trend (97).   
Ultimately, the Th17 response is currently understudied in pregnancy.  
The Th17 response appears to be heightened during some APOs when the ratio 
of Th17 to Tregs is increased.  Interestingly, the Th17 response generally 
appears to be suppressed in pregnancy.  Perhaps what leads to APOs is not the 
actions of Th17 alone, but rather, a disruption in the balance between Th17 and 
Treg cells.  
 
Th2 and Tregs in Pregnancy Maintenance and Fetal Tolerance  
Although Th2-type immunity dominates during normal pregnancy, loss of 
IL-4, IL-5, IL-9, and IL-13 in knockout mice does not prevent a normal pregnancy 
(97).  Some redundancy between Treg and Th2 cells in suppressing detrimental 
Th1 immunity may explain why Th2 does not appear to be absolutely necessary 
for pregnancy despite being the dominant response during normal pregnancy.  
For example, IL-10 can be produced by both Treg and Th2 cells.   
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As we have seen, some level of inflammation sustained by IFN-γ is 
necessary for fetoplacental implantation, but too much inflammation can lead to 
resorption of the embryo.  Treg cells may help regulate the balance of 
inflammation necessary for successful implantation to occur without inducing 
resorption.  Depletion of Tregs leads to impairment of implantation in allogenic 
but not syngeneic mice.  As Tregs are critical only when there is allogenic mis-
match between parents, this suggests Tregs may be necessary for 
immunological tolerance of the fetus (97).  Tregs accumulate in the lymph nodes 
draining the uterus of mice after mating.  Reduced expression of FoxP3 mRNA is 
associated with infertility (97).  Reduced Treg function and resulting chronic 
inflammation have been suggested to play a role in spontaneous abortion (97).  
Consistently with a protective role for Tregs against excess inflammation, 
adoptive transfer of Treg cells into BALB/c mice can inhibit lipopolysaccharide-
induced fetal brain inflammation (211).   
In short, Th1-type cytokines have been associated with APOs.  Th17-type 
cytokines have been associated with a few limited APOs, but Th17-type immunity 
is also dampened in pregnancy.  Treg and Th2 cells share some characteristics, 
including production of IL-10, and have both been associated with fetal tolerance 
and maintenance of pregnancy.  
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Summary of Relevant Background 
The presence of periodontal pathogens in human placentas associated 
with APOs supports the hypothesis that periodontal pathogens can spread from 
the oral cavity and colonize placental tissue.  This might occur before any second 
trimester interventions such as SRP.  CD4+ Th cells could therefore be primed by 
antigens from periodontal pathogens in the oral cavity or placenta.  Recirculating 
memory Th cells could be reactivated by periodontal pathogens in the placenta, 
inducing local inflammation through cytokines such as IFN-γ.  
Given that systemic IFN-γ has been associated with multiple APOs, a pro-
inflammatory T cell response against periodontal pathogens in the placenta could 
impair fetal nutrient transfer or induce placental apoptosis.  What is currently 
unknown is whether CD4+ T cells responding to oral pathogens are responsible 
for the systemic increase in IFN-γ that has been associated with APOs.  The 
possibility remains that other IFN-γ-producing cell types could be responsible for 
the observed increase in systemic IFN-γ.   
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Hypothesis 
An increase in frequency of P. gingivalis-specific CD4+ T cells producing Th1 
associated cytokines (IFN-γ) is correlated with low birth weight in C57BL/6J mice.  
Specific Aims 
To test the hypothesis, we pursued two specific aims:  
Specific Aim 1.   
Determine the association between phenotype of P. gingivalis-specific 
CD4+ T cells and fetal weight in C57BL/6J and BALB/cJ mice orally 
colonized with P. gingivalis.   
The rationale for this aim is that, while systemic increases in IFN-γ have been 
associated with APOs, it has not been proven that IFN-γ-producing T cells 
responding to periodontal pathogens lead to low fetal weight.  Utilizing mice that 
are and are not expected to have a Th1 bias in response to oral colonization with 
P. gingivalis will allow us to answer this question.  
The working hypothesis is that the increasing frequency of P. gingivalis-specific 
CD4+ T cells producing IFN-γ will negatively correlate with fetal weight in 
C57BL/6J mice.  In Th2 biased BALB/c mice, the frequency of P. gingivalis-
specific CD4+ T cells producing IL-4 is hypothesized to either have no correlation 
or a positive correlation with fetal weight.  
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Specific Aim 2.   
Determine the impact of P. gingivalis-specific effector Th1 and Th17 cells 
on pregnancy outcomes during oral colonization with P. gingivalis.   
The rationale for this aim is to determine whether Th1-biased mice and Th17-
biased mice yield different APOs on the same genetic (H-2b) background.  The 
working hypothesis is that frequency of P. gingivalis-specific CD4+ T cells 
producing IL-17A will be independent of fetal weight in C57BL/6NCrl (Th17-
biased) mice whereas increasing IFN-γ production will correlate with low fetal 
weight in C57BL/6J.  This was based on evidence that Th17 is involved in some 
APOs, but not low birth weight.   
 
To achieve these Specific Aims, we pursued these goals: 
1. Identified strains and substrains of mice that were susceptible to fetal 
weight reduction after oral colonization with P. gingivalis.   
2. Detected the presence of P. gingivalis in the placenta to determine the 
potential for re-stimulation of placental T cell.  
3. Determined the frequency of P. gingivalis-specific CD4+ T cells producing 
IL-17A, IFN-γ, or IL-4 in uterine-draining PaLN and oral-draining CLN. 
4. Correlated the frequency of P. gingivalis-specific CD4+ T cells producing 
IL-17A, IFN-γ, or IL-4 to fetal weight outcomes in mice susceptible or 
resistant to alveolar bone loss.  
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Materials and Methods 
Mouse Strains and Expected T Cell Phenotypes 
Utilizing different substrains from different vendors, we tested whether any 
of the Th cell phenotypes correlated with the consequent APOs.  
 
Specific Aim 1.  C57BL/6 and BALB/c mice: Th1- versus Th2-bias  
The murine strains selected in this aim are well-characterized as mouse 
models of periodontitis.  Specifically, C57BL/6J are resistant to alveolar bone 
loss when orally colonized with P. gingivalis strain ATCC 53977 and are 
historically defined as Th1-biased (IFN-γ) (70, 212).  BALB/cJ are susceptible to 
alveolar bone loss and are considered Th2-biased (IL-4) (70, 199, 200, 212-214).  
Using these models of alveolar bone destruction, we expected that C57BL/6J 
mice would be susceptible to low fetal weight because of their Th1-bias, whereas 
in BALB/c mice the Th2 response would lead to fetomaternal tolerance.   
 
Specific Aim 2.  C57BL/6J versus C57BL/6NCrl mice: Different Frequency of 
Small Intestine Lamina Propria Th17 Cells 
In C57BL/6N mice that harbor intestinal segmented filamentous bacterium 
(SFB), 10-15% of small intestine lamina propria (SI-LP) CD4+ T cells express IL-
17A.  SFB positive C57BL/6 mice include those from Taconic Farms (NTac) and 
Charles River Laboratory (NCrl) (215).   
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By contrast, C57BL/6 mice from Jackson Laboratory (J) lack SFB, and 
thus only 1-2% of their SI-LP CD4+ T cells express IL-17A (215).  C57BL/6J from 
Jackson Laboratory are therefore considered “Th17 deficient” in the SI-LP.  
When C57BL/6J mice from Jackson are co-housed for two weeks with mice that 
have SFB in their intestinal microbiota, the numbers of Th17 cells within their 
intestines increase in number to close to those of mice that were SFB colonized 
from birth (215).  This suggests that the difference in Th17 cell induction is 
related to the microbiome and not to genetic differences between C57BL/6 
vendor substrains.  
It is reasonable to hypothesize that SFB regulation of Th17 cell generation 
in the intestine can influence Th17 cell development at distant niche as the oral 
cavity.  For example, depletion of SFB with vancomycin leads to decreased IL-17 
production in murine lungs (216), with the caveat that vancomycin is not selective 
for SFB alone.  Introduction of SFB into the intestines of germ-free K/BxN mice 
leads to the development of Th17 cells associated with autoimmune arthritis 
(217, 218).  Intestinal SFB colonization has also been demonstrated to protect 
against development of diabetes in female non-obese diabetic mice (219), 
suggesting that intestinal priming of Th17 cells in response to SFB colonization 
can have effects at distant sites.  However, the influence of SFB colonization on 
Th17 cell development in the oral mucosa has not been established.   
In addition to the presence or absence of SFB in the microbiota, it must be 
noted that mice housed as Jackson have been separated for many generations 
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from mice housed at Charles River.  C57BL/6J and C57BL/6N (NTac or NCrl) 
have been described as having differences in metabolic phenotypes, weight 
regulation, and inflammatory immune responses (220, 221).  It is difficult to 
determine, without using co-housed mice, the exact role that genetic drift 
between the two substrains versus the microbiota of each substrain, plays in the 
observed phenotypic differences.   
 
SFB and Th17 in BALB/c mice 
Importantly, the effect of SFB on Th17 development in BALB/c mice has 
not been established.  Thus, both, BALB/cJ and BALB/cAnNCrl mice were 
evaluated for both fetal weight and Th cell phenotypes, in order to determine 
whether Th17 cells were increased in BALB/c mice from Charles River over 
BALB/c mice from Jackson, and whether a difference in Th17 might lead to a 
difference in fetal weight outcomes (Table 4).  Vendor substrain differences in 
BALB/c mice have been noted in a limited number of disease models (222, 223) 
but BALB/c mouse substrain genetic and microbiota differences have not been 
as fully characterized as C57BL/6 mouse substrains.   
 
Specific Aim 2.  C57BL/6UofM mice:  P. gingivalis-specific IL-17A and IFN-γ 
Production by CD4+ T Cells in the Draining Cervical Lymph Nodes  
Finally, our lab raises C57BL/6 mice originally purchased from Jackson 
Laboratories several generations ago.  Therefore, their microbiota and genetics 
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cannot be assumed to be identical to original Jackson substrain.  These mice 
have been used as wild-type littermate controls for transgenic mice and are 
designated C57BL/6UofM (Table 4).     
We determined that C57BL/6UofM mice have P. gingivalis gingipain-
specific Th17 cells their cervical draining lymph nodes (CLN) 28 days after initial 
oral colonization with P. gingivalis (224).  The frequency of P. gingivalis-specific 
Th1 cells gradually increases after day 28 of persistent P. gingivalis colonization, 
while the frequency of Th17 cells remains relatively heightened and constant 
over time.  C57BL/6UofM were therefore utilized to correlate concurrent 
production of IL-17A and IFN-γ in CD4+ T cells with fetal weight outcomes.   
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Table 4.  Expected T cell Substrain Phenotypes and SFB Colonization 
 
Substrain 
P. gingivalis-specific T cell 
response (predicted) 
SFB colonization 
C57BL/6J Th1 – IFN-γ No 
C57BL/6NCrl Th17 – IL-17A Yes 
C57BL/6UofM Th17/Th1– IL-17A/ IFN-γ To Be Determined 
BALB/cJ Th2 – IL-4 No 
BALB/cAnNCrl Th2 – IL-4 Yes 
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Animal Husbandry 
C57BL/6UfoM mice were bred in-house.  All other mice were purchased 
from their respective vendors.  Mice were housed in microisolator cages in 
accordance with University of Minnesota and National Institutes of Health 
guidelines.  All experiments were performed on female (8–10 weeks) mice with 
vendor substrain-matched male wild type mice used for mating.  Protocols were 
approved by the Institutional Animal Care and Use Committee of the University of 
Minnesota Protocol # 0912A75416, 1211A24161, 151133178A.   
 
P. gingivalis Culture and Inoculation 
P. gingivalis strain ATCC 53977 was grown on blood agar plates as 
previously described (212, 224).  P. gingivalis was harvested and re-suspended 
in 2% low viscosity carboxymethylcellulose (Sigma) such that each mouse 
received 4 x 109 CFU per 50 µl inoculation by oral gavage.  Two percent 
carboxymethylcellulose alone was used as sham vehicle control.  Inoculation 
began after 10 days of sulfamethoxazole and trimethoprim (SMZ) pre-treatment 
followed by four days of water only as previously described (212).  Mice were 
inoculated every 4 days until termination of experiment.  The timeline of 
inoculation and mating is included as Figure 1.      
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Figure 1. Experimental Timeline.  Time course of oral inoculations with P. gingivalis, 
mating, and harvesting of pregnant and non-pregnant female tissues and fetuses.   
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Mating and Evaluation of Copulation Plug 
Forty days after initial oral inoculation, female mice were cohoused with 
vendor substrain and age matched naïve male mice at a ratio of one male to two 
females.  Copulation plugs were evaluated each morning for four days, 
representing the duration of one mouse estrus cycle, after addition of females to 
male cage.  Females were removed from males at the first instance of an 
observable population plug or after four days/one estrus cycle without observable 
plug, whichever came first.  Day zero of pregnancy was determined by the 
presence of a copulation plug and subsequent separation from the male.   
 
Isolation of Lymph Nodes and Maternal Tissue  
On Day E17 of gestation, or equivalent in females that plugged but did not 
become pregnant, mice were euthanized by CO2 inhalation.  The uterus, with or 
without accompanying fetuses, was immediately removed.  Maternal draining 
cervical lymph nodes (CLN) and para-aortic (or lumbar, PaLN) lymph nodes were 
collected for ELISpot.  Maternal blood, liver, and spleens were also harvested for 
later PCR analysis.  All tools used for placenta dissection were initially cleaned 
with 10% bleach followed by DNA-Out (G-Biosciences) between procedural 
steps.   
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ELISpot 
Maternal PaLN-CLN were reduced to single cell suspensions as 
previously described (224).  CD4+ T cells were purified using a commercially 
available kit per company instructions, with LS type purification columns 
(Miltenyi-Biotech 130-104-454, 130-042-401).  Recovered cells were routinely a 
minimum of 94% CD4+ T cells.  CD4+ T cells were counted and plated at 3 x 105 
CD4+ T cells/well in a 96 well plate (EMD Milipore MAIPS4510) pre-coated with 
IL-17A, IFN-γ, or IL-4 ELISpot capture antibodies (Ebio17CK15A5, AN-18, 
11B11, Thermo Fisher).  3 x 105 irradiated antigen presenting cells (2000 rads, 
splenocytes) from a naïve strain-matched mouse were subsequently added to 
the purified CD4+ T cells and mixed in Click’s Medium supplemented with heat-
inactivated FBS (Atlas Biological) L-glutamine, 2-mercaptoethanol, and 
antibiotics as previously described (224). 
To the negative control wells, media only was added.  50ng/ml phorbol 
myristate acetate (PMA)/ plus 500ng/ml Ionomycin (Sigma) was added to 
positive control wells.  1 x 108 CFU of freeze-killed P. gingivalis was added to all 
other wells in order to determine the memory CD4+ T cell response to P. 
gingivalis.  After 40 hours of incubation at 37 degrees C and 5% CO2, cells were 
washed away, leaving only cytokines bound to the plate membrane surface.  
Biotin-conjugated anti IL-17A, IFN-γ, or IL-4 detection antibodies (Ebio17B7, R4-
6A2, BCD6-2462, Thermo Fisher) were incubated on the plates for 3 hours at 
room temperature.  Detection antibodies represented different clones against 
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different epitopes, with different binding sites on the cytokine from capture 
antibodies.   
Spots were revealed with avidin-horseradish peroxidase (Thermo Fisher) 
followed by 3-amino-9-ethylcarbazole (AEC) substrate for ELIspot (BD 
Biosciences part #551951).  Each spot was determined to represent one T cell 
producing a cytokine of interest, or one spot forming unit (Figure 2).  Spot counts 
were determined using Cellular Technology Limited (CTL) branded 
Immunocapture and ImmunoSpot® software with SmartCount™, hair (or debris) 
removal, 95% of well area analyzed and subsequently processed for quality 
control.  Edges of wells were excluded to avoid picking up spots caused by edge 
effects.   
We attempted to evaluate IL-10 production via ELISpot as well, however, 
there was a very high non-antigen specific background production of IL-10 in 
both sham and P. gingivalis colonized mice, even without any in vitro re-
stimulation.  This was true for both pregnant and non-pregnant females.  
The subset of females used for ELISpot were determined to have fetal 
weights representative of total experimental dams.  On a final note, some 
females that were pregnant without a known copulation plug date were used to 
increase ELISpot numbers comparing pregnant sham- and P. gingivalis-
colonized females but could not be used to correlate ELISpot cytokine results to 
fetal weight as the exact gestational ages of their fetus were unknown.   
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Figure 2.  Example of ELISpot Plate Readout for IL-17A.  3 x 105 purified CD4+ T 
cells from sham or P. gingivalis orally colonized mice were plated wells pre-coated with 
functional grade purified anti-IL17A.  3 x 105 irradiated splenocytes from strain-matched 
naïve mice were added and cells were thoroughly mixed by gentle pipetting followed by 
gentle rocking.  Finally, media only, freeze-killed P. gingivalis, or PMA/Ionomycin 
positive control (not shown) were added to wells in duplicate.  After 40 hours incubation, 
cells were washed off and cytokine production was revealed with anti-IL17A biotin, 
avidin-horseradish peroxidase, and AEC substrate.  Plates were imaged and counted on 
a CTL ELISpot classic imager, with proprietary CTL counting software.   
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Isolation of Fetus and Placenta 
All tools used for placenta dissection were initially cleaned with 10% 
bleach followed by DNA-Out (G-Biosciences) between procedural steps.  The 
uterus and fetuses were removed.  The uterine chain was washed three times in 
three changes of sterile PBS to remove external maternal bacterial and blood 
contamination.  Each fetus and placenta was separated into individual wells of a 
24-well tissue culture dish (Corning).  An individual 18 gauge needle was used to 
separate the fetus from placenta.  Fetuses were patted dry to remove excess 
amniotic fluid, weighed, photographed, and were ultimately decapitated to ensure 
humane euthanasia (IACUC protocol).  Each pair of placentas of one litter were 
divided in half.  The first half of each placenta was used for DNA purification and 
qPCR.  The other half was either fixed in neutral buffered 10% formalin (Cancer 
Diagnostics) for immunohistology or frozen in RNAlater (Sigma-Aldrich) for 
archival purposes and future RNAseq.   
 
DNA Purification 
DNA was purified from placenta samples using a MasterPure DNA 
Purification Kit (Epicentre) per manufacturer protocol with modifications.  
Samples were placed in 300 µL of Tissue Lysis Buffer containing 50 µg of 
proteinase K and allowed to incubate overnight at 55 °C in a water bath.  One 
hundred seventy-five µL of protein precipitation solution was added after samples 
were cooled to room temperature.  After centrifugation, the supernatant was 
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removed and cleaned with washes of isopropanol and ice cold 70% ethanol.  
DNA pellets were re-suspended in 500 µL of TE buffer (Genemate).  
Concentration of DNA in samples was determined with a NanoDrop 2000 
(Thermo Fisher).  Samples were uniformly re-suspended at 50 ng/µL of total 
DNA.  Laboratory tools and disposables used for DNA techniques and qPCR 
were kept separate from tools and disposables used to prepare bacteria or 
murine tissue harvesting.  Barrier tips were also exclusively used to prevent DNA 
carry over on pipet surfaces.  Pipets and other equipment were treated with 10% 
bleach and DNA Out to avoid carry over of DNA from one reaction to another.   
Pure cultures of P. gingivalis were processed in the same manner for 
positive controls.  Ear and tail cuttings from naïve, unexposed weanlings and 
breeding males were processed by the same technique to serve as negative and 
contamination controls.  Standards were prepared by isolating genomic DNA 
from sham inoculated or naïve mouse ears or tails and spiking them with known 
amounts of DNA from pure cultures of P. gingivalis strain 53977.   
 
Conventional Nested PCR for Presence of Pg in Placentas 
A: External nested PCR primers.  GoTaq Clear Master Mix (Promega) was 
combined with 0.5 µM of each external primer (Table 5) and 250 ng of total DNA.  
The first round of amplification was performed on a Mastercycler Gradient 
thermocycler (Eppendorf) with the following conditions:  95 °C for 2 minutes, 
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followed by 26 cycles of 95 °C for 30 seconds, 54 °C for 2 minutes, and 72 °C for 
3 minutes. 
B: Internal nested PCR primers:  Reaction produced by amplification “A” 
(just above) was diluted 1/200.  GoTaq Green Master Mix (Promega) was 
combined with 0.5 µM of each internal primer (Table 5) and 5 µl of 1/200 dilution 
from step A.  Second round amplification was performed on a Mastercycler 
Gradient (Eppendorf) with the following conditions: 95 °C for 2 minutes, followed 
by 30 cycles of 95 °C for 30 seconds, 60 °C for 30 seconds, and 72 °C for 3 
minutes. 
Products from reaction B were run on a 2% agarose gel to identify P. 
gingivalis-specific DNA amplicons.   
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Table 5.  External and Internal Nested Primers  
Reaction A & B. 
Primer name 
Nucleotide sequence Reference 
A. External F 5’-3’ GTGAGGTAACGGCTCACCAA 
Created with NCBI 
primer blast 
A. External R 5’-3’ AATATGGCTTTTCGCCGTGC 
Created with NCBI 
primer blast 
B. Internal F 5’-3’ AGGCAGCTTGCCATACTGCG (152, 225-228) 
B. Internal R 5’-3’ ACTGTTAGCAACTACCGATGT (152, 225-228) 
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Conventional PCR as Template for Nested qPCR. 
The first round of amplification for nested qPCR was identical to the first 
round of amplification for nested conventional PCR.  GoTaq Clear Master Mix 
(Promega) was combined with 0.5 µM of each external primer (Table 5, “A” 
primers) and 250 ng of total DNA.  Samples with known volumes of mouse 
genomic DNA plus known volumes of P. gingivalis DNA were used to establish a 
standard curve for downstream qPCR analysis.  The first round of amplification 
was performed on a Mastercycler Gradient thermocycler (Eppendorf) with the 
following conditions:  95 °C for 2 minutes, followed by 26 cycles of 95 °C for 30 
seconds, 5 °C for 2 minutes, and 72 °C for 3 minutes.  Pipets and other 
equipment were treated with 10% bleach and DNA Out to avoid carry over of 
DNA from one reaction to another.   
 
Quantitative PCR (qPCR) with Nested Internal Primers 
First round samples were diluted 1/200 in nuclease free water after 
amplification.  Maxima SYBR Green/ROX qPCR (Thermo Fisher) master mix 
was combined with 0.5 µM of each internal primer and 5 µl of 1/200 diluted 
sample from conventional PCR with external primers (Table 5, “B” primers).  
Each sample was prepared in duplicate.  Samples were processed on an 
Mx3000p qPCR thermocycler (Agilent Technologies) with the following 
conditions: Normal 2-step qPCR was selected with an annealing temperature of 
60 °C x 1 minute for 36 cycles, followed by standard melt curve analysis.  All 
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other parameters were as recommended by qPCR master mix instructions.  
Nested qPCR was determined to be approximately 10-fold more sensitive than 
conventional nested PCR.  Nested qPCR could detect P. gingivalis in samples 
that were deemed negative by conventional, non-nested qPCR.  Increasing 
amounts of starting total DNA decreased sensitivity.   
Pure P. gingivalis DNA produced a melt curve peak around 84 °C (Figure 
3).  Ng of P. gingivalis DNA detected were converted into equivalent CFU of P. 
gingivalis present necessary to produce that much P. gingivalis DNA (Figure 4).   
 
Statistical Analysis of Nested qPCR.   
Threshold cycle (Ct) is the cycle number at which the fluorescence 
generated within a reaction crosses the threshold. Ct is inversely correlated to 
log value of initial copy number of the template DNA.  DRn (Δ Rn) is the 
magnitude of the SyBR green fluorescence signal generated during the qPCR at 
a given time point, when normalized to a reference value generated by the 
reference dye ROX for this data set.  Fluorescence -R’(T) is a value generated by 
DNA-binding dye SyBR green in the qPCR assay.  As the amplicon fragment is 
heated a sudden decrease in fluorescence is detected when the melting 
temperature (Tm) is reached.  The temperature at which SyBR green loses 
fluorescence is displayed as a peak on the melt curve analysis.  A non-linear 
regression fit for line x is log and y is linear was used to calculate the standard 
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curve, where x was ng of P. gingivalis DNA and y was threshold cycle (Ct).  The 
slope of the standard curve is used for efficiency calculation.  A slope of -3.32 
indicates ideal efficiency of the qPCR reaction (within the range of -3.1 to -3.6 is 
generally considered acceptable).  
Statistical analysis of standard curves and unknowns was done with Prism 
6.0 (GraphPad). Prism was also used to interpolate unknown values from the 
standard curve.  Mass of P. gingivalis DNA in ng per 250 ng of total DNA was 
correlated with fetal weight using Spearman's correlation.   
 
Analysis of SFB in Intestinal Samples 
To isolate DNA, samples of intestine and placentas were digested as 
described above.  Isolated total DNA (genomic mouse plus bacterial) was 
analyzed via PCR as described in (229). 
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Figure 3. Nested qPCR.  A) Amplification curve which displays the cumulative 
magnitude of fluorescence signal of DS DNA at the end of each cycle.  The cycle at 
which the threshold is crossed (i.e. 12 cycles arrow) from two independent samples is 
dependent on the amount of target DNA sequence being amplified.  B)  Temperature at 
which a significant decrease in SyBR green fluorescence is detected displayed as an 
inverted peak.   P. gingivalis DNA after nested qPCR produced a melt curve peak 
around 84 °C using the given primers.   
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Figure 4. Recoverable DNA from Serial Dilutions of Pure Cultured P. gingivalis. 
OD600 was used to determine the colony forming units (CFU) of P. gingivalis in 
suspension based on growth curves from serial dilutions.  DNA was extracted using the 
same techniques and reagents as the mixed tissue-bacterial samples.  Total ng of DNA 
that could be recovered across multiple serial dilutions was determined.  Three 
independent replicates of this experiment were performed.  An average of these values 
was used to convert ng of DNA identified by qPCR into equivalent CFU of P. gingivalis 
present.   
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Results 
P. gingivalis is Detected in Murine Placentas after Mucosal 
Colonization 
Given the failure of oral-only focused treatment to reduce the risk of 
APOs, we deduced that the association between periodontitis-associated 
pathogens and APOs must be assessed in the reproductive organs.  We tested 
the hypothesis that periodontal pathogens such as P. gingivalis were present in 
the placenta or uterine tissues in association with low fetal weight.  The 
hypothesized mechanisms by which P. gingivalis in the placenta could lead to 
APOs were either direct damage of the fetoplacental unit via virulence factors or 
initiation of an inflammatory immune response against P. gingivalis that lead to 
indirect impairment of placental nutrient transfer.  To test whether P. gingivalis 
can be detected in the placental tissue, conventional nested PCR was used to 
evaluate the presence or absence of P. gingivalis DNA in murine placental tissue 
after oral colonization of the dam with P. gingivalis.   
P. gingivalis DNA was detected in most placentas from orally colonized 
C57BL/6J dams (Figure 5).  P. gingivalis DNA was not detected in placentas of 
sham colonized dams (Figure 5).  In dams that were orally colonized with P. 
gingivalis there was a significant reduction in fetal weight (p ≤ 0.05) as compared 
to dams that were sham colonized (Figure 5). 
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Within the dams that were orally colonized with P. gingivalis ultimately 
average fetal weight in placentas where P. gingivalis was detected and placentas 
where P. gingivalis not detected by conventional nested PCR were similar 
(Figure 5).  P. gingivalis DNA could not be detected in uterine tissues from these 
mice, even when P. gingivalis DNA was detected in placentas from the same 
dam (data not shown).   
Given that mere presence of P. gingivalis DNA in the placenta did not 
explain fetal weight outcomes, we next questioned whether the amount of P. 
gingivalis DNA in the placenta, and not just presence, might be correlated with 
fetal weight outcomes.   
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Figure 5.  P. gingivalis DNA can be Detected in the Placentas of C57BL/6J Dams 
after Oral Colonization with P. gingivalis.  Sham- or P. gingivalis-colonized C57BL/6J 
females were harvested on day E17 of gestation from the date the copulation plug was 
observed.  Placentas were harvested and total DNA was isolated for conventional 
nested PCR with primers specific for a region spanning between the 16s and 23s rRNA 
genes of P. gingivalis.  Fetal weight was determined after removal of amniotic fluid, sac, 
and placenta.  24 tested placentas from P. gingivalis orally colonized mice were negative 
for P. gingivalis DNA; 46 were positive.  Data is shown as average fetal weight ± SD.  * = 
Student’s t test p ≤ 0.05 
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Increasing Amounts of P. gingivalis DNA in C57BL/6J and 
C57BL/6UofM Placentas Correlates with Decreasing Fetal Weight 
The results for presence of P. gingivalis DNA in the placenta raised two 
possibilities.  First, some low fetal weight placentas may have had P. gingivalis 
DNA present, but there was not enough to meet the limit of detection of the 
conventional nested PCR assay.  The other was that presence of P. gingivalis in 
the placenta, as proxy measured by amount of P. gingivalis DNA, might be less 
important than the amount of P. gingivalis present.  Indeed, this is the situation in 
the oral cavity, where P. gingivalis is normally found at low levels in the orally 
healthy individual and significantly higher levels in the periodontally diseased 
individual.  We thus decided to use a more sensitive nested quantitative PCR 
(nested qPCR) methodology to assess the amount of P. gingivalis DNA present 
in murine placentas.  This would allow us to potentially detect bacteria in 
placentas that were negative by conventional nested PCR and quantitate an 
estimate of the bacterial burden per placenta.  Assay quality control was 
performed by spiking naïve mouse genomic DNA with known amounts of P. 
gingivalis genomic DNA (Figure 6).  
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Figure 6.  Nested qPCR for P. gingivalis DNA in Placentas of C57BL/6J Mice.  
Detection of a P. gingivalis specific sequence within 250 ng naïve mouse genomic DNA:  
7 ng (1 x 106 equivalent CFU) (A), 0.7 pg (equivalent 100 CFU) (B) or no P. gingivalis 
DNA (C).  7 ng of P. gingivalis DNA present in mouse genomic DNA produced a narrow 
melt curve that peaks at 84°C only (D).  Lower amounts of P. gingivalis DNA (0.7 pg) 
yielded two melt curves, a wide peak at 75°C and a narrow P. gingivalis-specific peak at 
84°C (E).  When P. gingivalis DNA is absent (F) only a wide 75°C melt curve was 
produced due to excess of primers and potential mispriming.   
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Nested qPCR had a lower limit of detection than conventional qPCR 
revealing that some samples that were P. gingivalis negative with conventional 
nested PCR were positive with nested qPCR.  Two-thirds of C57BL/6J mouse 
placentas were ultimately found to contain P. gingivalis DNA by nested qPCR, 
with a limit of detection equivalent to 10 CFU of P. gingivalis per 250 ng of 
placental DNA.  Increasing amounts of P. gingivalis DNA in C57BL/6UofM and 
C57BL/6J placentas were correlated with decreasing fetal weight (Figure 7A and 
7B).  P. gingivalis DNA was not detected in any placentas from sham-inoculated 
females (data not shown).   
We can therefore conclude that P. gingivalis in the placenta represents a 
hypothetical antigen pool that would be effective in attracting and re-stimulating 
P. gingivalis-specific memory CD4+ T.  This could result in the release of 
cytokines such as IFN-γ, which has been shown to be detrimental to pregnancy 
outcomes, into the placental tissue.   
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Figure 7.  Increasing Amounts of P. gingivalis DNA in Placentas is Correlated 
with Reduced Fetal Weight.  Nested PCR of placental tissue from C57BL/6UofM (A) 
and C57BL/6J (B) using primers specific for the intergeneric region between the 16s and 
23s rRNA genes of P. gingivalis were utilized to correlate fetal weight and amount of P. 
gingivalis DNA.  Nanograms of P. gingivalis DNA per 250ng of placental DNA in this 
assay was determined using a standard curve generated from naïve mouse DNA spiked 
with known amounts of P. gingivalis pure culture DNA.  All samples for which no P. 
gingivalis DNA could be detected were set as the limit of detection (0.07 pg or 10 CFU of 
P. gingivalis DNA per 250 ng total placental DNA).  Spearman correlation was used to 
compare amounts of P. gingivalis DNA (measured in ng) with fetal weight (grams).  Each 
data point represents the weight one fetus (x) to P. gingivalis DNA in the corresponding 
placenta (y). Data was converted to equivalent CFU of P. gingivalis to demonstrate 
clinical relevance. 
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C57BL/6Uof M and C57BL/6J Mice Experience Low Fetal Weight 
in Response to Oral Colonization with P. gingivalis 
C57BL/6JUofM mice were derived from C57BL/6J mice several 
generations ago, meaning that while they are similar to one another, the two 
substrains cannot be assumed to perfectly identical either in genetics or 
microbiome.  Both show a correlation between increasing P. gingivalis DNA in 
placentas and decreasing fetal weight. 
C57BL/6J mice have been characterized as unable to develop Th17 in the 
lamina propria of the small intestine (Th17-deficient).  This deficiency is credited 
to the absence of SFB microorganisms in the ileum.  Virgin and male 
C57BL/6UofM mice have a dual IL-17A/IFN-γ response to P. gingivalis in their 
CLN after chronic P. gingivalis colonization (greater than 35 days) with repeated 
inoculations (224).   
P. gingivalis colonized C57BL/6UofM and C57BL/6J females experienced 
significantly lower average fetal weight per dam than sham colonized females 
(Figure 8).  Although significant for both substrains, fetal weight reduction was 
more severe in C57BL/6J than in C57BL/6UofM dams after oral colonization with 
P. gingivalis.  
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Parameter C57BL/6UofM 
Sham vs P. gingivalis 
C57BL/6J 
Sham vs P. gingivalis 
Fetal Weight 0.909 vs 0.802 g 
*p < 0.0001 
0.900 vs 0.722 g 
*p < 0.0001 
n Sham dams 30 16 
n P. gingivalis dams 37 31 
 
Figure 8.  Reduced Fetal Weight in C57BL/6UofM and C57BL/6J mice in 
Response to Oral Colonization with P. gingivalis.  Fetuses were harvested on day 
E17 from dams that were orally colonized with P. gingivalis or sham only.  After removal 
of the placenta, amniotic sac, and amniotic fluid the fetuses were weighed.  Student’s 
unpaired t-test with Welch’s correction was used to compare the average fetal weight 
per dam and average fetal weight per group.  Symbols (circles and squares) show 
average fetal weight per dam/litter.  Experimental groups shown display average ± SD. 
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Frequency of P. gingivalis-specific CD4+ T cells Producing IL-
17A and IFN-γ were Similar between Sham and P. gingivalis 
colonized C57BL/6UofM or C57BL/6J dams 
Since C57BL/6UfoM and C57BL/6J mice experienced reduced fetal 
weight in response to oral P. gingivalis colonization (Figure 8), we hypothesized 
that an increased frequency of IFN-γ producing P. gingivalis-specific CD4+ T cells 
in the maternal PaLN-CLN would correlate with reduced fetal weight.  We utilized 
ELISpot assay to measure three subset-specific cytokines: IL-17A, IFN-γ, and IL-
4.  The frequency of P. gingivalis specific CD4+ Th cells of a specific phenotype 
as measured by number of spot forming units (SFU) were compared in mice that 
were orally colonized with P. gingivalis and sham-colonized mice after in vitro P. 
gingivalis re-stimulation.   
We discovered that pregnant C57BL/6UofM mice have a greater 
frequency of IL-4-producing P. gingivalis-specific CD4+ T cells in PaLN-CLN after 
oral colonization with P. gingivalis (Figure 9A).  Pregnant C57BL/6J mice had an 
equal frequency of IL-4 producing P. gingivalis-specific CD4+ T cells after oral 
colonization with sham or P. gingivalis (Figure 9B).  Sham and P. gingivalis orally 
colonized C57BL/6UofM and C57BL/6J dams had the same frequency of P. 
gingivalis-specific CD4+ T cells producing IL-17A or IFN-γ (Figure 9, A and B).  
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Figure 9.  Frequency of CD4+ T cells Producing IL-4 was Significantly Increased 
in Response to P. gingivalis in the PaLN-CLN of Pregnant C57BL/6UofM 
females.  CD4+ T cells were purified from PaLN-CLN on day E17 from dams that were 
sham- or orally-colonized with P. gingivalis.  CD4+ T cells were plated with irradiated 
naïve splenocytes for ELISpot to determine the frequency of T cells releasing IL-17A, 
IFN-γ or IL-4 after re-stimulation with freeze/thaw killed P. gingivalis.  Groups were 
compared with Mann Whitney non-parametric test, as the cytokine data did not have a 
normal distribution.  Median ± interquartile range is displayed. 
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The average fetal weight of each individual litter was then correlated with 
the production of cytokines in CD4+ T cells in PaLN-CLN of each individual dam.  
The frequency of P. gingivalis-specific CD4+ T cells producing IL-17A, IFN-γ, or 
IL-4 in either substrain was determined to be independent of fetal weight (Figure 
10, Figure 11).   
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Figure 10.  Fetal weight was Independent of Frequency of CD4+ T cells 
Producing IL-17A, IFN-γ, or IL-4 in Response to P. gingivalis in C57BL/6UofM 
Dams.  PaLN-CLN were harvested on day E17 from C57BL/6UofM dams that were 
sham- or orally-colonized with P. gingivalis.  CD4+ T cells were purified and plated with 
irradiated naïve splenocytes to determine phenotype of cytokine output.  After removal of 
the placenta, amniotic sac, and amniotic fluid fetuses were individually weighed.  
Spearman correlation test was utilized to assess the relationship between the average 
fetal weight ± SD and the frequency of CD4+ T cells producing IL-17A, IFN-γ, or IL-4 in 
response to P. gingivalis.  PMA/Ionomycin positive controls showed the plated CD4+ T 
cells were capable of cytokine production in culture (data not shown).   
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Figure 11.  Fetal Weight was Independent of Frequency of CD4+ T cells 
Producing IL-17A, IFN-γ, or IL-4 in Response to P. gingivalis in C57BL/6J Dams.  
PaLN-CLN were harvested on day E17 from C57BL/6J dams that were sham- or orally-
colonized with P. gingivalis.  CD4+ T cells were purified and plated with irradiated naïve 
splenocytes to determine phenotype of cytokine output.  After removal of the placenta, 
amniotic sac, and amniotic fluid fetuses were individually weighed.  Spearman 
correlation test was utilized to assess the relationship between the average fetal weight 
± SD and the frequency of CD4+ Th cells producing IL-17A, IFN-γ, or IL-4 in response to 
P. gingivalis. PMA/Ionomycin positive controls showed the plated CD4+ T cells were 
capable of cytokine production in culture (data not shown).  
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Non-Pregnant C57BL/6UofM mice have Th17 and IFN-γ 
Producing P. gingivalis-specific CD4+ T cells  
Using a P. gingivalis-specific MHC class II tetramer we had previously 
shown that virgin female and male C57BL/6UofM mice orally colonized with P. 
gingivalis had P. gingivalis-specific CD4+ T cells in their CLN producing IL-17A at 
day 28 after initial P. gingivalis inoculation, and both IL-17A and IFN-γ cytokines 
after 35 days following initial P. gingivalis inoculation (224).  It was a mystery 
when the ELISpot analysis did not show a similar result in pregnant females. 
We therefore decided to evaluate the effect of pregnancy on the CD4+ T 
cell response to P. gingivalis after oral colonization and compared pregnant and 
non-pregnant females.  The pregnant and non-pregnant females were compared 
at the same age and at the same experimental time point after oral P. gingivalis 
colonization.  
Non-pregnant C57BL/6UofM females had an increased frequency of P. 
gingivalis-specific CD4+ T cells producing IL-17A and IFN-γ after P. gingivalis 
oral colonization (Figure 12, A).  This ELISpot results validates our previous 
tetramer findings in non-pregnant females.  Interestingly, the parent strain 
C57BL/6J also had increased frequency of IL-17A-producing P. gingivalis-
specific CD4+ T cells.  However, the frequency of IFN-γ producing P. gingivalis-
specific CD4+ T cells was the same whether the C57BL/6J mouse was orally 
colonized with P. gingivalis or sham (Figure 12, B).  
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Figure 12.  Frequency of CD4+ T cells Producing IL-17A and IFN-γ were 
Significantly Increased in Response to P. gingivalis in the PaLN-CLN of Non-
pregnant C57BL/6UofM Females.  CD4+ T cells were purified from PaLN-CLN on 
predicted day E17 from dams that were sham- or orally-colonized with P. gingivalis. T 
cells were plated with irradiated naïve splenocytes for ELISpot to determine the 
frequency of T cell releasing IL-17A, IFN-γ or IL-4 after re-stimulation with freeze/thaw 
killed P. gingivalis.  Groups were compared with Mann Whitney non-parametric test, as 
the cytokine data did not have a normal distribution.  Median ± interquartile range is 
displayed.
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Summary of C57BL6/UofM and C57BL/6J Outcomes  
Both C57BL/6J and C57BL/6UofM mice experienced low fetal weight in 
response to P. gingivalis.  However, low fetal weight appeared to be independent 
of the frequency of P. gingivalis-specific CD4+ T cells producing IL-17A, IFN-γ or 
IL-4 in either substrain. 
In non-pregnant C57BL/6UofM colonized with P. gingivalis the frequency 
of P. gingivalis-specific CD4+ T cells producing IL-17A and IFN-γ were 
significantly higher than in sham-colonized females.  In pregnant C57BL/6UofM 
such frequency of T cells producing IL-17A and IFN-γ was equal to sham-
colonized.  Similar findings occurred for the C57BL/6J mice.  Thus, pregnancy 
appears to dampen the response to P. gingivalis mediated by IL-17A- and IFN-γ-
producing CD4+ T cells.   
Given that the CD4+ T cell response was independent of fetal weight in 
C57BL/6J and C57BL/6UofM mice, we tested a different C57BL/6 substrain that 
is prone to a heightened Th17 response.  The Th17 response is induced by 
segmented filamentous bacterium (SFB) colonizing the ileum of C57BL/6NCrl, 
while C57BL/6J are SFB-negative.  Other immunological differences between 
C57BL/6J and C57BL/6NCrl mice have been reported, but whether these 
differences are caused by genetics or microbiota has not been definitively 
evaluated (220, 221, 230).   
Originally, we had hypothesized that an IFN-γ biased response to P. 
gingivalis in C57BL/6 background mice would be associated with low fetal weight 
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and an IL-17A response would not.  The presence of elevated IL-17A in non-
pregnant females of both C57BL/6UofM and C57BL/6J substrains lead us to 
wonder if instead, having more IL-17A in the C57BL/6NCrl mice would lead to an 
even greater reduction in fetal weight due to the inability to fully dampen excess 
IL-17A production during pregnancy.   
 
C57BL/6NCrl mice Do Not Experience Low Fetal Weight in 
Response to Oral Colonization with P. gingivalis 
Surprisingly, despite having the same overall genetic background as 
C57BL/6J mice or C57BL/6UofM, in C57BL/6NCrl mice fetal weight was the 
same in females orally colonized with P. gingivalis or with sham (Figure 13).  
Given that the C57BL/6 substrains that did experience low fetal weight had 
detectable P. gingivalis DNA in their placentas, we hypothesized that there would 
be an absence of P. gingivalis in the placentas of C57BL/6NCrl mice.  
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Parameter Sham vs P. gingivalis 
Fetal Weight 0.847 vs 0.797 g, p = 0.09 
n sham dams 11 
n P. gingivalis dams 36 
 
Figure 13.  Fetal Weight in C57BL/6NCrl Mice Orally Colonized with P. gingivalis 
was Similar to Controls.  Fetuses were harvested on day E17 from dams that were 
orally colonized with P. gingivalis or sham only.  After removal of the placenta, amniotic 
sac, and amniotic fluid the fetuses were weighed.  Student’s unpaired t-test with Welch’s 
correction was used to compare the average fetal weight per dam and average fetal 
weight per group.  Symbols (circles and squares) show average fetal weight per 
dam/litter.  Experimental groups shown display average ± SD. 
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Fetal weight in the C57BL/6NCrl was Independent of P. gingivalis 
DNA in Placenta  
We discovered that only 6.7% of the placentas were colonized with P. 
gingivalis in C57BL/6NCrl mice whereas 66% of placentas of C57BL/6J mice 
were colonized.  Moreover, the fetal weight was independent of the amount of P. 
gingivalis in the placenta in C57BL/6NCrl dams (Figure 14).  This indicates that 
there is an environmental or genetic difference that impairs the ability of P. 
gingivalis to colonize the placenta in this substrain of mice.  We therefore 
hypothesized that in these dams there would be few P. gingivalis-specific T cells 
due to lack of P. gingivalis for local re-stimulation.  
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Figure 14.  Amounts of P. gingivalis DNA in C57BL/6NCRL Placentas is Not 
Correlated with Reduced Fetal Weight.  Nested qPCR with primers specific for a 
region spanning between the 16s and 23s rRNA genes of P. gingivalis was utilized.  
Fetal weight was determined after removal of amniotic fluid, sac, and placenta.  Ng of P. 
gingivalis DNA per 250ng of placental DNA was determined using a standard curve 
generated from naïve mouse DNA combined with known amounts of P. gingivalis pure 
culture DNA.  All samples for which no P. gingivalis DNA could be detected were set at 
the limit of detection, (0.07 pg or 10 CFU).  Amounts of P. gingivalis DNA (measured in 
ng) were independent of fetal weight when assessed by Spearman’s correlation.  Each 
data point represents the weight one fetus (x) to P. ginivalis DNA in the corresponding 
placenta (y).  Data was converted to equivalent CFU of P. gingivalis to demonstrate 
clinical relevance. 
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In P. gingivalis Colonized C57BL/6NCrl Pregnant Dams the 
Frequency of P. gingivalis specific CD4+ Th cells Producing IL-
17A, IFN-γ, or IL-4 in the CLN was Like Sham 
The frequency of P. gingivalis-specific CD4+ T cells producing IL-17A, 
IFN-γ, or IL-4 observed in P. gingivalis colonized C57BL/6NCrl pregnant females 
on day E17 was the same as that observed in sham colonized females (Figure 
15, Right).  Interestingly, there was an increased frequency of P. gingivalis-
specific CD4+ T cells producing IL-17A, IFN-γ, and IL-4 cytokines in non-
pregnant females (Figure 15, Left).  Thus, all three substrains of C57BL/6 mice 
(UofM, J and NCrl) have an increased frequency of P. gingivalis-specific CD4+ T 
cells producing IL-17A when non-pregnant.  The frequency of P. gingivalis-
specific CD4+ T cells producing IL-17A in non-pregnant females was similar 
across the three C57BL/6 substrains, when evaluated by a Mann-Whitney non-
parametric test.  C57BL/6J and C57BL/6NCrl were thus similar in their ability to 
produce IL-17A in response to oral colonization with P. gingivalis.  Non-pregnant 
C57BL/6UofM and C57BL/6NCrl had also an increased frequency of P. 
gingivalis-specific CD4+ T cells producing IFN-γ.  The results in this substrain 
showing an increased production of IL-17A and IFN-γ in non-pregnant but not 
pregnant females thus further supports the concept that pregnancy dampens Th1 
and Th17 responses.  
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Figure 15.  Non-pregnant C57BL/6NCrl Mice Orally Colonized with P. gingivalis 
Developed more P. gingivalis-specific CD4+ T cells Producing IL-17A, IFN-γ, and 
IL-4 than Pregnant Mice.  PaLN-CLN was harvested from dams that were orally 
colonized with P. gingivalis or sham only.  CD4+ T cells were purified and plated with 
irradiated naïve splenocytes for ELISpot to determine phenotype of cytokine output.  
After in vitro re-stimulation with whole P. gingivalis, Mann Whitney non-parametric test 
was used to compare frequency of CD4+ T cells producing IL-17A, IFN-γ, and IL-4 in the 
P. gingivalis colonized versus sham females.  Data is shown as median ± interquartile 
range.
96 
 
 
In C57BL/6NCrl, when the average weight of each single litter is 
considered, there was a significant negative correlation between average fetal 
weight of that litter and the frequency of P. gingivalis-specific CD4+ T cells 
producing IFN-γ in the CLN of the dam producing that litter (Figure 16).   
However, despite the impact that the frequency of P. gingivalis-specific 
CD4+ T cells producing IFN-γ had on average fetal weight of individual dams, the 
average fetal weight of all dams that were sham-colonized was the same as the 
average fetal weight of all dams that were P. gingivalis-orally colonized.   
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Figure 16.  In C57BL/6NCrl Dams Orally Colonized with P. gingivalis, Lower 
Fetal Weight Correlated with Increased Frequency of P. gingivalis-specific CD4+ 
T cells Producing IFN-γ.  PaLN-CLN were harvested on day E17 from dams that were 
orally colonized with P. gingivalis or sham only.  CD4+ T cells were purified and plated 
with irradiated naïve splenocytes to determine phenotype of cytokine output.  After 
removal of the placenta, amniotic sac, and amniotic fluid fetuses were individually 
weighed.  Spearman’s correlation was used to correlate the frequency of CD4+ T cells 
producing IFN-γ in response to in vitro whole P. gingivalis re-stimulation and the average 
fetal weight ± SD in dams that had been orally colonized with P. gingivalis or sham. 
98 
 
 
Summary of C57BL/6NCrl in comparison to C57BL/6J and UoM 
In stark contrast to the C57BL/6J and C57BL/6UofM subtrains, P. 
gingivalis in the placenta was independent offetal weight in C57BL/6NCrl mice.  
Additionally, far fewer placentas are colonized in C57BL/6NCrl mice as 
compared to C57BL/6J mice.  In C57BL/6 background mice, it appears that P. 
gingivalis colonization of the placenta leads to low fetal weight, although whether 
P. gingivalis leads to low fetal weight directly or indirectly remains unclear. 
Similarly, if P. gingivalis is unable to colonize the placenta, C57BL/6 mice are 
protected from low fetal weight.   
 
SFB colonization in C57BL/6UofM and C57BL/6NCrl mice 
Non-pregnant C57BL/6UofM, C57BL/6J, and C57BL/6NCrl female mice all 
produced significant and equal amounts of IL-17A in their CD4+ T cells in 
response to oral colonization with P. gingivalis.  Intestinal SFB therefore did not 
appear to be necessary to induce P. gingivalis-specific Th17-type CD4+ T cells in 
the oral cavity when measured in the CLN of C57BL/6J.  In all three cases, 
pregnancy appears to dampen the IL-17A response such that sham and P. 
gingivalis-orally colonized females become similar.   
It was verified that C57BL/6J and C57BL/6UofM mouse intestines did not 
harbor intestinal SFB in our experiments (Figure 17).  The SFB-specific PCR 
amplicon band was consistently stronger in BALB/cAnNCrl than C57BL/6NCrl 
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mice when the same amount of starting DNA was used.  SFB was not detected 
in any C57BL/6UofM mouse. 
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Figure 17.  Only BALB/cAnNCrl and C57BL/6NCrl Mice Harbor SFB in their 
Intestines.  Ilium intestinal sections were isolated from multiple mice from each 
substrain and digested for total DNA isolation.  Conventional PCR was then performed 
on a standardized amount of total collected DNA to determine the presence or absence 
of SFB in each substrain, as described in (229).  
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Average Fetal Weight was Similar in BALB/cJ and 
BALB/cAnNCrl mice in Response to Oral Colonization with P. 
gingivalis or Sham 
Considering there is a difference in fetal weight outcomes between 
C57BL/6J and C57BL/6NCrl mice, we also tested BALB/c mice from the same 
respective vendors.  Regardless of vendor substrain, BALB/c mice had similar 
fetal weights whether orally colonized with P. gingivalis or sham (Figure 18 A, B).   
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Parameter BALB/cAnNCrl  
Sham vs 
P. gingivalis 
BALB/cJ 
Sham vs 
P. gingivalis 
Fetal Weight 0.668 vs 0.725 g, 
p > 0.05 
0.733 vs 0.774 g, 
p > 0.05 
n sham dams 12 11 
n P. gingivalis dams 34 33 
 
Figure 18.  Equal Fetal Weight in BALB/cAnNCrl and BALB/cJ Dams After Oral 
Colonization with P. gingivalis.  Fetuses were harvested on day E17 from dams that 
were orally colonized with P. gingivalis or sham alone.  After removal of the placenta, 
amniotic sac, and amniotic fluid fetuses were weighed.  Student’s unpaired t-test with 
Welch’s correction was used to compare the average fetal weight per dam and average 
fetal weight per group in both vendor substrains of BALB/c after oral P. gingivalis 
colonization.   Symbols (circles and squares) show average fetal weight per dam/litter ± 
SD.  Experimental groups shown display average ± SD.
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We next decided to evaluate the presence of P. gingivalis in the placentas 
of BALB/c mice.  Given that C57BL/6J mice with P. gingivalis in their placentas 
had low fetal weight and C57BL/6NCrl mice without P. gingivalis in their 
placentas did not have low fetal weight, we predicted that we would not find P. 
gingivalis in the placentas of BALB/c mice. 
In contrast, we found that 26% of BALB/cAnNCrl placentas and 50% of 
BALB/cJ placentas harbored detectable levels of P. gingivalis.  In both vendor 
substrains of BALB/c mice, within individual dams, increasing amounts of P. 
gingivalis DNA in the placenta correlates with decreasing average fetal weight.  
However, the average combined fetal weight of all sham-colonized and P. 
gingivalis-orally-colonized BALB/c dams was the same.  BALB/c mice are 
therefore resistant to significant fetal weight reduction as a consequence of P. 
gingivalis colonization of the placenta whereas the C57BL/6 mice are 
susceptible.    
  
104 
 
 
 
 
Figure 19.  Increasing Amounts of P. gingivalis DNA in BALB/c Placentas is 
Correlated with Reduced Fetal Weight.  Nested PCR with primers specific for an 
intergenic region between the 16s and 23s rRNA genes of P. gingivalis was utilized.  
Fetal weight was determined after removal of amniotic fluid, sac, and placenta.  Ng of P. 
gingivalis DNA per 250ng of placental DNA was determined using a standard curve 
generated from naïve mouse DNA combined with known amounts of P. gingivalis pure 
culture DNA.  All samples for which no P. gingivalis DNA could be detected were set at 
the limit of detection (0.07 pg or equivalent 10 CFU) to ensure the most rigorous 
analysis.  Increasing amounts of P. gingivalis DNA (measured in ng) were compared 
with decreasing fetal weight by Spearman’s correlation.  Each data point represents the 
weight one fetus (x) to P. ginivalis DNA in the corresponding placenta (y). Data was 
converted to equivalent CFU of P. gingivalis to demonstrate clinical relevance. 
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Non-pregnant BALB/cJ females developed a greater frequency of P. 
gingivalis-specific CD4+ T cells producing IL-17A after oral colonization with P. 
gingivalis (Figure 20B).  Non-pregnant BALB/CAnNCrl mice had a non-significant 
trend towards increased frequency of IL-17A producing P. gingivalis-specific 
CD4+ T cells (Figure 20A = 0.082).  
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Figure 20.  Frequency of CD4+ T cells Producing IL-17A was Significantly 
Increased in Response to P. gingivalis in the PaLN-CLN of Non-pregnant 
BALB/cJ females.  PaLN-CLN was harvested on predicted day E17 from dams that 
were orally colonized with P. gingivalis or sham only.  CD4+ T cells were purified and 
plated with irradiated naïve splenocytes for ELISpot to determine phenotype of T cell 
cytokine output.  Mann Whitney non-parametric test was used to compare frequency of 
CD4+ T cells producing IL-17A, IFN-γ, or IL-4 in the PaLN-CLN of BALB/females.   
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Decreased frequency of P. gingivalis-specific CD4+ T cells producing IL-
17A was correlated with increasing fetal weight in sham colonized BALB/cAnNCrl 
females, but this association was possibly driven by small sample size (Figure 
21A).  Frequency of P. gingivalis CD4+ T cells producing IL-17A, IFN-γ, or IL-4 
was independent of fetal weight in both vendor substrains of BALB/c mice after 
oral colonization with P. gingivalis (Figure 21A,B).   
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Figure 21.  Fetal Weight was Independent of Frequency of CD4+ T Cells 
Producing IL-17A, IFN-γ, or IL-4 in Response to P. gingivalis on Day E17 in the 
PaLN-CLN of BALB/c Dams.  PaLN-CLN were harvested on day E17 from dams that 
were orally colonized with P. gingivalis or sham alone.  CD4+ T cells were purified and 
plated with irradiated naïve splenocytes to determine phenotype of cytokine output.  
After removal of the placenta, amniotic sac, and amniotic fluid fetuses were individually 
weighed.  Spearman’s correlation was used to evaluate any potential correlation 
between average fetal weight ± SD and frequency of CD4+ T cells producing IL-17A, 
IFN-γ, or IL-4 in response to in vitro whole P. gingivalis re-stimulation.  
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Summary of Outcomes Related to Fetus 
The following table summarizes the results for P-gingivalis-specific CD4+ T 
cell phenotype, P. gingivalis presence in placenta, and fetal weight for each 
vendor substrain of C57BL/6 and BALB/c mouse used (Table 6).   
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Table 6.  P. gingivalis-specific T Cell Phenotypes and Fetal Outcomes 
 
Substrain Fetal Weight:  
Sham versus P. 
gingivalis oral 
colonization 
P. 
gingivalis 
DNA in 
placenta 
and Fetal 
Weight 
Frequency of P. gingivalis-
specific T cell producing IL-
17A, IFN-γ or IL-4 after oral 
colonization with P. gingivalis 
(p < 0.05) 
C57BL/6UofM *0.909 vs 0.802 g 
p < 0.0001 
Negative 
Correlation 
Non-pregnant:  ↑ IL-17A and IFN-
γ  
Pregnant:          ↑ IL-4 
C57BL/6J *0.900 vs 0.722 g 
p < 0.0001 
Negative 
Correlation 
Non-pregnant:  ↑ IL-17  
Pregnant:           Not different 
C57BL/6NCrl 0.847 vs 0.797 g 
p = 0.09 
Not 
Correlated 
Non-pregnant:  ↑IL-17A, IFN-γ, 
and IL-4  
Pregnant:          Not different 
BALB/cJ 0.773 vs 0.774 g 
p > 0.05 
Negative 
Correlation 
Non-pregnant: ↑IL-17A  
Pregnant:         Not different 
BALB/cAnNCrl 0.668 vs 0.725 g 
p > 0.05 
Negative 
Correlation 
Non-Pregnant:  Trend ↑IL-17A) 
Pregnant:          Not different 
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Summary of Outcomes Related to Dam 
The weight of P. gingivalis-colonized non-pregnant females or of dams 
after uterine excision were similar to sham-colonized females in all strains and 
substrains.  Additionally, there was no difference in embryo lethality or litter size 
between any P. gingivalis- and sham-colonized groups.  This suggests that P. 
gingivalis does not play a role in late term spontaneous abortion in this model.   
The rate at which female mice with observed copulation plugs were 
pregnant at expected day 17 of gestation versus those females that were 
ultimately not pregnant was similar across all three C57BL/6 substrains, and 
between any sham or P. gingivalis-colonized C57BL/6 mice.  The rate at which 
females with observed copulation plugs were pregnant versus not pregnant at 
expected day 17 of gestation was also similar between the two BALB/c 
substrains, or between any sham versus P. gingivalis-colonized BALB/c mice.  
This comparison is underpowered because to detect a difference in pregnancy 
rate of 20% with 80% Power using a chi-square test at the 0.05 alpha level we 
would have needed 104 C57BL/6UofM dams.  In the C57BL/6NCrl to detect a 
25% pregnancy rate difference we would have needed 67 dams per group.  For 
other strain and substrains the number of dams needed would have been even 
higher as the difference in pregnancy rate was smaller. 
In P. gingivalis-colonized mice only, there was a significant difference in 
pregnancy rate between the C57BL/6 mice and BALB/c mice (p = 0.0179).  
However, also in P. gingivalis-colonized mice only, the rate of pregnancy was 
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similar among all three C57BL/6 substrains or between the two the BALB/c 
substrains (Table 7).   
SFB colonization of the ileum was as expected.  Mice from Charles River 
Laboratory harbored SFB whereas mice from Jackson Laboratory did not.  
C57BL6/UofM, which were derived from Jackson mice, also did not harbor SFB 
(Figure 17).   
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Table 7.  Rate of Pregnancy and Average Litter Size in Females with 
Observed Copulation Plugs 
 
Substrain 
Ratio 
Non-Pregnant to Pregnant 
Average Litter Size 
SFB 
Colonization 
of Ileum 
 Sham  P. gingivalis-
colonized  
Sham -vs-  
P. gingivalis-
colonized 
 
C57BL/6UofM 11:11 (50%) 16:36 (70%) 7 – 8 No 
C57BL/6J 9:16 (64%) 15:31 (67%) 8 – 8 No 
C57BL/6NCrl 16:11 (41%)  19: 36 (66%) 8 – 8 Yes 
     
BALB/cJ 11:11 (50%) 38:33 (46%) 7 – 7 No 
BALB/cAnNCRL 14:12 (46%) 36:34 (50%) 6 – 8 Yes 
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Discussion 
We hypothesized that increased frequency of P. gingivalis-specific CD4+ T 
cells producing IFN-γ in the PaLN-CLN would correlate with decreasing fetal 
weight in C57BL/6J mice.  In other words, we hypothesized that we could model 
the host response to periodontal inflammation attributable to P. gingivalis, and 
explain low birth weights based on the biology of responding T cells.  Our data 
generally did not support our hypothesis of a correlation between P. gingivalis-
specific CD4+ T cell response and low fetal weight.   
 
Low Fetal Weight Phenotype in C57BL/6UofM and C57BL/6J mice is 
Independent of Frequency of P. gingivalis-specific CD4+ T cells Producing IFN-γ, 
IL-17A, or IL-4.   
Frequency of recirculating memory P. gingivalis-specific CD4+ T cells 
producing IFN-γ or IL-17A in PaLN-CLN on day E17 of gestation was the same in 
P. gingivalis-colonized C57BL/6J or C57BL/6UofM dams as compared to sham-
colonized.  Low fetal weight in C57BL/6J or C57BL/6UofM mice colonized with P. 
gingivalis was independent of the frequency of P. gingivalis-specific CD4+ T cells 
producing IFN-γ, IL-17A or IL-4.  These were the only two substrains that 
experienced fetal weight reduction in response to oral colonization with P. 
gingivalis.   
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We considered whether the test of correlation between fetal weight and 
frequency of CD4+ T cells producing IL-17A, IFN-γ, or IL-4 was appropriately 
powered.  In P. gingivalis-colonized C57BL/6J mice, the non-significant 
Spearman r values were 0.1725 for IL-17A, 0.3627 for IFN-γ, and 0.1783 for IL-4.  
In P. gingivalis colonized C57BL/6UofM mice the non-significant Spearman’s r 
values were -0.01722 for IL-17A, 0.112 for IFN-γ, and -0.1216 for IL-4.  To 
achieve 80% Power at alpha = 0.05 for IFN-γ with those correlation values would 
require a n of over 50 for C57BL/6J to over 500 mice for C57BL/6UofM.  
Importantly, Spearman’s correlation measures the strength of association 
between two variables, with a value of 1 or negative 1 indicating a perfect 
positive or negative correlation respectively. In conclusion, testing 500 mice for 
the sake of reaching sufficient Power for a weak correlation would not be a good 
use of resources.   
The lack of ability to detect a significant correlation between fetal weight 
and frequency of CD4+ T cells producing IL-17A, IFN-γ, or IL-4, as well as the 
weak, positive r values for this non-significant correlation, suggests that 
recirculating P. gingivalis-specific CD4+ T cells in the PaLN-CLN of C57BL/6J or 
C57BL/6UofM mice during pregnancy do not drive the low fetal weight 
phenotype.   
Alternative potential explanations for this result are: i) that recirculating P. 
gingivalis-specific CD4+ T cells in CLN do not represent P. gingivalis-specific 
116 
 
 
CD4+ T cells present in the uterus and/or placenta and ii) that the frequency of 
such T cells in PaLN is too low.  
PaLN which drain the reproductive track should contain recirculating P. 
gingivalis-specific CD4+ T cells from the uterine and placental area, given the 
presence of P. gingivalis antigens in the placenta.  When combined for ELISpot 
assays, CLN and PaLN produced on average 3 x 106-8 x 106 CD4+ T cells per 
mouse but PaLN CD4+ T cells were proportionally lower than those isolated from 
the CLN.  
The lack of ability to detect a correlation between fetal weight and CD4+ T 
cell response could also be related to timing between initial oral inoculation and 
time of conception.  Our time course was designed such that periodontitis, 
measured by alveolar bone destruction, would be present in these mice at the 
time of conception.  However, we have also observed in related studies that 
detectable numbers of P. gingivalis-specific CD4+ T cells in the CLN decrease 
over time in a mouse that is chronically infected with oral P. gingivalis (224).  
Since P. gingivalis invades the tissues it is likely that its antigens are being 
presented by professional antigen presenting cells (APCs) in the tissue to 
memory CD4+ T cells, as opposed to presentation by APC to naïve CD4+T cells 
in the draining lymph nodes.  As chronic infection progresses in mice this antigen 
presentation would keep memory CD4+ T cells within the tissues.  Therefore, 
there may have simply been too few recirculating P. gingivalis-specific CD4+ T 
cells left in CLN and PaLN to obtain sufficient numbers of P. gingivalis-specific 
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CD4+ T cells to accurately phenotype them during gestation in the chronic 
mucosal infection model.  Unfortunately, pooled placentas or uterine tissue did 
not yield sufficient numbers of P. gingivalis-specific CD4+ T cells of a high 
enough purity to conduct the ELISpot even when the placentas contained within 
the uterus were positive for P. gingivalis DNA at E17 of gestation.  It might have 
been possible to detect higher numbers of P. gingivalis-specific CD4+ T cells in 
PaLN-CLN with a shorter time course.  However, we do not currently know 
whether fetal weight reduction would be observed with a shorter P. gingivalis 
inoculation time course or if prolonged chronic oral infection is required to induce 
low fetal weight.  It remains a question that future research may be able to 
answer.  
 
All Non-Pregnant Females Harbor P. gingivalis-specific CD4+ T cells Producing 
IL-17A after Oral Colonization with P. gingivalis 
P. gingivalis colonized non-pregnant females from all substrains of 
C57BL/6 mice and BALB/cJ had a significantly greater frequency of P. gingivalis-
specific CD4+ T cells producing IL-17A in their PaLN-CLN than sham-colonized 
non-pregnant mice.  BALB/cAnNCrl mice demonstrated a similar non-significant 
trend.  Non-pregnant C57BL/6NCrl mice had the same frequency of P. gingivalis-
specific CD4+ T cells producing IL-17A in their PaLN-CLN as C57BL/6J mice.  
Surprisingly, this means that female mice from strains lacking intestinal SFB still 
mounted the same magnitude of Th17-biased response against oral P. gingivalis.  
118 
 
 
Definitively then, while essential to a submucosal Th17 response in the small 
intestinal lamina propria, a lack of intestinal SFB does not seem to impair the 
ability of non-pregnant C57BL/6UofM or J mice to mount a Th17-specific 
response to oral P. gingivalis.  Some P. gingivalis is always swallowed by the 
mice during oral gavage.  Thus, the possibility of a role for SFB-driven bystander 
activation of P. gingivalis-specific intestinal Th17 cells remains for protection 
against P. gingivalis-mediated low fetal weight in C57BL/6NCrl mice.  Low fetal 
weight in C57BL/6NCrl mice may also be prevented by a placental microbiome 
that is not permissive to P. gingivalis colonization.  
Even though both non-pregnant BALB/c and C57BL/6 mice had an 
increased frequency of P. gingivalis-specific CD4+ T cells producing IL-17A, only 
non-pregnant C57BL/6UofM and C57BL/6NCrl females developed a significantly 
higher frequency of P. gingivalis-specific CD4+ T cells producing IFN-γ.  The 
C57BL/6J substrain was expected to have the highest IFN-γ response to oral P. 
gingivalis because they are historically considered Th1-biased.  Surprisingly, 
C57BL/6J was the only tested C57BL/6 substrain that did not have an increased 
frequency of IFN-γ P. gingivalis-specific CD4+ T cells in non-pregnant mice in 
response to oral colonization with P. gingivalis.  
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Potential Explanations for the Discrepancy Between Non-Pregnant and Pregnant 
Females in Response to P. gingivalis 
Non-pregnant and pregnant female mice were harvested on the same 
equivalent time point in the experimental timeline, ruling out that a temporal 
difference is responsible for the difference in cytokine output.  Non-pregnant and 
pregnant female mice both had observable copulation plugs.  The difference 
between the two conditions is whether fetuses were present in the uterus at 
expected embryonic day 17 (E17).   
It is formally possible that pregnancy dampens or attenuates the adaptive 
immune response against P. gingivalis, resulting in a non-significant difference in 
cytokines between sham and P. gingivalis colonized females.  Pregnancy has 
been seen to dampen the adaptive immune response in animal models of 
autoimmunity, as discussed previously.   
One alternative explanation is that cytokines being produced by P. 
gingivalis-specific CD4+ T cells were involved in failure of implantation or early 
fetal abortion. Strong anti-P. gingivalis adaptive response may have prevented 
implantation resulting in lack of pregnancies.  The lack of a difference in the 
successful copulation plug-to-pregnancy rates observed within or across 
C57BL/6 and BALB/c substrains would suggest against this possibility, but our 
study population was too small to definitively rule this possibility out.  Staining the 
uterus of non-pregnant females to identify implantation sites indicating early 
spontaneous abortion could potentially help resolve this issue in a future study. 
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Given that the difference in fetal weight outcomes cannot be explained by 
production of IL-17A, IFN-γ, or IL-4 by recirculating P. gingivalis-specific memory 
CD4+ T cells, it becomes necessary to evaluate other potential causes for low 
fetal weight only in specific mouse substrains induced by oral colonization with P. 
gingivalis.  The correlation of P. gingivalis in the placental to low fetal weight in 
C57BL/6J and C57BL/6UofM mice, but not C57BL/6NCrl mice suggests a role for 
the placental, oral, or intestinal microbiome in preventing P. gingivalis 
colonization of the placental and subsequent P. gingivalis-mediated fetal weight 
outcomes.  The lack of low fetal weight in BALB/c mice despite comparatively 
high amounts of P. gingivalis DNA in their placentas suggests a genetic 
component of P. gingivalis-mediated fetal weight outcomes, perhaps driven by 
differences in innate immunity or components of the adaptive immune system 
other than CD4+ T cells.   
 
Microbial Communities and P. gingivalis-mediated Low Fetal 
Weight  
Reducing P. gingivalis from the periodontal pocket in SRP trials fails to 
reduce the risk of APOs (125, 136, 139, 231).  Therefore, P. gingivalis in the oral 
cavity alone does not appear to be a major driver of periodontitis-associated 
APOs, as that would require an immune response of significant magnitude to 
produce enough systemic cytokines to influence the fetoplacental unit.  For this 
reason, we needed to evaluate the presence of periodontal pathogens in the 
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placenta, and the potential that periodontal pathogens in the placenta could lead 
to local re-stimulation of memory CD4+ T cells. 
We determined that mere presence of P. gingivalis in the placenta, as 
proxy measured by amount of P. gingivalis DNA, was less useful in predicting 
whether low fetal weight would occur in C57BL/6J mice than the amount of P. 
gingivalis present.  This mimics the situation in the oral cavity, where P. gingivalis 
is normally found at low levels in the orally healthy individual and significantly 
higher levels in the periodontally diseased individual.   
 
P. gingivalis in the C57BL/6 placenta  
Sustained oral colonization with P. gingivalis of C57BL/6J and 
C57BL/6UfoM for six weeks leads to low fetal weight.  After embryo implantation 
and placental development, P. gingivalis can be detected in the established 
placenta but not in uterine tissues or blood at E17.  The amount of P. gingivalis 
DNA within 250 ng of placental DNA increased as fetal weight decreased.  This 
observation is not an artifact because the amount of starting total DNA in each 
qPCR sample was identical.  In C57BL/6NCrl, the strain that did not experience 
low fetal weight, fetal weight was independent of amount of P. gingivalis DNA 
and fetal weight.  Additionally, far fewer placentas were colonized with P. 
gingivalis in C57BL/6NCrl as compared to C57BL/6J mice.  
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Does either the C57BL/6NCrl Microbiome or SFB Have a Role in Pregnancy 
Outcomes?  
There are three major explanations for this difference in placental 
colonization between C57BL/6J and C57BL/6UfoM versus the C57BL/6NCrl 
mice.  First, it is possible that the non-P. gingivalis-specific SFB-mediated Th17-
biased predisposition of the C57BL/6NCrl mouse may be more effective at 
preventing P. gingivalis colonization or facilitating P. gingivalis clearance.  
Second, P. gingivalis may be less able to invade and colonize the placental 
microbiomes of the C57BL/6NCrl mouse as compared to other substrains.  SFB 
or the intestinal Th17 cell response it induces may be involved in protection 
against P. gingivalis-mediated low fetal weight, although it should not be 
assumed that SFB is the only important microbial difference between the 
C57BL/6 substrains.  Third, the potential environmental niche for P. gingivalis 
within the microbial community could be already occupied by another bacterium 
or the niche could be entirely absent in C57BL/6NCrl placental microbiomes.  
There could even be bacterial species that actively antagonize P. gingivalis.   
Despite the absence of SFB, C57BL/6UofM and J mouse CD4+ T cells still 
produce IL-17A in response to oral P. gingivalis.  Intestinal SFB colonization in 
C57BL/6NCrl and the consequent intestinal Th17 cells may protect against P. 
gingivalis-mediated low fetal weight by preventing P. gingivalis colonization of the 
placenta.  Once stimulated by swallowed P. gingivalis, the intestinal memory P. 
gingivalis-specific CD4+ T cells, rather than the oral ones, could recirculate and 
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eliminate potential P. gingivalis colonizing the C57BL/6NCrl placenta.  This 
hypothesis is supported by the observation that P. gingivalis is found only in 6% 
of C57BL/6NCrl placentas as compared to 66% of C57BL/6J placentas.  
 
Potential Alternative Mechanisms of P. gingivalis-mediated Low 
Fetal Weight 
P. gingivalis colonizing the placenta is not entirely the reason for low fetal 
weight.  Despite the presence of P. gingivalis in placentas in both BALB/c 
substrains, fetal weight was similar in P. gingivalis- and sham- colonized mice.  
Perhaps as periodontal pathogens such as P. gingivalis are necessary but not 
sufficient to induce periodontitis, it is plausible that species like P. gingivalis are 
necessary but not sufficient to induce APOs.  Given that the adaptive, P. 
gingivalis-specific CD4+ T cell response does not contribute to P. gingivalis-
mediated low fetal weight susceptibility, it is reasonable to speculate that the 
difference in fetal weight outcomes in BALB/cJ and BALB/cAnNCrl versus 
C57BL/6J and C57BL/6UfoM can be attributed in part to variation in the innate 
immune response or other parts of the adaptive immune response.   
It is likely that interactions between genetically determined variations in 
immunity and the environment determine susceptibility to infection and 
inflammation-induced APOS in mice, and probably also in humans.  
C57BL/6NCrl mice represent the intersection between genetics and microbiome 
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in determining susceptibility to low fetal weight in response to oral colonization 
with P. gingivalis.  Although belonging to the same H-2 haplotype, C57BL/6N 
mice have a different inflammatory phenotype than C57BL/6J mice.  Whether 
that difference is driven by genetic drift or differences in microbiota, or a 
combination of both, is still an open to debate.  While SFB in C57BL/6N shows 
that the microbiota can alter the immune response, murine strain variations in the 
immune phenotype may also affect the populations of microorganisms that are 
capable of permanently colonizing the different strains of BALB/c or C57BL/6 
mice and substrains of each.   
 
Alternative Sources of IFN-γ from Innate and Adaptive Immunity 
Our hypothesis focused on IFN-γ producing CD4+ T cells specific for P. 
gingivalis because increasing amounts of systemic IFN-γ have been correlated 
with low fetal weight in previous animal studies.  However, CD4+ T cells 
producing IFN-γ may be specific for other species reacting to the presence of the 
keystone pathogen P. gingivalis or to the changes it induces in local nutrient 
availability, and not P. gingivalis itself.  It is also possible that the source of 
elevated IFN-γ is not CD4+ T cells.  CD8+ cytotoxic T cells, mucosal epithelial 
cells, natural killer and natural killer T cells can also produce IFN-γ in significant 
amounts.  While excessive inflammation has been associated with APOs, some 
production of IFN-γ by uterine natural killer cells (uNK cells) is necessary for 
murine implantation (97, 232).   
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IL-10 Modulates the IFN-γ Response and can be Produced by Adaptive Tregs or 
Innate Cells of the Female Reproductive Track 
The “increase” in Th1-associated cytokines detected historically may be a 
by-product of a decrease in Th2- and/or Th17-associated cytokines, or even 
failure of Treg to control inflammation.   
IL-10 has been associated with both Th2 and Treg cells.  The role of CD4+ 
T cell production of IL-10, which may be involved in protection against low fetal 
weight, was not evaluated in these experiments.  This is because in pilot 
experiments we detected high frequency of irradiated splenocytes producing IL-
10.  The frequency of irradiated splenocytes plus CD4+ T cells from PaLN-CLN 
producing IL-10 from sham- or P. gingivalis-colonized mice was even higher than 
splenocytes alone and not different from one another.  This finding prevented the 
determination of the true signal of IL-10 from CD4+ T cells specific for P. 
gingivalis via ELISpot.  Simply measuring systemic IL-10 would not suffice 
because, like IFN-γ, it can be produced by cells other than CD4+ T cells.  IL-10 
can be produced by uterine natural killer cells and placental trophoblasts for 
example.  It is especially worth noticing that uterine natural killer cells produce 
IFN-γ to assist with implantation, but also produce IL-10 to assist with fetal 
tolerance.  Uterine natural killer cells can thus be pro- and anti-inflammatory, and 
both roles are important for normal pregnancy (232-234).  
126 
 
 
Tregs have been implicated in fetal tolerance and maintenance of 
pregnancy (97).  We determined that pregnancy dampens the cytokine response 
as compared to non-pregnant females at the same time point, which suggests 
the involvement of Tregs and/or Treg-associated cytokines.  Even though Tregs 
are known to produce IL-10, Tregs are usually identified by the expression of 
transcription factor FoxP3 rather than specific cytokines, which makes ELISpot 
not viable for detecting Tregs.  Alternative techniques such as MCH class II 
tetramer staining or fate-tracking mice that express fluorescent proteins in Treg 
cells may be useful in determining whether adaptive Treg or IL-10 producing 
Treg/Th2 cells are involved in protection against P. gingivalis-mediated low fetal 
weight.  We may need to consider the balance of Tregs to Th1 and Th17 cells to 
determine the mechanism of P. gingivalis-mediated low fetal weight.   
 
Innate Immunity: P. gingivalis Modulates Complement and Toll-like Receptor 
Response 
The actions of P. gingivalis on complement and toll-like receptors 
demonstrates one way the microbiome and host immunity can interact in a 
manner that is favorable to growth of the microorganism.  P. gingivalis-mediated 
low fetal weight in BALB/c versus C57BL/6 may depend on differences in 
complement and toll-like receptor regulation and function.   
The complement system always operates at a low, steady level of 
activation (235).  There are three pathways that can activate complement to 
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provide host defense against microbial pathogens.  Complement activation is 
tightly controlled by both soluble and membrane bound inhibitors.  Complement 
regulation and some degree of complement deposition and activation occurs at 
the placental interface during normal pregnancy.  APOs such as PLBW have 
been associated with excessive or misdirected complement activation, as 
demonstrated by women inherited or acquired complement disorders.  Most 
inherited gene disorders in complement regulatory proteins that increase the risk 
of APOs are loss of function mutations, such as mutations in C4b binding protein. 
Human C3 deficiency leads to infertility in women because C3 is important in 
trophoblast invasion of the decidua and endometrial blood vessels.  C1q knock-
out mice have abnormal placentas, LBW, and demonstrate preeclampsia-like 
hypertension.  Placental ischemia and hypertension in rats has been 
mechanistically linked to activation of C3a and C5a.  Miscarriage events have 
been associated with hypocomplementia (235).  Alternatively, gain of function in 
complement effector molecules has not been linked to APOs.  Differences in C3b 
deposition in the alternative complement pathway have been reported between 
C57BL/6 and BALB/c mice, and has been proposed as a mechanism to explain 
differences in innate response to infection between these two strains (236). 
P. gingivalis has several virulence factors that can manipulate 
complement in ways that promote slight inflammation which ultimately provides 
nutrients to favor its own growth.  For example, gingipains can inhibit 
complement activation by degrading C3, the central complement component.  
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Arg-specific gingipains can bind the inhibitory C4b complement binding protein, 
which results in inhibition of the complement cascade and serum-induced killing 
(237).   
Toll-like receptors (TLRs) are pattern recognition receptors and part of the 
microbial recognition system.  They are considered innate immunity receptors 
because they are invariant.  Most cells in the body express at least some TLRs, 
including gingival epithelial cells and the female reproductive tract (238).  
Placental trophoblasts express TLR2 and TLR4, and can express other TLRs 
(239).   
TLRs recognize microbe associated molecular patterns (MAMPs).  
MAMPs are otherwise known as pathogen associated molecular patterns 
(PAMPs).  For example, TLR4 recognizes lipopolysaccharide (LPS), TLR9 
recognizes bacterial DNA, and TLR2 recognizes lipoteichoic acid (240).  TLRs 
have been implicated in both the pathogenesis of periodontitis and APOs (238, 
239, 241-243).  For example, polymorphisms in TLR4 have been reported to be 
positively associated with both PTB and periodontitis (238, 244, 245).  Reduced 
expression of TLR4 in endothelial cells of terminal villi has been associated with 
preeclampsia (246).  Combined oral inoculation with Campylobacter rectus and 
P. gingivalis leads to a trend of increased TLR4 expression in murine placental 
labyrinth tissue (153, 247).  Chorionic tissues from high risk pregnancies react to 
P. gingivalis LPS by releasing IL-6 and IL-8 in a TLR2-dependent manner (248).  
In contrast, tissue explants from normal, full term fetal membrane showed an 
129 
 
 
increase in mRNA for TLR7 after incubation with P. gingivalis (249).  
Interestingly, different bacteria have been shown to induce increases in different 
toll-like receptor mRNA in full term fetal membrane explants (249), indicating 
species-specificity in the TLR response.  Changes in mRNA expression for TLRs 
indicate that P. gingivalis can induce an innate host immune response in 
placental tissue.  If P. gingivalis induces APOs through changing the placental 
microbiome, changes in mRNA expression for TLRs may reflect changes in 
abundance of bacterial species including but not limited to P. gingivalis.   
Strain-specific differences in TLR response to pathogens has been 
reported in BALB/c versus C57BL/6 mice.  For example, in response to 
Ureaplasma parvum, BALB/cJ mice develop chorioamnionitis and fetal 
inflammatory response syndrome-like pathology in conjunction with an increased 
expression of TLRs 1, 2, 6 in infected placentas.  In contrast, expression of these 
TLRs in response to Ureaplasma parvum in unaffected C57BL/6J mice was 
unchanged or down-regulated (240).   
Even in naïve mice there appears to be strain-specific differences in TLR 
expression between BALB/c and C57BL/6 mice.  Dendritic cells from spleens of 
naïve C57BL/6NCrl mice preferentially expressed TLR9 mRNA.  In contrast, 
BALB/cAnNCrl mice preferentially expressed TLR2, 4, 5, and 6 mRNAs.  
C57BL/6NCrl dendritic cells respond to ligands for TLR4, TLR2, and TLR9 by 
producing IL-12p40 whereas BALB/cAnNCrl produced monocyte 
chemoattractant protein 1 (MCP-1) (250).  It is thus plausible that differences in 
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P. gingivalis-mediated fetal weight outcomes between BALB/c and C57BL/6 mice 
may be driven by differences in interactions between either complement or toll-
like receptors and P. gingivalis.  
P. gingivalis LPS is rather unique, as it contains multiple lipid A species 
that functionally interact with both TLR2 and TLR4 (150, 251-253).  Lipid A 1- 
and 4’- phosphatases generate LPS structures that function as antagonists of 
TLR4 allowing P. gingivalis to escape TLR4-mediated antimicrobial functions, 
such as induction of antimicrobial peptides (254).  P. gingivalis releases LPS-
bearing membrane vesicles that can inhibit TLR4 responses against other 
bacteria in the same biofilm (254).  The TLR system can compensate for the 
action of P. gingivalis on TLR4 by sensing P. gingivalis primarily through TLR2.  
P gingivalis therefore has evolved different mechanisms to evade TLR2 and 
TLR4 signaling in neutrophils and macrophages (251).   
 
P. gingivalis and Neutrophils 
P. gingivalis can inhibit neutrophil migration, apoptosis and neutrophil 
killing functions, while activating neutrophils to release pro-inflammatory 
mediators (31, 255).  All three gingipain enzymes can lead to complement 
inactivation (251).  Gingipains can clip complement C5 protein to generate the 
anaphylatoxin C5a and destroy C5b.  Binding of C5a to C5aReceptor induces 
ubiquitination of MyD88 and generation of phosphatidylinositol-3-kinase (PI3K) in 
neutrophils.  The TLR2-dependent recognition of P. gingivalis and of bystander 
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microorganisms is therefore inhibited by lack of MyD88 signaling.  The 
generation of PI3K inhibits actin polymerization and therefore phagocytosis in 
neutrophils, but most importantly it promotes periodontal inflammation via TNF, 
IL-1β, IL-17 and IL-6 resulting in a dysbiotic microbiota (31, 150, 251).  This two-
pronged mechanism uncouples the synergistic effect of C5aR and TLR2, 
resulting in inhibition of bacterial immune clearance by neutrophils but favoring a 
pro-inflammatory environment.  The pro-inflammatory environment generates a 
nutritionally favorable state for P. gingivalis and the bystander microbiota.   
   
P. gingivalis and Macrophages. 
P. gingivalis fimbriae binds complement receptor-3 (CR3) activating 
phagocytosis in macrophages while preventing TLR2-induced IL-12 production.  
CR3-mediated phagocytosis, however, fails to kill P. gingivalis because of the 
inhibition of inducible nitric oxide synthase (iNOS) mediated by the increased 
cyclic adenosine monophosphate (cAMP) produced secondary to Arg-gingipain-
dependent C5a-C5aR binding.  Increases in cAMP and subsequent increases in 
protein kinase A (PKA) further impairs nitric-oxide dependent killing of P. 
gingivalis in macrophages (150, 251, 254).  Fimbriae also bind to CXCR4 and 
TLR2 to induce cAMP-dependent PKA signaling.  cAMP impairs TLR2-driven 
nitric oxide dependent killing of P. gingivalis in macrophages (150, 254).  
Maximum cAMP and therefore maximum inhibition of iNOS is achieved when 
both C5aR-TLR2 and CXCR4-TLR2 pathways are activated by P. gingivalis 
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(254).  The resulting scenario is persistence of live P. gingivalis in endocytic 
vacuoles in a sustained inflammatory environment which may lead to 
inflammation-induced APOs (251, 254).   
While P. gingivalis-mediated C5aR-TLR2 and CXCR4-TLR2 crosstalk has 
been heavily studied in periodontitis models, very little has been reported on 
modulation of TLRs and complement by P. gingivalis in the placenta.  Even less 
has been reported on P. gingivalis-mediated manipulation of complement in 
placentas.  Since it has now been established that P. gingivalis can be detected 
in placentas associated with APOs in both humans and mice, studies of P. 
gingivalis subversion of TLR-complement cross talk should focus on placental as 
well as gingival tissue.  These studies should consider that P. gingivalis may not 
have the same effect on TLR and complement in BALB/c as compared to 
C57BL/6 mice.   
 
Epigenetics: A Bridge Between Genetics and Environment 
Epigenetic changes result in changes in the availability of DNA for 
transcription and translation into mRNA and protein.  Epigenetic changes have 
been implicated in both periodontitis and APOs (256-259), although they have 
been more well characterized with regards to PTB than LBW.  Epigenetics may 
explain why periodontitis shows strong heritability, but genome-wide association 
studies have largely failed to find reliability reproducible genes responsible for 
periodontitis susceptibility.  Most known epigenetic modifications that affect 
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periodontitis risk are in immune regulating genes (256).  Traditional Mendelian 
gene variations in immune regulating genes also increase risk of periodontitis 
(44).  The differences in susceptibility to P. gingivalis-mediated low fetal weight 
between C57BL/6 substrains may have been epigenetically “programmed” into 
the mice due to the environment at their respective vendor facilities.   
 
Future Directions  
Evaluate Tissue-Resident P. gingivalis-specific CD4+ T Cells in Placenta 
We were unable to evaluate the role of tissue-resident CD4+ T cells in P. 
gingivalis-mediated fetal weight outcomes due to the low numbers of these cells 
detected in placental tissue.  Single-cell RNAseq analysis of individual P. 
gingivalis-specific T cells sorted from placental tissue using the MHC class II 
tetramer may allow for a future correlation between frequency of tissue-resident 
P. gingivalis-specific CD4+ T cells, including Treg cells, and low fetal weight in 
C57BL/6 mice.  The major hurdle to this objective remains difficulty separating a 
small number of T cells from large volumes of placental tissue.  Numerous 
separation gradients have been tried, yet placental tissue debris remains a major 
contaminant.  Trypsin digestion of the placental tissue is often used to study 
other placental cell types, but appears to reduce the ability to stain for key T cell 
markers as compared to digestion with collagen D.   
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C57BL/6J and C57BL/6NCrl mice: Determining the Role of Microbiome in P. 
gingivalis-mediated Low Fetal Weight 
Acting as a keystone pathogen, P. gingivalis is known to cause changes in 
nutrient availability in the gingiva.  This altered nutrient environment shifts the 
normal symbiotic oral microbiota to become more dysbiotic and ultimately more 
pathogenic for the host.  If P. gingivalis behaves similarly in the placenta, the key 
to why P. gingivalis induces low fetal weight in only some substrains of C57BL/6 
mice may lie in the immune response to the pathobionts within the placental 
microbiota and not to P. gingivalis itself.  Pathobionts in the normal microbiota 
are in sufficient low frequency not to induce pathology.  The altered nutrient base 
initiated by P. gingivalis may be changing the prevalence or behavior of such 
pathobionts of the mouse oral or placental microbiome.   
We thus hypothesize the presence of a microbial species in the normal 
mouse microbiota of C57BL/6J and UofM mice that is necessary in tandem with 
P. gingivalis to induce low fetal weight.  Alternatively, there could be a species 
that is protective against P. gingivalis-mediated low fetal weight in C57BL/6NCrl 
mice.   
This theory could be tested in two ways.  First, C57BL/6J and UofM mice 
could be co-housed with C5BL/6NCrl mice prior to experimentation.  If there is a 
bacterial species that makes C57BL/6J and UofM mice susceptible to low fetal 
weight, C57BL/6NCrl co-housed mice would experience reduced fetal weight.  If 
there is a protective species in C57BL/6NCrl mice, the opposite would be 
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observed.  If the microbiome plays no role and the differences in fetal weight are 
driven by substrain specific genetic differences, then co-housing would have no 
effect on fetal weight outcomes.   
This theory could also be tested by treating C57BL/6J and U of M mice 
with different antibiotics prior to oral colonization with P. gingivalis to determine if 
depletion of specific populations of microorganisms could protect against P. 
gingivalis-mediated low fetal weight.  The same antibiotics would be delivered to 
C57BL/6NCrl mice to see if depletion of a specific population induces P. 
gingivalis-mediated low fetal weight.  This strategy was used to identify SFB as a 
major driver of Th17 SI-LP cell differentiation (260-265).   
Microbiome sequencing assays to determine the difference between “fetal 
weight reduction permissive” and “fetal weight reduction prohibitive” microbiome 
populations could further pinpoint the relevant species in either experimental 
design.  Alternatively, it must be considered that a change in the metabolic or 
enzymatic profile of the microbiome, and not an individual species, may be 
responsible for why only some substrains of C57BL/6 experience low fetal weight 
in response to P. gingivalis.  
It is possible that CD4+ T cells producing IFN-γ are responding not to P. 
gingivalis itself but to microorganisms that change in abundance because of P. 
gingivalis-driven changes in the nutrient foundation.  Identification of co-species 
that are essential for P. gingivalis-mediated fetal weight reduction may identify a 
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novel population of CD4+ T cells producing IFN-γ that correlate with low fetal 
weight in C57BL/6J and C57BL/6UofM dams.   
This set of experiments may identify a species, or several species, or 
metabolic functions of a set of species that are necessary for P. gingivalis-
mediated low fetal weight.   
If the microbiome is determined not to be responsible for the difference 
between fetal weight outcomes in C57BL/6J and UofM mice as compared to 
C57BL/6NCrl mice, then the difference must be driven by either genetic or 
epigenetic changes.  Most likely, both the microbiome and the genome are 
involved in P. gingivalis-mediated low fetal weight.  This is demonstrated by the 
fact that P. gingivalis is detected in the placentas of mice both susceptible 
(C57BL/6J, UofM) and resistant (BALB/c) to low fetal weight.  Understanding the 
proportional difference in the placental microbiome of fetal weight resistant or 
susceptible mice is an essential preliminary step before probing the genetic 
differences in P. gingivalis-mediated fetal weight outcomes occurring in different 
murine strains.   
 
Determining the Role of the Innate Immunity in P. gingivalis-mediated Low Fetal 
Weight 
Different SNPs can distinguish C57BL/6J from C57BL/6N mice.  Whether 
these SNPs or other genetic variations influence P. gingivalis-mediated low fetal 
weight remains unknown.  Genetically encoded differences in C57BL/6J, 
137 
 
 
C57BL/6N, and BALB/c mice may differentially regulate the innate immunity in 
response to P. gingivalis.  For example, differential expression of certain TLRs is 
associated to APOs in BALB/c but not C57BL/6 mice after infection with 
Ureaplasma parvum (240).  It is plausible that a difference in TLR expression 
also drives APOs in C57BL/6 but not BALB/c mice after oral and placental 
colonization with P. gingivalis.  TLR and complement show strain-specific 
differences in function and interact with P. gingivalis virulence factors in a way 
that favors P. gingivalis growth and survival.  Substrain-specific differences in 
TLR and complement between C57BL/6J and C57BL/6N mice have not been 
evaluated in the current literature.  
Strains of P. gingivalis that lack the key virulence factors for interacting 
with TLR and complement have been developed (Kgp-deficient (KDP 129); Rgp-
deficient (KDP 133); or Kgp- and Rgp-deficient (KDP 136)) (266-270).  Oral 
colonization of C57BL/6J mice with P. gingivalis that lack the key virulence 
factors that interact with TLR or complement can dissect the contribution of P. 
gingivalis to low fetal weight.   
TLR or complement mutant mice could also be used to elucidate the role 
of innate immunity in P. gingivalis-mediated low fetal weight.  Alternatively, 
BALB/c and C57BL/6 mice could be crossed to create F1 offspring.  It could then 
be determined whether F1 hybrids have a fetal weight phenotype in response to 
P. gingivalis that is more similar to the BALB/c or the C57BL/6 parent.  
Similarities and differences in complement and TLR gene expression and fetal 
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weight phenotype between the F1 and its two parents could then include or 
exclude their involvement in P. gingivalis-mediated fetal weight outcomes.  
 
Conclusions 
Removing or reducing the amount of P. gingivalis and other oral 
pathogens from the periodontal pocket alone through SRP therapy does not 
reduce the risk of APOs in women.  The prevalence of APO in women with 
periodontitis points to a potential role for local inflammation of placenta due to 
colonization with P. gingivalis alone or with other oral pathobionts capable to 
persist in the placenta despite therapy around teeth.  
After oral colonization, C57BL/6J and C57BL/6UofM mice experience low 
fetal weight, but C57BL/6NCrl do not.  P. gingivalis seeding of the placenta is 
correlated to low fetal weight only in C57BL/6J and C57BL/6UofM mice and not 
in C57BL/6NCrl.  BALB/c mice regardless of vendor did not experience low fetal 
weight despite presence of P. gingivalis in the placenta.  The immune response 
that potentially ensues against placental P. gingivalis or against other 
pathobionts leading to low fetal weight is not related to CD4+ T cells specific for 
P. gingivalis recirculating to the PaLN-CLN.  Specifically, production of IL-17A, 
IFN-γ, or IL-4 by P. gingivalis-specific CD4+ T cells in the PaLN-CLN cannot 
explain why low fetal weight occurred in C57BL/6J and C57BL/6UofM mice.  
These findings suggest a role for both environmental and genetic factors 
in P. gingivalis-mediated low fetal weight.  Future experiments should be 
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designed to understand which components of the microbiome lead to P. 
gingivalis-mediated low fetal weight in C57BL/6J and UofM but not C57BL/6NCrl 
mice.  There may also be genetic differences between mice on the C57BL/6J 
(including UofM) background versus C57BL/6N or BALB/c mice that lead to P. 
gingivalis-driven low fetal weight, with or without a simultaneous contribution of 
the microbiome.  Evaluation of genetic components of the innate or adaptive 
immune system that vary between strains of mice may answer the question of 
why some substrains of C57BL/6 but no substrains of BALB/c mice are 
susceptible to P. gingivalis-associated low fetal weight.  Particularily, differences 
in complement and toll-like receptor function will be evaluated, as these innate 
systems are known to differ in C57BL/6 versus BALB/c mice, interact with P. 
gingivalis virulence factors and have an impact in APOs.    
 
140 
 
 
References 
1. Costalonga, M., and M. C. Herzberg. 2014. The oral microbiome and the 
immunobiology of periodontal disease and caries. Immunol Lett 162: 22-
38. 
2. Loos, B. G., G. Papantonopoulos, S. Jepsen, and M. L. Laine. 2015. What 
is the Contribution of Genetics to Periodontal Risk? Dent Clin North Am 
59: 761-780. 
3. Armitage, G. C. 1999. Development of a classification system for 
periodontal diseases and conditions. Ann Periodontol 4: 1-6. 
4. Armitage, G. C. 2000. Development of a classification system for 
periodontal diseases and conditions. Northwest Dent 79: 31-35. 
5. Armitage, G. C. 2003. Diagnosis of periodontal diseases. J Periodontol 74: 
1237-1247. 
6. Armitage, G. C. 2004. Periodontal diagnoses and classification of 
periodontal diseases. Periodontol 2000 34: 9-21. 
7. Highfield, J. 2009. Diagnosis and classification of periodontal disease. 
Aust Dent J 54 Suppl 1: S11-26. 
8. Lang, N. P., R. Adler, A. Joss, and S. Nyman. 1990. Absence of bleeding 
on probing. An indicator of periodontal stability. J Clin Periodontol 17: 714-
721. 
9. Michalowicz, B. S., J. S. Hodges, and B. L. Pihlstrom. 2013. Is change in 
probing depth a reliable predictor of change in clinical attachment loss? J 
Am Dent Assoc 144: 171-178. 
10. Barendregt, D. S., U. Van der Velden, J. Reiker, and B. G. Loos. 1996. 
Clinical evaluation of tine shape of 3 periodontal probes using 2 probing 
forces. J Clin Periodontol 23: 397-402. 
11. Al Shayeb, K. N., W. Turner, and D. G. Gillam. 2014. Accuracy and 
reproducibility of probe forces during simulated periodontal pocket depth 
measurements. Saudi Dent J 26: 50-55. 
12. Walsh, T. F., and M. S. Saxby. 1989. Inter- and intra-examiner variability 
using standard and constant force periodontal probes. J Clin Periodontol 
16: 140-143. 
13. Gemmell, E., K. Yamazaki, and G. J. Seymour. 2007. The role of T cells in 
periodontal disease: homeostasis and autoimmunity. Periodontol 2000 43: 
14-40. 
14. Greenstein, G. 1984. The role of bleeding upon probing in the diagnosis of 
periodontal disease. A literature review. J Periodontol 55: 684-688. 
141 
 
 
15. Offenbacher, S., V. Katz, G. Fertik, J. Collins, D. Boyd, G. Maynor, R. 
McKaig, and J. Beck. 1996. Periodontal infection as a possible risk factor 
for preterm low birth weight. J Periodontol 67: 1103-1113. 
16. Mdala, I., I. Olsen, A. D. Haffajee, S. S. Socransky, M. Thoresen, and B. 
F. de Blasio. 2014. Comparing clinical attachment level and pocket depth 
for predicting periodontal disease progression in healthy sites of patients 
with chronic periodontitis using multi-state Markov models. J Clin 
Periodontol 41: 837-845. 
17. Eke, P. I., X. Zhang, H. Lu, L. Wei, G. Thornton-Evans, K. J. Greenlund, J. 
B. Holt, and J. B. Croft. 2016. Predicting Periodontitis at State and Local 
Levels in the United States. J Dent Res 95: 515-522. 
18. Hajishengallis, G., S. Liang, M. A. Payne, A. Hashim, R. Jotwani, M. A. 
Eskan, M. L. McIntosh, A. Alsam, K. L. Kirkwood, J. D. Lambris, R. P. 
Darveau, and M. A. Curtis. 2011. Low-abundance biofilm species 
orchestrates inflammatory periodontal disease through the commensal 
microbiota and complement. Cell Host Microbe 10: 497-506. 
19. Irie, K., C. M. Novince, and R. P. Darveau. 2014. Impact of the Oral 
Commensal Flora on Alveolar Bone Homeostasis. J Dent Res 93: 801-
806. 
20. Cho, I., and M. J. Blaser. 2012. The human microbiome: at the interface of 
health and disease. Nat Rev Genet 13: 260-270. 
21. Haffajee, A. D., and S. S. Socransky. 1994. Microbial etiological agents of 
destructive periodontal diseases. Periodontol 2000 5: 78-111. 
22. Haffajee, A. D., S. S. Socransky, M. R. Patel, and X. Song. 2008. 
Microbial complexes in supragingival plaque. Oral Microbiol Immunol 23: 
196-205. 
23. Socransky, S. S., A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent, 
Jr. 1998. Microbial complexes in subgingival plaque. J Clin Periodontol 25: 
134-144. 
24. Griffen, A. L., C. J. Beall, J. H. Campbell, N. D. Firestone, P. S. Kumar, Z. 
K. Yang, M. Podar, and E. J. Leys. 2012. Distinct and complex bacterial 
profiles in human periodontitis and health revealed by 16S 
pyrosequencing. Isme j 6: 1176-1185. 
25. Wade, W. G. 2013. The oral microbiome in health and disease. Pharmacol 
Res 69: 137-143. 
26. Diaz, P. I., N. I. Chalmers, A. H. Rickard, C. Kong, C. L. Milburn, R. J. 
Palmer, Jr., and P. E. Kolenbrander. 2006. Molecular characterization of 
subject-specific oral microflora during initial colonization of enamel. Appl 
Environ Microbiol 72: 2837-2848. 
142 
 
 
27. Dewhirst, F. E., T. Chen, J. Izard, B. J. Paster, A. C. Tanner, W. H. Yu, A. 
Lakshmanan, and W. G. Wade. 2010. The human oral microbiome. J 
Bacteriol 192: 5002-5017. 
28. Jorth, P., K. H. Turner, P. Gumus, N. Nizam, N. Buduneli, and M. 
Whiteley. 2014. Metatranscriptomics of the human oral microbiome during 
health and disease. MBio 5: e01012-01014. 
29. Ximenez-Fyvie, L. A., A. D. Haffajee, and S. S. Socransky. 2000. 
Comparison of the microbiota of supra- and subgingival plaque in health 
and periodontitis. J Clin Periodontol 27: 648-657. 
30. Riep, B., L. Edesi-Neuss, F. Claessen, H. Skarabis, B. Ehmke, T. F. 
Flemmig, J. P. Bernimoulin, U. B. Gobel, and A. Moter. 2009. Are putative 
periodontal pathogens reliable diagnostic markers? J Clin Microbiol 47: 
1705-1711. 
31. Maekawa, T., J. L. Krauss, T. Abe, R. Jotwani, M. Triantafilou, K. 
Triantafilou, A. Hashim, S. Hoch, M. A. Curtis, G. Nussbaum, J. D. 
Lambris, and G. Hajishengallis. 2014. Porphyromonas gingivalis 
manipulates complement and TLR signaling to uncouple bacterial 
clearance from inflammation and promote dysbiosis. Cell Host Microbe 15: 
768-778. 
32. Schmidt, J., H. Jentsch, C. S. Stingu, and U. Sack. 2014. General immune 
status and oral microbiology in patients with different forms of periodontitis 
and healthy control subjects. PLoS One 9: e109187. 
33. Diaz, P. I., A. Hoare, and B. Y. Hong. 2016. Subgingival Microbiome Shifts 
and Community Dynamics in Periodontal Diseases. J Calif Dent Assoc 44: 
421-435. 
34. Palmer, R. J., Jr. 2014. Composition and development of oral bacterial 
communities. Periodontol 2000 64: 20-39. 
35. Kilian, M., I. L. Chapple, M. Hannig, P. D. Marsh, V. Meuric, A. M. 
Pedersen, M. S. Tonetti, W. G. Wade, and E. Zaura. 2016. The oral 
microbiome - an update for oral healthcare professionals. Br Dent J 221: 
657-666. 
36. Vartoukian, S. R., R. M. Palmer, and W. G. Wade. 2009. Diversity and 
morphology of members of the phylum "synergistetes" in periodontal 
health and disease. Appl Environ Microbiol 75: 3777-3786. 
37. Lamont, R. J., and G. Hajishengallis. 2015. Polymicrobial synergy and 
dysbiosis in inflammatory disease. Trends Mol Med 21: 172-183. 
38. Kumar, P. S., A. L. Griffen, J. A. Barton, B. J. Paster, M. L. Moeschberger, 
and E. J. Leys. 2003. New bacterial species associated with chronic 
periodontitis. J Dent Res 82: 338-344. 
143 
 
 
39. Kumar, P. S., A. L. Griffen, M. L. Moeschberger, and E. J. Leys. 2005. 
Identification of candidate periodontal pathogens and beneficial species by 
quantitative 16S clonal analysis. J Clin Microbiol 43: 3944-3955. 
40. Campbell, L., E. Millhouse, J. Malcolm, and S. Culshaw. 2016. T cells, 
teeth and tissue destruction - what do T cells do in periodontal disease? 
Mol Oral Microbiol 31: 445-456. 
41. Garlet, G. P. 2010. Destructive and protective roles of cytokines in 
periodontitis: a re-appraisal from host defense and tissue destruction 
viewpoints. J Dent Res 89: 1349-1363. 
42. Van Dyke, T. E., and D. Sheilesh. 2005. Risk factors for periodontitis. J Int 
Acad Periodontol 7: 3-7. 
43. Hart, T. C. 1994. Genetic considerations of risk in human periodontal 
disease. Curr Opin Periodontol: 3-11. 
44. Hart, T. C., and J. C. Atkinson. 2007. Mendelian forms of periodontitis. 
Periodontol 2000 45: 95-112. 
45. Eke, P. I., B. A. Dye, L. Wei, G. D. Slade, G. O. Thornton-Evans, W. S. 
Borgnakke, G. W. Taylor, R. C. Page, J. D. Beck, and R. J. Genco. 2015. 
Update on Prevalence of Periodontitis in Adults in the United States: 
NHANES 2009 to 2012. J Periodontol 86: 611-622. 
46. Eke, P. I., L. Wei, G. O. Thornton-Evans, L. N. Borrell, W. S. Borgnakke, 
B. Dye, and R. J. Genco. 2016. Risk Indicators for Periodontitis in US 
Adults: NHANES 2009 to 2012. J Periodontol 87: 1174-1185. 
47. Hong, M., H. Y. Kim, H. Seok, C. D. Yeo, Y. S. Kim, J. Y. Song, Y. B. Lee, 
D. H. Lee, J. I. Lee, T. K. Lee, H. S. Ahn, Y. H. Ko, S. C. Jeong, H. S. 
Chae, and T. S. Sohn. 2016. Prevalence and risk factors of periodontitis 
among adults with or without diabetes mellitus. Korean J Intern Med 31: 
910-919. 
48. Mealey, B. L., and M. P. Rethman. 2003. Periodontal disease and 
diabetes mellitus. Bidirectional relationship. Dent Today 22: 107-113. 
49. Chee, B., B. Park, and P. M. Bartold. 2013. Periodontitis and type II 
diabetes: a two-way relationship. Int J Evid Based Healthc 11: 317-329. 
50. Michalowicz, B. S., S. R. Diehl, J. C. Gunsolley, B. S. Sparks, C. N. 
Brooks, T. E. Koertge, J. V. Califano, J. A. Burmeister, and H. A. 
Schenkein. 2000. Evidence of a substantial genetic basis for risk of adult 
periodontitis. J Periodontol 71: 1699-1707. 
51. Michalowicz, B. S., D. Aeppli, J. G. Virag, D. G. Klump, J. E. Hinrichs, N. 
L. Segal, T. J. Bouchard, Jr., and B. L. Pihlstrom. 1991. Periodontal 
findings in adult twins. J Periodontol 62: 293-299. 
52. Dhanrajani, P. J. 2009. Papillon-Lefevre syndrome: clinical presentation 
and a brief review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
108: e1-7. 
144 
 
 
53. Moutsopoulos, N. M., J. Konkel, M. Sarmadi, M. A. Eskan, T. Wild, N. 
Dutzan, L. Abusleme, C. Zenobia, K. B. Hosur, T. Abe, G. Uzel, W. Chen, 
T. Chavakis, S. M. Holland, and G. Hajishengallis. 2014. Defective 
neutrophil recruitment in leukocyte adhesion deficiency type I disease 
causes local IL-17-driven inflammatory bone loss. Sci Transl Med 6: 
229ra240. 
54. Tarannum, F., and M. Faizuddin. 2012. Effect of gene polymorphisms on 
periodontal diseases. Indian J Hum Genet 18: 9-19. 
55. Ribeiro, M. S., R. B. Pacheco, R. G. Fischer, and J. M. Macedo. 2016. 
Interaction of IL1B and IL1RN polymorphisms, smoking habit, gender, and 
ethnicity with aggressive and chronic periodontitis susceptibility. Contemp 
Clin Dent 7: 349-356. 
56. Loos, B. G., R. P. John, and M. L. Laine. 2005. Identification of genetic 
risk factors for periodontitis and possible mechanisms of action. J Clin 
Periodontol 32 Suppl 6: 159-179. 
57. Sun, X., H. Meng, D. Shi, L. Xu, L. Zhang, Z. Chen, X. Feng, and R. Lu. 
2011. Analysis of plasma calprotectin and polymorphisms of S100A8 in 
patients with aggressive periodontitis. J Periodontal Res 46: 354-360. 
58. Li, Q., H. Meng, L. Zhang, L. Xu, Z. Chen, D. Shi, X. Feng, X. Zhu, H. 
Zhao, and C. Cao. 2007. Correlation between single nucleotide 
polymorphisms in a calprotectin subunit gene and risk of periodontitis in a 
Chinese population. Ann Hum Genet 71: 312-324. 
59. Ren, X. Y., L. Xu, H. X. Meng, H. S. Zhao, R. F. Lu, Z. B. Chen, X. H. 
Feng, D. Shi, L. Zhang, and Y. Tian. 2009. Family-based association 
analysis of S100A8 genetic polymorphisms with aggressive periodontitis. J 
Periodontal Res 44: 184-192. 
60. Baker, P. J., R. T. Evans, and D. C. Roopenian. 1994. Oral infection with 
Porphyromonas gingivalis and induced alveolar bone loss in 
immunocompetent and severe combined immunodeficient mice. Arch Oral 
Biol 39: 1035-1040. 
61. De-Gennaro, L. A., J. D. Lopes, and M. Mariano. 2006. Autoantibodies 
directed to extracellular matrix components in patients with different 
clinical forms of periodontitis. J Periodontol 77: 2025-2030. 
62. Anusaksathien, O., G. Singh, N. Matthews, and A. E. Dolby. 1992. 
Autoimmunity to collagen in adult periodontal disease: immunoglobulin 
classes in sera and tissue. J Periodontal Res 27: 55-61. 
63. Govze, Y., and M. C. Herzberg. 1993. Serum and gingival crevicular fluid 
anti-desmosomal antibodies in periodontitis. J Periodontol 64: 603-608. 
64. Sugawara, M., K. Yamashita, H. Yoshie, and K. Hara. 1992. Detection of, 
and anti-collagen antibody produced by, CD5-positive B cells in inflamed 
gingival tissues. J Periodontal Res 27: 489-498. 
145 
 
 
65. Aoyagi, T., M. Sugawara-Aoyagi, K. Yamazaki, and K. Hara. 1995. 
Interleukin 4 (IL-4) and IL-6-producing memory T-cells in peripheral blood 
and gingival tissue in periodontitis patients with high serum antibody titers 
to Porphyromonas gingivalis. Oral Microbiol Immunol 10: 304-310. 
66. Muthukuru, M. 2012. Technical advance: decreased helper T cells and 
increased natural killer cells in chronic periodontitis analyzed by a novel 
method for isolating resident lymphocytes. J Leukoc Biol 92: 683-692. 
67. Amanuma, R., T. Nakajima, H. Yoshie, and K. Yamazaki. 2006. Increased 
infiltration of CD1d and natural killer T cells in periodontal disease tissues. 
J Periodontal Res 41: 73-79. 
68. Baker, P. J., N. R. Boutaugh, M. Tiffany, and D. C. Roopenian. 2009. B 
Cell IgD Deletion Prevents Alveolar Bone Loss Following Murine Oral 
Infection. Interdiscip Perspect Infect Dis 2009: 864359. 
69. Baker, P. J., M. Dixon, R. T. Evans, L. Dufour, E. Johnson, and D. C. 
Roopenian. 1999. CD4(+) T cells and the proinflammatory cytokines 
gamma interferon and interleukin-6 contribute to alveolar bone loss in 
mice. Infect Immun 67: 2804-2809. 
70. Baker, P. J., M. Dixon, and D. C. Roopenian. 2000. Genetic control of 
susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in 
mice. Infect Immun 68: 5864-5868. 
71. Baker, P. J. 2005. Genetic control of the immune response in 
pathogenesis. J Periodontol 76: 2042-2046. 
72. Baker, P. J., L. Howe, J. Garneau, and D. C. Roopenian. 2002. T cell 
knockout mice have diminished alveolar bone loss after oral infection with 
Porphyromonas gingivalis. FEMS Immunol Med Microbiol 34: 45-50. 
73. Baker, P. J., J. Garneau, L. Howe, and D. C. Roopenian. 2001. T-cell 
contributions to alveolar bone loss in response to oral infection with 
Porphyromonas gingivalis. Acta Odontol Scand 59: 222-225. 
74. Listl, S., J. Galloway, P. A. Mossey, and W. Marcenes. 2015. Global 
Economic Impact of Dental Diseases. J Dent Res 94: 1355-1361. 
75. Jin, L. J., I. B. Lamster, J. S. Greenspan, N. B. Pitts, C. Scully, and S. 
Warnakulasuriya. 2016. Global burden of oral diseases: emerging 
concepts, management and interplay with systemic health. Oral Dis 22: 
609-619. 
76. 2016. US Department of Health and Human Services. Health, United 
States, 2015: With Special Feature on Racial and Ethnic Health 
Disparities. C. f. D. C. a. Prevention, ed. National Center for Health 
Statistics, Hyattsville, MD. 
77. Agency for Healthcare Research and Quality. Medical Expenditure Panel 
Survey.  Table 3: Dental Services-Median and Mean Expenses per 
Person With Expense and Distribution of Expenses by Source of 
146 
 
 
Payment: United States, 2014   All Dental Visits. Rockville, MD. 
https://meps.ahrq.gov/mepsweb/. 
78. Wall, T., and M. Vujicic. U.S. dental spending continues to be flat. Health 
Policy Institute Research Brief. American Dental Association. December 
2015. Available from: 
http://www.ada.org/~/media/ADA/Science%20and%20Research/HPI/Files/
HPIBrief_1215_2.ashx. 
79. Brown, L. J., B. A. Johns, and T. P. Wall. 2002. The economics of 
periodontal diseases. Periodontol 2000 29: 223-234. 
80. Bernabe, E., and W. Marcenes. 2010. Periodontal disease and quality of 
life in British adults. J Clin Periodontol 37: 968-972. 
81. Cunha-Cruz, J., P. P. Hujoel, and N. R. Kressin. 2007. Oral health-related 
quality of life of periodontal patients. J Periodontal Res 42: 169-176. 
82. Needleman, I., C. McGrath, P. Floyd, and A. Biddle. 2004. Impact of oral 
health on the life quality of periodontal patients. J Clin Periodontol 31: 454-
457. 
83. Ng, S. K., and W. K. Leung. 2006. Oral health-related quality of life and 
periodontal status. Community Dent Oral Epidemiol 34: 114-122. 
84. Meusel, D. R., J. C. Ramacciato, R. H. Motta, R. B. Brito Junior, and F. M. 
Florio. 2015. Impact of the severity of chronic periodontal disease on 
quality of life. J Oral Sci 57: 87-94. 
85. Mourao, L. C., M. Cataldo Dde, H. Moutinho, and A. Canabarro. 2015. 
Impact of chronic periodontitis on quality-of-life and on the level of blood 
metabolic markers. J Indian Soc Periodontol 19: 155-158. 
86. Davis, D. M., J. Fiske, B. Scott, and D. R. Radford. 2000. The emotional 
effects of tooth loss: a preliminary quantitative study. Br Dent J 188: 503-
506. 
87. Kumar, P. S. 2017. From focal sepsis to periodontal medicine: a century of 
exploring the role of the oral microbiome in systemic disease. J Physiol 
595: 465-476. 
88. Ganesh, P., R. Karthikeyan, A. Muthukumaraswamy, and J. Anand. 2017. 
A Potential Role of Periodontal Inflammation in Alzheimer's Disease: A 
Review. Oral Health Prev Dent 15: 7-12. 
89. Katz, J., N. Chegini, K. T. Shiverick, and R. J. Lamont. 2009. Localization 
of P. gingivalis in preterm delivery placenta. J Dent Res 88: 575-578. 
90. Boggess, K. A., S. Lieff, A. P. Murtha, K. Moss, J. Beck, and S. 
Offenbacher. 2003. Maternal periodontal disease is associated with an 
increased risk for preeclampsia. Obstet Gynecol 101: 227-231. 
147 
 
 
91. Barak, S., O. Oettinger-Barak, E. E. Machtei, H. Sprecher, and G. Ohel. 
2007. Evidence of periopathogenic microorganisms in placentas of women 
with preeclampsia. J Periodontol 78: 670-676. 
92. Conde-Agudelo, A., J. Villar, and M. Lindheimer. 2008. Maternal infection 
and risk of preeclampsia: systematic review and metaanalysis. Am J 
Obstet Gynecol 198: 7-22. 
93. Matthews, T. J., M. F. MacDorman, and M. E. Thoma. 2015. Infant 
Mortality Statistics From the 2013 Period Linked Birth/Infant Death Data 
Set. Natl Vital Stat Rep 64: 1-30. 
94. Martin, J. A., B. E. Hamilton, M. J. Osterman, A. K. Driscoll, and T. J. 
Mathews. 2017. Births: Final Data for 2015. Natl Vital Stat Rep 66: 1. 
95. Hovi, P., S. Andersson, J. G. Eriksson, A. L. Jarvenpaa, S. Strang-
Karlsson, O. Makitie, and E. Kajantie. 2007. Glucose regulation in young 
adults with very low birth weight. N Engl J Med 356: 2053-2063. 
96. Committee to Study the Prevention of Low, B., P. Division of Health 
Promotion and Disease, and M. Institute of. 1985.  In Preventing Low 
Birthweight. National Academies Press (US) 
Copyright (c) National Academy of Sciences. All rights reserved., Washington 
(DC). 
97. Saito, S., A. Nakashima, T. Shima, and M. Ito. 2010. Th1/Th2/Th17 and 
regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63: 601-
610. 
98. Paige, D. M., M. Augustyn, W. K. Adih, F. Witter, and J. Chang. 1998. 
Bacterial vaginosis and preterm birth: a comprehensive review of the 
literature. J Nurse Midwifery 43: 83-89. 
99. Zhou, X., C. J. Brown, Z. Abdo, C. C. Davis, M. A. Hansmann, P. Joyce, J. 
A. Foster, and L. J. Forney. 2007. Differences in the composition of 
vaginal microbial communities found in healthy Caucasian and black 
women. Isme j 1: 121-133. 
100. Koumans, E. H., M. Sternberg, C. Bruce, G. McQuillan, J. Kendrick, M. 
Sutton, and L. E. Markowitz. 2007. The prevalence of bacterial vaginosis 
in the United States, 2001-2004; associations with symptoms, sexual 
behaviors, and reproductive health. Sex Transm Dis 34: 864-869. 
101. Leitich, H., B. Bodner-Adler, M. Brunbauer, A. Kaider, C. Egarter, and P. 
Husslein. 2003. Bacterial vaginosis as a risk factor for preterm delivery: a 
meta-analysis. Am J Obstet Gynecol 189: 139-147. 
102. Flynn, C. A., A. L. Helwig, and L. N. Meurer. 1999. Bacterial vaginosis in 
pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 48: 
885-892. 
148 
 
 
103. McDonald, H. M., J. A. O'Loughlin, P. Jolley, R. Vigneswaran, and P. J. 
McDonald. 1991. Vaginal infection and preterm labour. Br J Obstet 
Gynaecol 98: 427-435. 
104. Minkoff, H., A. N. Grunebaum, R. H. Schwarz, J. Feldman, M. Cummings, 
W. Crombleholme, L. Clark, G. Pringle, and W. M. McCormack. 1984. 
Risk factors for prematurity and premature rupture of membranes: a 
prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 
150: 965-972. 
105. McDonald, H., R. Vigneswaran, and J. A. O'Loughlin. 1989. Group B 
streptococcal colonization and preterm labour. Aust N Z J Obstet 
Gynaecol 29: 291-293. 
106. Moller, M., A. C. Thomsen, K. Borch, K. Dinesen, and M. Zdravkovic. 
1984. Rupture of fetal membranes and premature delivery associated with 
group B streptococci in urine of pregnant women. Lancet 2: 69-70. 
107. White, C. P., E. G. Wilkins, C. Roberts, and D. C. Davidson. 1984. 
Premature delivery and group B streptococcal bacteriuria. Lancet 2: 586. 
108. Xiong, X., P. Buekens, W. D. Fraser, J. Beck, and S. Offenbacher. 2006. 
Periodontal disease and adverse pregnancy outcomes: a systematic 
review. Bjog 113: 135-143. 
109. Vettore, M. V., A. Lamarca Gde, A. T. Leao, F. B. Thomaz, A. Sheiham, 
and C. Leal Mdo. 2006. Periodontal infection and adverse pregnancy 
outcomes: a systematic review of epidemiological studies. Cad Saude 
Publica 22: 2041-2053. 
110. Blencowe, H., A. C. Lee, S. Cousens, A. Bahalim, R. Narwal, N. Zhong, D. 
Chou, L. Say, N. Modi, J. Katz, T. Vos, N. Marlow, and J. E. Lawn. 2013. 
Preterm birth-associated neurodevelopmental impairment estimates at 
regional and global levels for 2010. Pediatr Res 74 Suppl 1: 17-34. 
111. Baraldi, E., and M. Filippone. 2007. Chronic lung disease after premature 
birth. N Engl J Med 357: 1946-1955. 
112. Leung, J. Y., H. S. Lam, G. M. Leung, and C. M. Schooling. 2016. 
Gestational Age, Birthweight for Gestational Age, and Childhood 
Hospitalisations for Asthma and Other Wheezing Disorders. Paediatr 
Perinat Epidemiol 30: 149-159. 
113. Been, J. V., M. J. Lugtenberg, E. Smets, C. P. van Schayck, B. W. 
Kramer, M. Mommers, and A. Sheikh. 2014. Preterm birth and childhood 
wheezing disorders: a systematic review and meta-analysis. PLoS Med 
11: e1001596. 
114. Hovi, P., S. Andersson, A. L. Jarvenpaa, J. G. Eriksson, S. Strang-
Karlsson, E. Kajantie, and O. Makitie. 2009. Decreased bone mineral 
density in adults born with very low birth weight: a cohort study. PLoS Med 
6: e1000135. 
149 
 
 
115. Fardini, Y., P. Chung, R. Dumm, N. Joshi, and Y. W. Han. 2010. 
Transmission of diverse oral bacteria to murine placenta: evidence for the 
oral microbiome as a potential source of intrauterine infection. Infect 
Immun 78: 1789-1796. 
116. Cohen, D. W., J. Shapiro, L. Friedman, G. C. Kyle, and S. Franklin. 1971. 
A longitudinal investigation of the periodontal changes during pregnancy 
and fifteen months post-partum. II. J Periodontol 42: 653-657. 
117. Gursoy, M., R. Pajukanta, T. Sorsa, and E. Kononen. 2008. Clinical 
changes in periodontium during pregnancy and post-partum. J Clin 
Periodontol 35: 576-583. 
118. Laine, M. A. 2002. Effect of pregnancy on periodontal and dental health. 
Acta Odontol Scand 60: 257-264. 
119. Hugoson, A. 1970. Gingival inflammation and female sex hormones. A 
clinical investigation of pregnant women and experimental studies in dogs. 
J Periodontal Res Suppl 5: 1-18. 
120. Hugoson, A. 1971. Gingivitis in pregnant women. A longitudinal clinical 
study. Odontol Revy 22: 65-84. 
121. Loe, H., and J. Silness. 1963. PERIODONTAL DISEASE IN 
PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand 
21: 533-551. 
122. Silness, J., and H. Loe. 1964. PERIODONTAL DISEASE IN 
PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND 
PERIODONTAL CONDTION. Acta Odontol Scand 22: 121-135. 
123. Kornman, K. S., and W. J. Loesche. 1980. The subgingival microbial flora 
during pregnancy. J Periodontal Res 15: 111-122. 
124. Tilakaratne, A., M. Soory, A. W. Ranasinghe, S. M. Corea, S. L. 
Ekanayake, and M. de Silva. 2000. Periodontal disease status during 
pregnancy and 3 months post-partum, in a rural population of Sri-Lankan 
women. J Clin Periodontol 27: 787-792. 
125. Polyzos, N. P., I. P. Polyzos, A. Zavos, A. Valachis, D. Mauri, E. G. 
Papanikolaou, S. Tzioras, D. Weber, and I. E. Messinis. 2010. Obstetric 
outcomes after treatment of periodontal disease during pregnancy: 
systematic review and meta-analysis. Bmj 341: c7017. 
126. Manau, C., A. Echeverria, A. Agueda, A. Guerrero, and J. J. Echeverria. 
2008. Periodontal disease definition may determine the association 
between periodontitis and pregnancy outcomes. J Clin Periodontol 35: 
385-397. 
127. Xiong, X., P. Buekens, R. L. Goldenberg, S. Offenbacher, and X. Qian. 
2011. Optimal timing of periodontal disease treatment for prevention of 
adverse pregnancy outcomes: before or during pregnancy? Am J Obstet 
Gynecol 205: 111.e111-116. 
150 
 
 
128. Eke, P. I., G. O. Thornton-Evans, L. Wei, W. S. Borgnakke, and B. A. Dye. 
2010. Accuracy of NHANES periodontal examination protocols. J Dent 
Res 89: 1208-1213. 
129. Eke, P. I., B. A. Dye, L. Wei, G. O. Thornton-Evans, and R. J. Genco. 
2012. Prevalence of periodontitis in adults in the United States: 2009 and 
2010. J Dent Res 91: 914-920. 
130. Azofeifa, A., L. F. Yeung, C. J. Alverson, and E. Beltran-Aguilar. 2016. 
Dental caries and periodontal disease among U.S. pregnant women and 
nonpregnant women of reproductive age, National Health and Nutrition 
Examination Survey, 1999-2004. J Public Health Dent 76: 320-329. 
131. Xiong, X., P. Buekens, S. Vastardis, and T. Wu. 2006. Periodontal disease 
as one possible explanation for the Mexican paradox. Med Hypotheses 
67: 1348-1354. 
132. Konopka, T., and A. Paradowska-Stolarz. 2012. Periodontitis and risk of 
preterm birth and low birthweight--a meta-analysis. Ginekol Pol 83: 446-
453. 
133. Shanthi, V., A. Vanka, A. Bhambal, V. Saxena, S. Saxena, and S. S. 
Kumar. 2012. Association of pregnant women periodontal status to 
preterm and low-birth weight babies: A systematic and evidence-based 
review. Dent Res J (Isfahan) 9: 368-380. 
134. Offenbacher, S., J. D. Beck, H. L. Jared, S. M. Mauriello, L. C. Mendoza, 
D. J. Couper, D. D. Stewart, A. P. Murtha, D. L. Cochran, D. J. Dudley, M. 
S. Reddy, N. C. Geurs, and J. C. Hauth. 2009. Effects of periodontal 
therapy on rate of preterm delivery: a randomized controlled trial. Obstet 
Gynecol 114: 551-559. 
135. Macones, G. A., S. Parry, D. B. Nelson, J. F. Strauss, J. Ludmir, A. W. 
Cohen, D. M. Stamilio, D. Appleby, B. Clothier, M. D. Sammel, and M. 
Jeffcoat. 2010. Treatment of localized periodontal disease in pregnancy 
does not reduce the occurrence of preterm birth: results from the 
Periodontal Infections and Prematurity Study (PIPS). Am J Obstet 
Gynecol 202: 147.e141-148. 
136. Michalowicz, B. S., J. S. Hodges, A. J. DiAngelis, V. R. Lupo, M. J. Novak, 
J. E. Ferguson, W. Buchanan, J. Bofill, P. N. Papapanou, D. A. Mitchell, S. 
Matseoane, and P. A. Tschida. 2006. Treatment of periodontal disease 
and the risk of preterm birth. N Engl J Med 355: 1885-1894. 
137. Jeffcoat, M. K., J. C. Hauth, N. C. Geurs, M. S. Reddy, S. P. Cliver, P. M. 
Hodgkins, and R. L. Goldenberg. 2003. Periodontal disease and preterm 
birth: results of a pilot intervention study. J Periodontol 74: 1214-1218. 
138. Newnham, J. P., I. A. Newnham, C. M. Ball, M. Wright, C. E. Pennell, J. 
Swain, and D. A. Doherty. 2009. Treatment of periodontal disease during 
pregnancy: a randomized controlled trial. Obstet Gynecol 114: 1239-1248. 
151 
 
 
139. Kim, A. J., A. J. Lo, D. A. Pullin, D. S. Thornton-Johnson, and N. Y. 
Karimbux. 2012. Scaling and root planing treatment for periodontitis to 
reduce preterm birth and low birth weight: a systematic review and meta-
analysis of randomized controlled trials. J Periodontol 83: 1508-1519. 
140. Lopez, N. J., I. Da Silva, J. Ipinza, and J. Gutierrez. 2005. Periodontal 
therapy reduces the rate of preterm low birth weight in women with 
pregnancy-associated gingivitis. J Periodontol 76: 2144-2153. 
141. Uppal, A., S. Uppal, A. Pinto, M. Dutta, S. Shrivatsa, V. Dandolu, and M. 
Mupparapu. 2010. The effectiveness of periodontal disease treatment 
during pregnancy in reducing the risk of experiencing preterm birth and 
low birth weight: a meta-analysis. J Am Dent Assoc 141: 1423-1434. 
142. Chambrone, L., C. M. Pannuti, M. R. Guglielmetti, and L. A. Chambrone. 
2011. Evidence grade associating periodontitis with preterm birth and/or 
low birth weight: II: a systematic review of randomized trials evaluating the 
effects of periodontal treatment. J Clin Periodontol 38: 902-914. 
143. Aagaard, K., J. Ma, K. M. Antony, R. Ganu, J. Petrosino, and J. 
Versalovic. 2014. The placenta harbors a unique microbiome. Sci Transl 
Med 6: 237ra265. 
144. Aagaard, K. M. 2014. Author response to comment on "the placenta 
harbors a unique microbiome". In Sci Transl Med, United States. 254lr253. 
145. Antony, K. M., J. Ma, K. B. Mitchell, D. A. Racusin, J. Versalovic, and K. 
Aagaard. 2015. The preterm placental microbiome varies in association 
with excess maternal gestational weight gain. Am J Obstet Gynecol 212: 
653.e651-616. 
146. Wassenaar, T. M., and P. Panigrahi. 2014. Is a foetus developing in a 
sterile environment? Lett Appl Microbiol 59: 572-579. 
147. Prince, A. L., J. Ma, P. S. Kannan, M. Alvarez, T. Gisslen, R. A. Harris, E. 
L. Sweeney, C. L. Knox, D. S. Lambers, A. H. Jobe, C. A. Chougnet, S. G. 
Kallapur, and K. M. Aagaard. 2016. The placental membrane microbiome 
is altered among subjects with spontaneous preterm birth with and without 
chorioamnionitis. Am J Obstet Gynecol 214: 627.e621-627.e616. 
148. Hajishengallis, G., R. P. Darveau, and M. A. Curtis. 2012. The keystone-
pathogen hypothesis. Nat Rev Microbiol 10: 717-725. 
149. Darveau, R. P., G. Hajishengallis, and M. A. Curtis. 2012. Porphyromonas 
gingivalis as a potential community activist for disease. J Dent Res 91: 
816-820. 
150. Zenobia, C., and G. Hajishengallis. 2015. Porphyromonas gingivalis 
virulence factors involved in subversion of leukocytes and microbial 
dysbiosis. Virulence 6: 236-243. 
151. Lin, D., M. A. Smith, C. Champagne, J. Elter, J. Beck, and S. Offenbacher. 
2003. Porphyromonas gingivalis infection during pregnancy increases 
152 
 
 
maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, 
and enhances fetal growth restriction and resorption in mice. Infect Immun 
71: 5156-5162. 
152. Lin, D., M. A. Smith, J. Elter, C. Champagne, C. L. Downey, J. Beck, and 
S. Offenbacher. 2003. Porphyromonas gingivalis infection in pregnant 
mice is associated with placental dissemination, an increase in the 
placental Th1/Th2 cytokine ratio, and fetal growth restriction. Infect Immun 
71: 5163-5168. 
153. Arce, R. M., S. P. Barros, B. Wacker, B. Peters, K. Moss, and S. 
Offenbacher. 2009. Increased TLR4 expression in murine placentas after 
oral infection with periodontal pathogens. Placenta 30: 156-162. 
154. Han, Y. W., R. W. Redline, M. Li, L. Yin, G. B. Hill, and T. S. McCormick. 
2004. Fusobacterium nucleatum induces premature and term stillbirths in 
pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 
72: 2272-2279. 
155. Han, Y. W., Y. Fardini, C. Chen, K. G. Iacampo, V. A. Peraino, J. M. 
Shamonki, and R. W. Redline. 2010. Term stillbirth caused by oral 
Fusobacterium nucleatum. Obstet Gynecol 115: 442-445. 
156. Coppenhagen-Glazer, S., A. Sol, J. Abed, R. Naor, X. Zhang, Y. W. Han, 
and G. Bachrach. 2015. Fap2 of Fusobacterium nucleatum is a galactose-
inhibitable adhesin involved in coaggregation, cell adhesion, and preterm 
birth. Infect Immun 83: 1104-1113. 
157. Ikegami, A., P. Chung, and Y. W. Han. 2009. Complementation of the 
fadA mutation in Fusobacterium nucleatum demonstrates that the surface-
exposed adhesin promotes cellular invasion and placental colonization. 
Infect Immun 77: 3075-3079. 
158. Fardini, Y., X. Wang, S. Temoin, S. Nithianantham, D. Lee, M. Shoham, 
and Y. W. Han. 2011. Fusobacterium nucleatum adhesin FadA binds 
vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 
82: 1468-1480. 
159. Liu, H., R. W. Redline, and Y. W. Han. 2007. Fusobacterium nucleatum 
induces fetal death in mice via stimulation of TLR4-mediated placental 
inflammatory response. J Immunol 179: 2501-2508. 
160. Blanc, V., F. O'Valle, E. Pozo, A. Puertas, R. Leon, and F. Mesa. 2015. 
Oral bacteria in placental tissues: increased molecular detection in 
pregnant periodontitis patients. Oral Dis 21: 905-912. 
161. Amarasekara, R., R. W. Jayasekara, H. Senanayake, and V. H. 
Dissanayake. 2015. Microbiome of the placenta in pre-eclampsia supports 
the role of bacteria in the multifactorial cause of pre-eclampsia. J Obstet 
Gynaecol Res 41: 662-669. 
153 
 
 
162. Vanterpool, S. F., J. V. Been, M. L. Houben, P. G. Nikkels, R. R. De 
Krijger, L. J. Zimmermann, B. W. Kramer, A. Progulske-Fox, and L. 
Reyes. 2016. Porphyromonas gingivalis within Placental Villous 
Mesenchyme and Umbilical Cord Stroma Is Associated with Adverse 
Pregnancy Outcome. PLoS One 11: e0146157. 
163. Modlin, R. L. 1994. Th1-Th2 paradigm: insights from leprosy. J Invest 
Dermatol 102: 828-832. 
164. Cheng, W. C., F. J. Hughes, and L. S. Taams. 2014. The presence, 
function and regulation of IL-17 and Th17 cells in periodontitis. J Clin 
Periodontol 41: 541-549. 
165. Stashenko, P., R. B. Goncalves, B. Lipkin, A. Ficarelli, H. Sasaki, and A. 
Campos-Neto. 2007. Th1 immune response promotes severe bone 
resorption caused by Porphyromonas gingivalis. Am J Pathol 170: 203-
213. 
166. Seymour, G. J., E. Gemmell, R. A. Reinhardt, J. Eastcott, and M. A. 
Taubman. 1993. Immunopathogenesis of chronic inflammatory periodontal 
disease: cellular and molecular mechanisms. J Periodontal Res 28: 478-
486. 
167. Gamonal, J., A. Acevedo, A. Bascones, O. Jorge, and A. Silva. 2001. 
Characterization of cellular infiltrate, detection of chemokine receptor 
CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J 
Periodontal Res 36: 194-203. 
168. Taubman, M. A., and T. Kawai. 2001. Involvement of T-lymphocytes in 
periodontal disease and in direct and indirect induction of bone resorption. 
Crit Rev Oral Biol Med 12: 125-135. 
169. Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N. Y. 
Karimbux, R. B. Goncalves, P. Valverde, S. Dibart, Y. P. Li, L. A. Miranda, 
C. W. Ernst, Y. Izumi, and M. A. Taubman. 2006. B and T lymphocytes 
are the primary sources of RANKL in the bone resorptive lesion of 
periodontal disease. Am J Pathol 169: 987-998. 
170. Vernal, R., N. Dutzan, M. Hernandez, S. Chandia, J. Puente, R. Leon, L. 
Garcia, I. Del Valle, A. Silva, and J. Gamonal. 2006. High expression 
levels of receptor activator of nuclear factor-kappa B ligand associated 
with human chronic periodontitis are mainly secreted by CD4+ T 
lymphocytes. J Periodontol 77: 1772-1780. 
171. Han, X., X. Lin, A. R. Seliger, J. Eastcott, T. Kawai, and M. A. Taubman. 
2009. Expression of receptor activator of nuclear factor-kappaB ligand by 
B cells in response to oral bacteria. Oral Microbiol Immunol 24: 190-196. 
172. Han, X., X. Lin, X. Yu, J. Lin, T. Kawai, K. B. LaRosa, and M. A. Taubman. 
2013. Porphyromonas gingivalis infection-associated periodontal bone 
resorption is dependent on receptor activator of NF-kappaB ligand. Infect 
Immun 81: 1502-1509. 
154 
 
 
173. Kotake, S., N. Udagawa, M. Hakoda, M. Mogi, K. Yano, E. Tsuda, K. 
Takahashi, T. Furuya, S. Ishiyama, K. J. Kim, S. Saito, T. Nishikawa, N. 
Takahashi, A. Togari, T. Tomatsu, T. Suda, and N. Kamatani. 2001. 
Activated human T cells directly induce osteoclastogenesis from human 
monocytes: possible role of T cells in bone destruction in rheumatoid 
arthritis patients. Arthritis Rheum 44: 1003-1012. 
174. Lappin, D. F., C. P. MacLeod, A. Kerr, T. Mitchell, and D. F. Kinane. 2001. 
Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis 
granulation tissue. Clin Exp Immunol 123: 294-300. 
175. Seymour, G. J., K. L. Cole, R. N. Powell, E. Lewins, A. W. Cripps, and R. 
L. Clancy. 1985. Interleukin-2 production and bone-resorption activity in 
vitro by unstimulated lymphocytes extracted from chronically-inflamed 
human periodontal tissues. Arch Oral Biol 30: 481-484. 
176. Takeichi, O., J. Haber, T. Kawai, D. J. Smith, I. Moro, and M. A. Taubman. 
2000. Cytokine profiles of T-lymphocytes from gingival tissues with 
pathological pocketing. J Dent Res 79: 1548-1555. 
177. Berglundh, T., B. Liljenberg, and J. Lindhe. 2002. Some cytokine profiles 
of T-helper cells in lesions of advanced periodontitis. J Clin Periodontol 
29: 705-709. 
178. Garlet, G. P., C. R. Cardoso, A. P. Campanelli, T. P. Garlet, M. J. Avila-
Campos, F. Q. Cunha, and J. S. Silva. 2008. The essential role of IFN-
gamma in the control of lethal Aggregatibacter actinomycetemcomitans 
infection in mice. Microbes Infect 10: 489-496. 
179. Myneni, S. R., R. P. Settem, T. D. Connell, A. D. Keegan, S. L. Gaffen, 
and A. Sharma. 2011. TLR2 signaling and Th2 responses drive Tannerella 
forsythia-induced periodontal bone loss. J Immunol 187: 501-509. 
180. Beklen, A., M. Ainola, M. Hukkanen, C. Gurgan, T. Sorsa, and Y. T. 
Konttinen. 2007. MMPs, IL-1, and TNF are regulated by IL-17 in 
periodontitis. J Dent Res 86: 347-351. 
181. Cardoso, C. R., G. P. Garlet, G. E. Crippa, A. L. Rosa, W. M. Junior, M. A. 
Rossi, and J. S. Silva. 2009. Evidence of the presence of T helper type 17 
cells in chronic lesions of human periodontal disease. Oral Microbiol 
Immunol 24: 1-6. 
182. Allam, J. P., Y. Duan, F. Heinemann, J. Winter, W. Gotz, J. Deschner, M. 
Wenghoefer, T. Bieber, S. Jepsen, and N. Novak. 2011. IL-23-producing 
CD68(+) macrophage-like cells predominate within an IL-17-polarized 
infiltrate in chronic periodontitis lesions. J Clin Periodontol 38: 879-886. 
183. Adibrad, M., P. Deyhimi, M. Ganjalikhani Hakemi, P. Behfarnia, M. 
Shahabuei, and L. Rafiee. 2012. Signs of the presence of Th17 cells in 
chronic periodontal disease. J Periodontal Res 47: 525-531. 
155 
 
 
184. Awang, R. A., D. F. Lappin, A. MacPherson, M. Riggio, D. Robertson, P. 
Hodge, G. Ramage, S. Culshaw, P. M. Preshaw, J. Taylor, and C. Nile. 
2014. Clinical associations between IL-17 family cytokines and 
periodontitis and potential differential roles for IL-17A and IL-17E in 
periodontal immunity. Inflamm Res 63: 1001-1012. 
185. Awang, R. A., D. F. Lappin, A. MacPherson, M. Riggio, D. Robertson, P. 
Hodge, G. Ramage, S. Culshaw, P. M. Preshaw, J. Taylor, and C. Nile. 
2015. Erratum to: Clinical associations between IL-17 family cytokines and 
periodontitis and potential differential roles for IL-17A and IL-17E in 
periodontal immunity. Inflamm Res 64: 83. 
186. Gaffen, S. L., and G. Hajishengallis. 2008. A new inflammatory cytokine 
on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in 
the context of Th17 cells and IL-17. J Dent Res 87: 817-828. 
187. Dutzan, N., R. Vernal, J. P. Vaque, J. Garcia-Sesnich, M. Hernandez, L. 
Abusleme, A. Dezerega, J. S. Gutkind, and J. Gamonal. 2012. Interleukin-
21 expression and its association with proinflammatory cytokines in 
untreated chronic periodontitis patients. J Periodontol 83: 948-954. 
188. Moutsopoulos, N. M., H. M. Kling, N. Angelov, W. Jin, R. J. Palmer, S. 
Nares, M. Osorio, and S. M. Wahl. 2012. Porphyromonas gingivalis 
promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun 
39: 294-303. 
189. Eskan, M. A., R. Jotwani, T. Abe, J. Chmelar, J. H. Lim, S. Liang, P. A. 
Ciero, J. L. Krauss, F. Li, M. Rauner, L. C. Hofbauer, E. Y. Choi, K. J. 
Chung, A. Hashim, M. A. Curtis, T. Chavakis, and G. Hajishengallis. 2012. 
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated 
inflammatory bone loss. Nat Immunol 13: 465-473. 
190. Shin, J., T. Maekawa, T. Abe, E. Hajishengallis, K. Hosur, K. Pyaram, I. 
Mitroulis, T. Chavakis, and G. Hajishengallis. 2015. DEL-1 restrains 
osteoclastogenesis and inhibits inflammatory bone loss in nonhuman 
primates. Sci Transl Med 7: 307ra155. 
191. Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, 
R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in 
preventing pathogen-initiated bone destruction: recruitment of neutrophils 
to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 
3794-3802. 
192. Yu, J. J., M. J. Ruddy, H. R. Conti, K. Boonanantanasarn, and S. L. 
Gaffen. 2008. The interleukin-17 receptor plays a gender-dependent role 
in host protection against Porphyromonas gingivalis-induced periodontal 
bone loss. Infect Immun 76: 4206-4213. 
193. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ 
regulatory T cells in immunological tolerance to self and non-self. Nat 
Immunol 6: 345-352. 
156 
 
 
194. Ernst, C. W., J. E. Lee, T. Nakanishi, N. Y. Karimbux, T. M. Rezende, P. 
Stashenko, M. Seki, M. A. Taubman, and T. Kawai. 2007. Diminished 
forkhead box P3/CD25 double-positive T regulatory cells are associated 
with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone 
resorption lesion of periodontal disease. Clin Exp Immunol 148: 271-280. 
195. Garlet, G. P., C. R. Cardoso, F. S. Mariano, M. Claudino, G. F. de Assis, 
A. P. Campanelli, M. J. Avila-Campos, and J. S. Silva. 2010. Regulatory T 
cells attenuate experimental periodontitis progression in mice. J Clin 
Periodontol 37: 591-600. 
196. Parachuru, V. P., D. E. Coates, T. J. Milne, H. M. Hussaini, A. M. Rich, 
and G. J. Seymour. 2014. Forkhead box P3-positive regulatory T-cells and 
interleukin 17-positive T-helper 17 cells in chronic inflammatory 
periodontal disease. J Periodontal Res 49: 817-826. 
197. Kobayashi, R., T. Kono, B. A. Bolerjack, Y. Fukuyama, R. S. Gilbert, K. 
Fujihashi, J. Ruby, K. Kataoka, M. Wada, and M. Yamamoto. 2011. 
Induction of IL-10-producing CD4+ T-cells in chronic periodontitis. J Dent 
Res 90: 653-658. 
198. Nakajima, T., K. Ueki-Maruyama, T. Oda, Y. Ohsawa, H. Ito, G. J. 
Seymour, and K. Yamazaki. 2005. Regulatory T-cells infiltrate periodontal 
disease tissues. J Dent Res 84: 639-643. 
199. Krishnan, L., L. J. Guilbert, A. S. Russell, T. G. Wegmann, T. R. 
Mosmann, and M. Belosevic. 1996. Pregnancy impairs resistance of 
C57BL/6 mice to Leishmania major infection and causes decreased 
antigen-specific IFN-gamma response and increased production of T 
helper 2 cytokines. J Immunol 156: 644-652. 
200. Krishnan, L., L. J. Guilbert, T. G. Wegmann, M. Belosevic, and T. R. 
Mosmann. 1996. T helper 1 response against Leishmania major in 
pregnant C57BL/6 mice increases implantation failure and fetal 
resorptions. Correlation with increased IFN-gamma and TNF and reduced 
IL-10 production by placental cells. J Immunol 156: 653-662. 
201. Liu, Z., Q. H. Sun, Y. Yang, J. M. Liu, and J. P. Peng. 2003. Effect of 
IFNgamma on caspase-3, Bcl-2 and Bax expression, and apoptosis in 
rabbit placenta. Cytokine 24: 201-209. 
202. Liu, Z., Y. Chen, Y. Yang, and J. P. Peng. 2002. The effect on MHC class 
II expression and apoptosis in placenta by IFNgamma administration. 
Contraception 65: 177-184. 
203. Almeria, S., R. Araujo, W. Tuo, F. Lopez-Gatius, J. P. Dubey, and L. C. 
Gasbarre. 2010. Fetal death in cows experimentally infected with 
Neospora caninum at 110 days of gestation. Vet Parasitol 169: 304-311. 
204. Serrano-Perez, B., I. Garcia-Ispierto, N. M. de Sousa, J. F. Beckers, S. 
Almeria, and F. Lopez-Gatius. 2014. Gamma interferon production and 
plasma concentrations of pregnancy-associated glycoproteins 1 and 2 in 
157 
 
 
gestating dairy cows naturally infected with Neospora caninum. Reprod 
Domest Anim 49: 275-280. 
205. Lopez-Gatius, F., S. Almeria, G. Donofrio, C. Nogareda, I. Garcia-Ispierto, 
G. Bech-Sabat, P. Santolaria, J. L. Yaniz, M. Pabon, N. M. de Sousa, and 
J. F. Beckers. 2007. Protection against abortion linked to gamma 
interferon production in pregnant dairy cows naturally infected with 
Neospora caninum. Theriogenology 68: 1067-1073. 
206. Sun, Q. H., J. P. Peng, H. F. Xia, and Y. Yang. 2007. IFN-gamma 
promotes apoptosis of the uterus and placenta in pregnant rat and human 
cytotrophoblast cells. J Interferon Cytokine Res 27: 567-578. 
207. Almeida, A., G. Correia-da-Silva, M. Cepa, S. C. Bell, and N. A. Teixeira. 
2007. Synergistic induction of apoptosis in primary rat decidual cells by 
INF-gamma and TNF. Mol Reprod Dev 74: 371-377. 
208. Bell, M. J., J. M. Hallenbeck, and V. Gallo. 2004. Determining the fetal 
inflammatory response in an experimental model of intrauterine 
inflammation in rats. Pediatr Res 56: 541-546. 
209. Collins, J. G., H. W. Windley, 3rd, R. R. Arnold, and S. Offenbacher. 1994. 
Effects of a Porphyromonas gingivalis infection on inflammatory mediator 
response and pregnancy outcome in hamsters. Infect Immun 62: 4356-
4361. 
210. Collins, J. G., M. A. Smith, R. R. Arnold, and S. Offenbacher. 1994. 
Effects of Escherichia coli and Porphyromonas gingivalis 
lipopolysaccharide on pregnancy outcome in the golden hamster. Infect 
Immun 62: 4652-4655. 
211. Wang, F., M. Xiao, R. J. Chen, X. J. Lin, M. Siddiq, and L. Liu. 2017. 
Adoptive transfer of T regulatory cells inhibits lipopolysaccharide-induced 
inflammation in fetal brain tissue in a late-pregnancy preterm birth mouse 
model. Cell Biol Int 41: 155-162. 
212. Costalonga, M., L. Batas, and B. J. Reich. 2009. Effects of Toll-like 
receptor 4 on Porphyromonas gingivalis-induced bone loss in mice. J 
Periodontal Res 44: 537-542. 
213. Heinzel, F. P., M. D. Sadick, S. S. Mutha, and R. M. Locksley. 1991. 
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 
10 by CD4+ lymphocytes in vivo during healing and progressive murine 
leishmaniasis. Proc Natl Acad Sci U S A 88: 7011-7015. 
214. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. 
Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 
4 during the resolution or progression of murine leishmaniasis. Evidence 
for expansion of distinct helper T cell subsets. J Exp Med 169: 59-72. 
215. Ivanov, II, L. Frutos Rde, N. Manel, K. Yoshinaga, D. B. Rifkin, R. B. 
Sartor, B. B. Finlay, and D. R. Littman. 2008. Specific microbiota direct the 
158 
 
 
differentiation of IL-17-producing T-helper cells in the mucosa of the small 
intestine. Cell Host Microbe 4: 337-349. 
216. McAleer, J. P., N. L. Nguyen, K. Chen, P. Kumar, D. M. Ricks, M. Binnie, 
R. A. Armentrout, D. A. Pociask, A. Hein, A. Yu, A. Vikram, K. Bibby, Y. 
Umesaki, A. Rivera, D. Sheppard, W. Ouyang, L. V. Hooper, and J. K. 
Kolls. 2016. Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut 
Microbiome. J Immunol 197: 97-107. 
217. Wu, H. J., Ivanov, II, J. Darce, K. Hattori, T. Shima, Y. Umesaki, D. R. 
Littman, C. Benoist, and D. Mathis. 2010. Gut-residing segmented 
filamentous bacteria drive autoimmune arthritis via T helper 17 cells. 
Immunity 32: 815-827. 
218. Teng, F., C. N. Klinger, K. M. Felix, C. P. Bradley, E. Wu, N. L. Tran, Y. 
Umesaki, and H. J. Wu. 2016. Gut Microbiota Drive Autoimmune Arthritis 
by Promoting Differentiation and Migration of Peyer's Patch T Follicular 
Helper Cells. Immunity 44: 875-888. 
219. Kriegel, M. A., E. Sefik, J. A. Hill, H. J. Wu, C. Benoist, and D. Mathis. 
2011. Naturally transmitted segmented filamentous bacteria segregate 
with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U 
S A 108: 11548-11553. 
220. Simon, M. M., S. Greenaway, J. K. White, H. Fuchs, V. Gailus-Durner, S. 
Wells, T. Sorg, K. Wong, E. Bedu, E. J. Cartwright, R. Dacquin, S. Djebali, 
J. Estabel, J. Graw, N. J. Ingham, I. J. Jackson, A. Lengeling, S. Mandillo, 
J. Marvel, H. Meziane, F. Preitner, O. Puk, M. Roux, D. J. Adams, S. 
Atkins, A. Ayadi, L. Becker, A. Blake, D. Brooker, H. Cater, M. F. Champy, 
R. Combe, P. Danecek, A. di Fenza, H. Gates, A. K. Gerdin, E. Golini, J. 
M. Hancock, W. Hans, S. M. Holter, T. Hough, P. Jurdic, T. M. Keane, H. 
Morgan, W. Muller, F. Neff, G. Nicholson, B. Pasche, L. A. Roberson, J. 
Rozman, M. Sanderson, L. Santos, M. Selloum, C. Shannon, A. 
Southwell, G. P. Tocchini-Valentini, V. E. Vancollie, H. Westerberg, W. 
Wurst, M. Zi, B. Yalcin, R. Ramirez-Solis, K. P. Steel, A. M. Mallon, M. H. 
de Angelis, Y. Herault, and S. D. Brown. 2013. A comparative phenotypic 
and genomic analysis of C57BL/6J and C57BL/6N mouse strains. 
Genome Biol 14: R82. 
221. Fontaine, D. A., and D. B. Davis. 2016. Attention to Background Strain Is 
Essential for Metabolic Research: C57BL/6 and the International Knockout 
Mouse Consortium. Diabetes 65: 25-33. 
222. Kawedia, J. D., L. Janke, A. J. Funk, L. B. Ramsey, C. Liu, D. Jenkins, K. 
L. Boyd, and M. V. Relling. 2012. Substrain-specific differences in survival 
and osteonecrosis incidence in a mouse model. Comp Med 62: 466-471. 
223. Nicholson, S. M., J. D. Peterson, S. D. Miller, K. Wang, M. C. Dal Canto, 
and R. W. Melvold. 1994. BALB/c substrain differences in susceptibility to 
159 
 
 
Theiler's murine encephalomyelitis virus-induced demyelinating disease. J 
Neuroimmunol 52: 19-24. 
224. Bittner-Eddy, P. D., L. A. Fischer, D. H. Kaplan, K. Thieu, and M. 
Costalonga. 2016. Mucosal Langerhans Cells Promote Differentiation of 
Th17 Cells in a Murine Model of Periodontitis but Are Not Required for 
Porphyromonas gingivalis-Driven Alveolar Bone Destruction. J Immunol 
197: 1435-1446. 
225. Ashimoto, A., C. Chen, I. Bakker, and J. Slots. 1996. Polymerase chain 
reaction detection of 8 putative periodontal pathogens in subgingival 
plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol 
Immunol 11: 266-273. 
226. Slots, J., A. Ashimoto, M. J. Flynn, G. Li, and C. Chen. 1995. Detection of 
putative periodontal pathogens in subgingival specimens by 16S 
ribosomal DNA amplification with the polymerase chain reaction. Clin 
Infect Dis 20 Suppl 2: S304-307. 
227. Boggess, K. A., P. N. Madianos, J. S. Preisser, K. J. Moise, Jr., and S. 
Offenbacher. 2005. Chronic maternal and fetal Porphyromonas gingivalis 
exposure during pregnancy in rabbits. Am J Obstet Gynecol 192: 554-557. 
228. Novak, M. J., K. F. Novak, J. S. Hodges, S. Kirakodu, M. Govindaswami, 
A. Diangelis, W. Buchanan, P. N. Papapanou, and B. S. Michalowicz. 
2008. Periodontal bacterial profiles in pregnant women: response to 
treatment and associations with birth outcomes in the obstetrics and 
periodontal therapy (OPT) study. J Periodontol 79: 1870-1879. 
229. Yin, Y., Y. Wang, L. Zhu, W. Liu, N. Liao, M. Jiang, B. Zhu, H. D. Yu, C. 
Xiang, and X. Wang. 2013. Comparative analysis of the distribution of 
segmented filamentous bacteria in humans, mice and chickens. Isme j 7: 
615-621. 
230. Zurita, E., M. Chagoyen, M. Cantero, R. Alonso, A. Gonzalez-Neira, A. 
Lopez-Jimenez, J. A. Lopez-Moreno, C. P. Landel, J. Benitez, F. Pazos, 
and L. Montoliu. 2011. Genetic polymorphisms among C57BL/6 mouse 
inbred strains. Transgenic Res 20: 481-489. 
231. Baccaglini, L. 2011. A meta-analysis of randomized controlled trials shows 
no evidence that periodontal treatment during pregnancy prevents 
adverse pregnancy outcomes. J Am Dent Assoc 142: 1192-1193. 
232. Ashkar, A. A., and B. A. Croy. 2001. Functions of uterine natural killer cells 
are mediated by interferon gamma production during murine pregnancy. 
Semin Immunol 13: 235-241. 
233. Murphy, S. P., L. D. Fast, N. N. Hanna, and S. Sharma. 2005. Uterine NK 
cells mediate inflammation-induced fetal demise in IL-10-null mice. J 
Immunol 175: 4084-4090. 
160 
 
 
234. Vigano, P., B. Gaffuri, E. Somigliana, M. Infantino, M. Vignali, and A. M. Di 
Blasio. 2001. Interleukin-10 is produced by human uterine natural killer 
cells but does not affect their production of interferon-gamma. Mol Hum 
Reprod 7: 971-977. 
235. Regal, J. F., J. S. Gilbert, and R. M. Burwick. 2015. The complement 
system and adverse pregnancy outcomes. Mol Immunol 67: 56-70. 
236. Ogunremi, O., H. Tabel, E. Kremmer, and M. Wasiliu. 1993. Differences in 
the activity of the alternative pathway of complement in BALB/c and 
C57Bl/6 mice. Exp Clin Immunogenet 10: 31-37. 
237. Potempa, M., J. Potempa, M. Okroj, K. Popadiak, S. Eick, K. A. Nguyen, 
K. Riesbeck, and A. M. Blom. 2008. Binding of complement inhibitor C4b-
binding protein contributes to serum resistance of Porphyromonas 
gingivalis. J Immunol 181: 5537-5544. 
238. Parthiban, P., and J. Mahendra. 2015. Toll-Like Receptors: A Key Marker 
for Periodontal Disease and Preterm Birth - A Contemporary Review. J 
Clin Diagn Res 9: Ze14-17. 
239. Noguchi, T., T. Sado, K. Naruse, H. Shigetomi, A. Onogi, S. Haruta, R. 
Kawaguchi, A. Nagai, Y. Tanase, S. Yoshida, T. Kitanaka, H. Oi, and H. 
Kobayashi. 2010. Evidence for activation of Toll-like receptor and receptor 
for advanced glycation end products in preterm birth. Mediators Inflamm 
2010: 490406. 
240. Allam, A. B., M. von Chamier, M. B. Brown, and L. Reyes. 2014. Immune 
profiling of BALB/C and C57BL/6 mice reveals a correlation between 
Ureaplasma parvum-Induced fetal inflammatory response syndrome-like 
pathology and increased placental expression of TLR2 and CD14. Am J 
Reprod Immunol 71: 241-251. 
241. Kang, X., X. Zhang, Z. Liu, H. Xu, T. Wang, L. He, and A. Zhao. 2015. 
Excessive TLR9 signaling contributes to the pathogenesis of spontaneous 
abortion through impairment of Treg cell survival by activation of Caspase 
8/3. Int Immunopharmacol 29: 285-292. 
242. Karody, V. R., M. Le, S. Nelson, K. Meskin, S. Klemm, P. Simpson, R. 
Hines, and V. Sampath. 2013. A TIR domain receptor-associated protein 
(TIRAP) variant SNP (rs8177374) confers protection against premature 
birth. J Perinatol 33: 341-346. 
243. Karody, V., S. Reese, N. Kumar, J. Liedel, J. Jarzembowski, and V. 
Sampath. 2016. A toll-like receptor 9 (rs352140) variant is associated with 
placental inflammation in newborn infants. J Matern Fetal Neonatal Med 
29: 2210-2216. 
244. Moco, N. P., L. F. Martin, A. C. Pereira, J. Polettini, J. C. Peracoli, K. I. 
Coelho, and M. G. da Silva. 2013. Gene expression and protein 
localization of TLR-1, -2, -4 and -6 in amniochorion membranes of 
161 
 
 
pregnancies complicated by histologic chorioamnionitis. Eur J Obstet 
Gynecol Reprod Biol 171: 12-17. 
245. Salminen, A., R. Paananen, R. Vuolteenaho, J. Metsola, M. Ojaniemi, H. 
Autio-Harmainen, and M. Hallman. 2008. Maternal endotoxin-induced 
preterm birth in mice: fetal responses in toll-like receptors, collectins, and 
cytokines. Pediatr Res 63: 280-286. 
246. Khattab, A., P. G. Kremsner, and S. Meri. 2013. Complement activation in 
primiparous women from a malaria endemic area is associated with 
reduced birthweight. Placenta 34: 162-167. 
247. Arce, R. M., K. M. Caron, S. P. Barros, and S. Offenbacher. 2012. Toll-like 
receptor 4 mediates intrauterine growth restriction after systemic 
Campylobacter rectus infection in mice. Mol Oral Microbiol 27: 373-381. 
248. Hasegawa-Nakamura, K., F. Tateishi, T. Nakamura, Y. Nakajima, K. 
Kawamata, T. Douchi, M. Hatae, and K. Noguchi. 2011. The possible 
mechanism of preterm birth associated with periodontopathic 
Porphyromonas gingivalis. J Periodontal Res 46: 497-504. 
249. Abrahams, V. M., J. A. Potter, G. Bhat, M. R. Peltier, G. Saade, and R. 
Menon. 2013. Bacterial modulation of human fetal membrane Toll-like 
receptor expression. Am J Reprod Immunol 69: 33-40. 
250. Liu, T., T. Matsuguchi, N. Tsuboi, T. Yajima, and Y. Yoshikai. 2002. 
Differences in expression of toll-like receptors and their reactivities in 
dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 70: 6638-6645. 
251. Hajishengallis, G., and J. D. Lambris. 2012. Complement and dysbiosis in 
periodontal disease. Immunobiology 217: 1111-1116. 
252. Hajishengallis, G., and J. D. Lambris. 2016. More than complementing 
Tolls: complement-Toll-like receptor synergy and crosstalk in innate 
immunity and inflammation. Immunol Rev 274: 233-244. 
253. Darveau, R. P., T. T. Pham, K. Lemley, R. A. Reife, B. W. Bainbridge, S. 
R. Coats, W. N. Howald, S. S. Way, and A. M. Hajjar. 2004. 
Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A 
species that functionally interact with both toll-like receptors 2 and 4. Infect 
Immun 72: 5041-5051. 
254. Hajishengallis, G. 2011. Immune evasion strategies of Porphyromonas 
gingivalis. J Oral Biosci 53: 233-240. 
255. Olsen, I., and G. Hajishengallis. 2016. Major neutrophil functions 
subverted by Porphyromonas gingivalis. J Oral Microbiol 8: 30936. 
256. Ari, G., S. Cherukuri, and A. Namasivayam. 2016. Epigenetics and 
Periodontitis: A Contemporary Review. J Clin Diagn Res 10: Ze07-ze09. 
257. Knight, A. K., and A. K. Smith. 2016. Epigenetic Biomarkers of Preterm 
Birth and Its Risk Factors. Genes (Basel) 7. 
162 
 
 
258. Mallia, T., A. Grech, A. Hili, J. Calleja Agius, and N. P. Pace. 2017. 
Genetic determinants of low birth weight. Minerva Ginecol. 
259. Toure, D. M., W. ElRayes, D. Barnes-Josiah, T. Hartman, D. Klinkebiel, 
and L. Baccaglini. 2017. Epigenetic modifications of human placenta 
associated with preterm birth: a systematic review. J Matern Fetal 
Neonatal Med: 1-12. 
260. Furusawa, Y., Y. Obata, and K. Hase. 2015. Commensal microbiota 
regulates T cell fate decision in the gut. Semin Immunopathol 37: 17-25. 
261. Umesaki, Y., H. Setoyama, S. Matsumoto, A. Imaoka, and K. Itoh. 1999. 
Differential roles of segmented filamentous bacteria and clostridia in 
development of the intestinal immune system. Infect Immun 67: 3504-
3511. 
262. Ivanov, II, K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. 
Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, T. Tanoue, A. Imaoka, K. 
Itoh, K. Takeda, Y. Umesaki, K. Honda, and D. R. Littman. 2009. Induction 
of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-
498. 
263. Atarashi, K., T. Tanoue, and K. Honda. 2010. Induction of lamina propria 
Th17 cells by intestinal commensal bacteria. Vaccine 28: 8036-8038. 
264. Farkas, A. M., C. Panea, Y. Goto, G. Nakato, M. Galan-Diez, S. 
Narushima, K. Honda, and Ivanov, II. 2015. Induction of Th17 cells by 
segmented filamentous bacteria in the murine intestine. J Immunol 
Methods 421: 104-111. 
265. Ivanov, II, and D. R. Littman. 2010. Segmented filamentous bacteria take 
the stage. Mucosal Immunol 3: 209-212. 
266. Giacaman, R. A., A. C. Asrani, K. F. Ross, and M. C. Herzberg. 2009. 
Cleavage of protease-activated receptors on an immortalized oral 
epithelial cell line by Porphyromonas gingivalis gingipains. Microbiology 
155: 3238-3246. 
267. Nakayama, K., T. Kadowaki, K. Okamoto, and K. Yamamoto. 1995. 
Construction and characterization of arginine-specific cysteine proteinase 
(Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence 
for significant contribution of Arg-gingipain to virulence. J Biol Chem 270: 
23619-23626. 
268. Shi, Y., D. B. Ratnayake, K. Okamoto, N. Abe, K. Yamamoto, and K. 
Nakayama. 1999. Genetic analyses of proteolysis, hemoglobin binding, 
and hemagglutination of Porphyromonas gingivalis. Construction of 
mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem 
274: 17955-17960. 
269. Okamoto, K., K. Nakayama, T. Kadowaki, N. Abe, D. B. Ratnayake, and 
K. Yamamoto. 1998. Involvement of a lysine-specific cysteine proteinase 
163 
 
 
in hemoglobin adsorption and heme accumulation by Porphyromonas 
gingivalis. J Biol Chem 273: 21225-21231. 
270. Potempa, J., A. Banbula, and J. Travis. 2000. Role of bacterial 
proteinases in matrix destruction and modulation of host responses. 
Periodontol 2000 24: 153-192. 
 
 
 
 
 
 
 
